##fileformat=VCFv4.1
##fileDate=20150410
##source=Ingenuity VCS 3.1.20140729
##LabTestID=Abc,Abc(P-0002409-N01)
##reference=NCBIb37
##INFO=<ID=GENE_REGION,Number=.,Type=String,Description="Gene region containing variant,Header=Gene Region">
##INFO=<ID=GENE_SYMBOL,Number=.,Type=String,Description="Gene containing variant,Header=Gene Symbol">
##INFO=<ID=TRANSCRIPT_ID,Number=.,Type=String,Description="Transcript containing variant,Header=Transcript ID">
##INFO=<ID=HGVS_TRANSCRIPT,Number=.,Type=String,Description="HGVS transcript variant,Header=Transcript Variant">
##INFO=<ID=HGVS_PROTEIN,Number=.,Type=String,Description="HGVS protein variant,Header=Protein Variant">
##INFO=<ID=TRANSLATION_IMPACT,Number=.,Type=String,Description="Translation impact,Header=Translation Impact">
##INFO=<ID=SIFT_FUNCTION,Number=.,Type=String,Description="SIFT functional prediction,Source=SIFT,Version=01/2013,Header=SIFT Function Prediction">
##INFO=<ID=POLYPHEN_FUNCTION,Number=.,Type=String,Description="PolyPhen-2 functional prediction,Source=Polyphen-2,Version=HumVar Training set 2011_12,Header=PolyPhen-2 Function Prediction">
##INFO=<ID=BLOSUM50,Number=.,Type=Float,Description="BLOSUM50 biochemical conservation score">
##INFO=<ID=PHYLOP,Number=.,Type=Float,Description="PhyloP vertebrate conservation p-value,Source=PhyloP,Version=hg19 (01/2009),Header=Conservation phyloP p-value">
##INFO=<ID=ING_FINDINGS,Number=.,Type=Float,Description="Ingenuity variant findings,Source=Ingenuity Knowledge Base,Version=Dagobah 141227.000">
##INFO=<ID=ING_CLASSIFICATION,Number=.,Type=String,Description="Ingenuity computed clinical classification,Header=Classification">
##INFO=<ID=AFC_AF,Number=.,Type=Float,Description="Allele Frequency Community allele frequency (percent),Source=QIAGEN,Version=20150115,Header=Community Frequency">
##INFO=<ID=DBSNP,Number=.,Type=String,Description="dbSNP identifiers,Source=dbSNP,Version=141,Header=dbSNP ID">
##INFO=<ID=1000G_AF,Number=.,Type=Float,Description="1000 Genomes project allele frequency (percent),Source=1000 Genomes,Version=5,Header=1000 Genomes Frequency">
##INFO=<ID=ESP_AF,Number=.,Type=Float,Description="Exome Server Project allele frequency (percent),Source=EVS,Version=v0.0.30,Header=NHLBI ESP Frequency">
##INFO=<ID=ESP_AF_AA,Number=.,Type=Float,Description="Exome Server Project African American allele frequency (percent),Source=EVS,Version=v0.0.30,Header=NHLBI ESP African Frequency">
##INFO=<ID=ESP_AF_EA,Number=.,Type=Float,Description="Exome Server Project European American allele frequency (percent),Source=EVS,Version=v0.0.30,Header=NHLBI ESP European Frequency">
##INFO=<ID=ING_DRUGGED_GENE,Number=.,Type=String,Description="Does an approved drug target this gene?,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=ING_PGX_DRUGS,Number=.,Type=String,Description="Approved drug(s) with a pharmacogenetic effect,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=ESP_PUBLIC_HOMOZYGOTES,Number=.,Type=Float,Description="Exome Server Project homozygotes,Source=EVS,Version=v0.0.29">
##INFO=<ID=ING_MIN_PROTEIN_LENGTH,Number=.,Type=Float,Description="Minimal functional protein length">
##INFO=<ID=ING_COMPLEX_VARIANT,Number=.,Type=String,Description="Do any variant findings indicate variant contributes to complex genetics,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=CLINVAR_OBSERVATIONS,Number=.,Type=Float,Description="Number of individuals reported with this variant in ClinVar,Source=ClinVar,Version=08/07/2014">
##INFO=<ID=CLINVAR,Number=.,Type=String,Description="Reference ClinVar accession,Source=ClinVar,Version=08/07/2014">
##INFO=<ID=ING_AFFECTED,Number=.,Type=Float,Description="Number of affected individuals with variant reported in the literature,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=ING_AFFECTED_HOM,Number=.,Type=Float,Description="Number of affected homozygous individuals for variant reported in the literature,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=ING_UNAFFECTED,Number=.,Type=Float,Description="Number of unaffected individuals with variant reported in the literature,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=PUBMED,Number=.,Type=String,Description="PubMed identifiers for articles about this variant">
##INFO=<ID=ING_FUNCTIONAL_VALIDATION,Number=.,Type=String,Description="Type of functional validation observed">
##INFO=<ID=ING_DISCORDANT_FAMILIES,Number=.,Type=Float,Description="Number of families with affected individuals who lack claimed causal variant,Source=Ingenuity Knowledge Base,Version=Camelot 141004.000">
##INFO=<ID=ING_PHENOTYPE,Number=.,Type=String,Description="Phenotype for variant assessment">
##INFO=<ID=CLI_ASSESSMENT,Number=.,Type=String,Description="Laboratory assessment of variant">
##INFO=<ID=CLI_REPORTABLE,Number=.,Type=String,Description="Whether and where variant should be included in report">
##INFO=<ID=END,Number=1,Type=Integer,Description="End position of the variant described in this record">
##INFO=<ID=SVLEN,Number=.,Type=Integer,Description="Difference in length between REF and ALT alleles">
##INFO=<ID=SVTYPE,Number=1,Type=String,Description="Type of structural variant">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=CQ,Number=1,Type=Integer,Description="Call Quality">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=AF,Number=1,Type=Integer,Description="Allele Frequency">
##FORMAT=<ID=ING_CH,Number=1,Type=String,Description="Ingenuity Inferred Compound Heterozygous">
##FORMAT=<ID=ING_IA,Number=1,Type=String,Description="Ingenuity Inferred Activity">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	P-0002409-N01
chr1	17359676	.	C	A	.	PASS	DBSNP="1022580, 386511175";1000G_AF=95.91;ESP_AF=95.23;ESP_AF_AA=91.24;ESP_AF_EA=97.28;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=paraganglioma;ESP_PUBLIC_HOMOZYGOTES=5904;ING_AFFECTED=11;ING_AFFECTED_HOM=1;ING_UNAFFECTED=52;PUBMED=23079201,17848412;TRANSCRIPT_ID=NM_003000.2;HGVS_TRANSCRIPT=c.201-36G>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHB	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	17371223	.	C	T	.	PASS	DBSNP=2647169;1000G_AF=10.62;ESP_AF=10.78;ESP_AF_AA=16.61;ESP_AF_EA=7.79;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=paraganglioma;ESP_PUBLIC_HOMOZYGOTES=87;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=3;PUBMED=16912137,19215943,17102081;TRANSCRIPT_ID=NM_003000.2;HGVS_TRANSCRIPT=c.200+33G>A;GENE_REGION=Intronic;GENE_SYMBOL=SDHB	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	17380497	.	G	T	.	PASS	DBSNP=2746462;1000G_AF=95.71;ESP_AF=95.15;ESP_AF_AA=90.94;ESP_AF_EA=97.30;ING_FINDINGS=12;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=paraganglioma;ESP_PUBLIC_HOMOZYGOTES=5893;ING_AFFECTED=30;ING_AFFECTED_HOM=2;ING_UNAFFECTED=52;PUBMED=19768395,20505258,23079201,22566157,23407919,17848412;TRANSCRIPT_ID=NM_003000.2;HGVS_TRANSCRIPT=c.18C>A;HGVS_PROTEIN=p.A6A;GENE_REGION=Exonic;GENE_SYMBOL=SDHB;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=281	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001293191.1;HGVS_TRANSCRIPT=c.1426-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001048171.1;HGVS_TRANSCRIPT=c.1435-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001293196.1;HGVS_TRANSCRIPT=c.1117-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001048172.1;HGVS_TRANSCRIPT=c.1396-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001293192.1;HGVS_TRANSCRIPT=c.1117-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_012222.2;HGVS_TRANSCRIPT=c.1468-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001048174.1;HGVS_TRANSCRIPT=c.1393-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001128425.1;HGVS_TRANSCRIPT=c.1477-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001293190.1;HGVS_TRANSCRIPT=c.1438-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001293195.1;HGVS_TRANSCRIPT=c.1393-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45796269	.	G	C	.	PASS	DBSNP=3219493;1000G_AF=93.53;ESP_AF=92.63;ESP_AF_AA=95.55;ESP_AF_EA=91.13;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5582;ING_AFFECTED=120;ING_AFFECTED_HOM=26;PUBMED=14579148,16774938,24799981,16645203,17956577,15943555,16557584;TRANSCRIPT_ID=NM_001048173.1;HGVS_TRANSCRIPT=c.1393-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001293191.1;HGVS_TRANSCRIPT=c.963G>C;HGVS_PROTEIN=p.Q321H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=533	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001048171.1;HGVS_TRANSCRIPT=c.972G>C;HGVS_PROTEIN=p.Q324H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000131427.1;ING_MIN_PROTEIN_LENGTH=536	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001293196.1;HGVS_TRANSCRIPT=c.654G>C;HGVS_PROTEIN=p.Q218H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=430	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001048172.1;HGVS_TRANSCRIPT=c.933G>C;HGVS_PROTEIN=p.Q311H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=523	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001293192.1;HGVS_TRANSCRIPT=c.654G>C;HGVS_PROTEIN=p.Q218H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=430	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_012222.2;HGVS_TRANSCRIPT=c.1005G>C;HGVS_PROTEIN=p.Q335H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=547	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001048174.1;HGVS_TRANSCRIPT=c.930G>C;HGVS_PROTEIN=p.Q310H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=522	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001128425.1;HGVS_TRANSCRIPT=c.1014G>C;HGVS_PROTEIN=p.Q338H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=550	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001293190.1;HGVS_TRANSCRIPT=c.975G>C;HGVS_PROTEIN=p.Q325H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=537	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001293195.1;HGVS_TRANSCRIPT=c.930G>C;HGVS_PROTEIN=p.Q310H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=522	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45797505	.	C	G	.	PASS	DBSNP=3219489;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=31.35;ESP_AF=25.41;ESP_AF_AA=26.37;ESP_AF_EA=24.92;ING_FINDINGS=246;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=425;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5566;ING_AFFECTED_HOM=1118;ING_UNAFFECTED=309;PUBMED=21777424,19479711,18271935,22922830,14991577,16395669,17524638,15761860,16408224,18844936,19536092,14579148,22176645,19443904,18422726,18534194,22469746,18547414,17207658,20571908,20149637,25069792,24036326,24289550,21355073,17122612,24728327,17931073,15180946,17108146,21287799,16134147,22466227,16134146,16774938,19279422,19161591,20063264,24039736,20663686,17949294,19338676,12707038,21195504,17220334,18776649,17219200,22780951,19300419,17219385,23443124,15943555,18091433,19888426,16941501,17368238,17161978,16081110,22469480,19506731,11295288,18270339,23460202,12606733,20843780,16574953,17031395,16465622,16287072,19623759,24799981,16645203,22788377,15205355,17252231,15523092,18823566,23618615,22641385,23499241,22926731,22720119,16616356,15366000,19836313,22473953,22297469,22703879;ING_FUNCTIONAL_VALIDATION=loss;TRANSCRIPT_ID=NM_001048173.1;HGVS_TRANSCRIPT=c.930G>C;HGVS_PROTEIN=p.Q310H;GENE_REGION=Exonic;GENE_SYMBOL=MUTYH;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=522	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001293191.1;HGVS_TRANSCRIPT=c.453+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001048171.1;HGVS_TRANSCRIPT=c.462+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001293196.1;HGVS_TRANSCRIPT=c.144+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001048172.1;HGVS_TRANSCRIPT=c.423+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001293192.1;HGVS_TRANSCRIPT=c.144+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_012222.2;HGVS_TRANSCRIPT=c.495+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001048174.1;HGVS_TRANSCRIPT=c.420+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001128425.1;HGVS_TRANSCRIPT=c.504+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001293190.1;HGVS_TRANSCRIPT=c.465+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001293195.1;HGVS_TRANSCRIPT=c.420+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	45798555	.	T	C	.	PASS	DBSNP="3219487, 386581188";1000G_AF=93.71;ESP_AF=93.03;ESP_AF_AA=96.60;ESP_AF_EA=91.20;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=5633;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=312;ING_AFFECTED_HOM=30;PUBMED=15180946,21287799,14579148,17417778,16774938,24799981,16645203,17956577,16557584;TRANSCRIPT_ID=NM_001048173.1;HGVS_TRANSCRIPT=c.420+35A>G;GENE_REGION=Intronic;GENE_SYMBOL=MUTYH	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	115251319	.	C	T	.	PASS	DBSNP=9724641;1000G_AF=4.83;ESP_AF=5.71;ESP_AF_AA=16.77;ESP_AF_EA=0.05;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=66;TRANSCRIPT_ID=NM_002524.4;HGVS_TRANSCRIPT=c.451-44G>A;GENE_REGION=Intronic;GENE_SYMBOL=NRAS	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr1	161284224	.	A	AGT	.	PASS	DBSNP=75726722;1000G_AF=16.97;ESP_AF=11.22;ESP_AF_AA=20.84;ESP_AF_EA=6.25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=97;TRANSCRIPT_ID=NM_001278172.1;HGVS_TRANSCRIPT=c.20+9_20+10insGT;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161284224	.	A	AGT	.	PASS	DBSNP=75726722;1000G_AF=16.97;ESP_AF=11.22;ESP_AF_AA=20.84;ESP_AF_EA=6.25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=97;TRANSCRIPT_ID=NM_001035512.1;HGVS_TRANSCRIPT=c.20+9_20+10insGT;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161284224	.	A	AGT	.	PASS	DBSNP=75726722;1000G_AF=16.97;ESP_AF=11.22;ESP_AF_AA=20.84;ESP_AF_EA=6.25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=97;TRANSCRIPT_ID=NM_001035513.1;HGVS_TRANSCRIPT=c.20+9_20+10insGT;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161284224	.	A	AGT	.	PASS	DBSNP=75726722;1000G_AF=16.97;ESP_AF=11.22;ESP_AF_AA=20.84;ESP_AF_EA=6.25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=97;TRANSCRIPT_ID=NM_001035511.1;HGVS_TRANSCRIPT=c.20+9_20+10insGT;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161284224	.	A	AGT	.	PASS	DBSNP=75726722;1000G_AF=16.97;ESP_AF=11.22;ESP_AF_AA=20.84;ESP_AF_EA=6.25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=97;TRANSCRIPT_ID=NM_003001.3;HGVS_TRANSCRIPT=c.20+9_20+10insGT;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293485	.	T	TTA	.	PASS	DBSNP=202172527;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001278172.1;HGVS_TRANSCRIPT=c.77+25_77+26insTA;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293485	.	T	TTA	.	PASS	DBSNP=202172527;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035512.1;HGVS_TRANSCRIPT=c.77+25_77+26insTA;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293485	.	T	TTA	.	PASS	DBSNP=202172527;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035513.1;HGVS_TRANSCRIPT=c.20+9270_20+9271insTA;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293485	.	T	TTA	.	PASS	DBSNP=202172527;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035511.1;HGVS_TRANSCRIPT=c.77+25_77+26insTA;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293485	.	T	TTA	.	PASS	DBSNP=202172527;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_003001.3;HGVS_TRANSCRIPT=c.77+25_77+26insTA;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293492	.	A	T	.	PASS	DBSNP=77828459;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001278172.1;HGVS_TRANSCRIPT=c.77+32A>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293492	.	A	T	.	PASS	DBSNP=77828459;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035512.1;HGVS_TRANSCRIPT=c.77+32A>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293492	.	A	T	.	PASS	DBSNP=77828459;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035513.1;HGVS_TRANSCRIPT=c.20+9277A>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293492	.	A	T	.	PASS	DBSNP=77828459;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_001035511.1;HGVS_TRANSCRIPT=c.77+32A>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293492	.	A	T	.	PASS	DBSNP=77828459;1000G_AF=12.2;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";TRANSCRIPT_ID=NM_003001.3;HGVS_TRANSCRIPT=c.77+32A>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293508	.	C	T	.	PASS	DBSNP=112946310;1000G_AF=12.84;ESP_AF=6.04;ESP_AF_AA=7.48;ESP_AF_EA=5.31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=22;TRANSCRIPT_ID=NM_001278172.1;HGVS_TRANSCRIPT=c.77+48C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293508	.	C	T	.	PASS	DBSNP=112946310;1000G_AF=12.84;ESP_AF=6.04;ESP_AF_AA=7.48;ESP_AF_EA=5.31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=22;TRANSCRIPT_ID=NM_001035512.1;HGVS_TRANSCRIPT=c.77+48C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293508	.	C	T	.	PASS	DBSNP=112946310;1000G_AF=12.84;ESP_AF=6.04;ESP_AF_AA=7.48;ESP_AF_EA=5.31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=22;TRANSCRIPT_ID=NM_001035513.1;HGVS_TRANSCRIPT=c.20+9293C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293508	.	C	T	.	PASS	DBSNP=112946310;1000G_AF=12.84;ESP_AF=6.04;ESP_AF_AA=7.48;ESP_AF_EA=5.31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=22;TRANSCRIPT_ID=NM_001035511.1;HGVS_TRANSCRIPT=c.77+48C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr1	161293508	.	C	T	.	PASS	DBSNP=112946310;1000G_AF=12.84;ESP_AF=6.04;ESP_AF_AA=7.48;ESP_AF_EA=5.31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="head and neck paraganglioma";ESP_PUBLIC_HOMOZYGOTES=22;TRANSCRIPT_ID=NM_003001.3;HGVS_TRANSCRIPT=c.77+48C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29416037	.	C	G	.	PASS	DBSNP=80088378;1000G_AF=3.04;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=neuroblastoma;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.*53G>C;GENE_REGION=3'UTR;GENE_SYMBOL=ALK	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29416117	.	C	T	.	PASS	DBSNP=78174819;PHYLOP=7.145E-3;1000G_AF=0.26;ESP_AF=0.48;ESP_AF_AA=1.43;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=neuroblastoma;ING_DRUGGED_GENE=Y;ING_AFFECTED=1;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.4836G>A;HGVS_PROTEIN=p.K1612K;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29416366	.	G	C	.	PASS	DBSNP="1881421, 386502420";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=57.29;ESP_AF=43.35;ESP_AF_AA=60.85;ESP_AF_EA=34.38;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=1342;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=163;ING_AFFECTED_HOM=32;ING_UNAFFECTED=137;PUBMED=16604305,25069792,22183965,24728327;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.4587C>G;HGVS_PROTEIN=p.D1529E;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=missense;BLOSUM50=2;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	29416572	.	T	C	.	PASS	DBSNP=1670283;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=99.22;ESP_AF=99.03;ESP_AF_AA=97.21;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=6379;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2;ING_AFFECTED_HOM=1;PUBMED=25069792,22183965,24728327;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.4381A>G;HGVS_PROTEIN=p.I1461V;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=missense;BLOSUM50=4;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	29416794	.	G	A	.	PASS	DBSNP=17007646;1000G_AF=16.09;ESP_AF=20.25;ESP_AF_AA=34.89;ESP_AF_EA=12.74;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=363;ING_DRUGGED_GENE=Y;ING_AFFECTED=1;PUBMED=20054657;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.4165-6C>T;GENE_REGION=Intronic;GENE_SYMBOL=ALK	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29419591	.	G	T	.	PASS	DBSNP=1670284;1000G_AF=42.07;ESP_AF=54.70;ESP_AF_AA=36.75;ESP_AF_EA=63.90;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=2074;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.4164+45C>A;GENE_REGION=Intronic;GENE_SYMBOL=ALK	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29432625	.	C	A	.	PASS	DBSNP=3738868;1000G_AF=10.3;ESP_AF=9.17;ESP_AF_AA=26.40;ESP_AF_EA=0.35;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=157;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.3836+27G>T;GENE_REGION=Intronic;GENE_SYMBOL=ALK	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29432776	.	T	C	.	PASS	DBSNP=3738867;1000G_AF=10.9;ESP_AF=10.11;ESP_AF_AA=26.26;ESP_AF_EA=1.84;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=157;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.3744-32A>G;GENE_REGION=Intronic;GENE_SYMBOL=ALK	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29449819	.	C	T	.	PASS	DBSNP=2293563;1000G_AF=16.99;ESP_AF=18.96;ESP_AF_AA=22.11;ESP_AF_EA=17.35;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=242;ING_DRUGGED_GENE=Y;ING_AFFECTED=2;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.3036G>A;HGVS_PROTEIN=p.T1012T;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	29455267	.	A	G	.	PASS	DBSNP=2256740;1000G_AF=50.0;ESP_AF=66.14;ESP_AF_AA=54.93;ESP_AF_EA=71.88;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=2881;ING_DRUGGED_GENE=Y;ING_AFFECTED=1;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.2535T>C;HGVS_PROTEIN=p.G845G;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	29543663	.	T	C	.	PASS	DBSNP=2293564;1000G_AF=77.66;ESP_AF=79.09;ESP_AF_AA=53.47;ESP_AF_EA=92.22;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=4275;ING_DRUGGED_GENE=Y;ING_AFFECTED=1;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.1500A>G;HGVS_PROTEIN=p.Q500Q;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	29940529	.	A	T	.	PASS	DBSNP=2246745;1000G_AF=58.93;ESP_AF=62.70;ESP_AF_AA=26.60;ESP_AF_EA=81.20;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=neuroblastoma;ESP_PUBLIC_HOMOZYGOTES=2997;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004304.4;HGVS_TRANSCRIPT=c.702T>A;HGVS_PROTEIN=p.P234P;GENE_REGION=Exonic;GENE_SYMBOL=ALK;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1621	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	47601106	.	T	C	.	PASS	DBSNP=1126497;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=66.61;ESP_AF=56.67;ESP_AF_AA=82.82;ESP_AF_EA=43.28;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="tufting enteropathy";ESP_PUBLIC_HOMOZYGOTES=2331;ING_AFFECTED=279;ING_AFFECTED_HOM=23;PUBMED=24718422,25069792,24304228,20683652,22322561,21918173;TRANSCRIPT_ID=NM_002354.2;HGVS_TRANSCRIPT=c.344T>C;HGVS_PROTEIN=p.M115T;GENE_REGION=Exonic;GENE_SYMBOL=EPCAM;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=315	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr2	47612298	.	C	T	.	PASS	DBSNP=72882786;1000G_AF=2.1;ESP_AF=2.30;ESP_AF_AA=6.70;ESP_AF_EA=0.05;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="tufting enteropathy";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_002354.2;HGVS_TRANSCRIPT=c.859-7C>T;GENE_REGION=Intronic;GENE_SYMBOL=EPCAM	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	47630550	.	C	G	.	PASS	DBSNP=2303426;1000G_AF=62.84;ESP_AF=47.59;ESP_AF_AA=70.91;ESP_AF_EA=35.77;ING_FINDINGS=48;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1739;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1486;ING_AFFECTED_HOM=340;ING_UNAFFECTED=51;PUBMED=19250818,15996210,15655560,25598504,11376800,22283331,9718327,12070261,20937110,21212431,16251890,20564624,21681824,21708280,19526325,19419416,18641418,19685281,19930554,16810763,14961575,12362047,11606497,9322509,15365996,22766992,11179758,21283657,15849733,11870161,10978353,12792735,20305446,11879922,18726168,18772310,15520370;TRANSCRIPT_ID=NM_000251.2;HGVS_TRANSCRIPT=c.211+9C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH2;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000144620.1; RCV000030249.2"	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	47630550	.	C	G	.	PASS	DBSNP=2303426;1000G_AF=62.84;ESP_AF=47.59;ESP_AF_AA=70.91;ESP_AF_EA=35.77;ING_FINDINGS=48;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1739;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1486;ING_AFFECTED_HOM=340;ING_UNAFFECTED=51;PUBMED=19250818,15996210,15655560,25598504,11376800,22283331,9718327,12070261,20937110,21212431,16251890,20564624,21681824,21708280,19526325,19419416,18641418,19685281,19930554,16810763,14961575,12362047,11606497,9322509,15365996,22766992,11179758,21283657,15849733,11870161,10978353,12792735,20305446,11879922,18726168,18772310,15520370;TRANSCRIPT_ID=NM_001258281.1;HGVS_TRANSCRIPT=c.13+9C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	47693959	.	G	A	.	PASS	DBSNP=3732183;1000G_AF=48.34;ESP_AF=37.87;ESP_AF_AA=59.93;ESP_AF_EA=26.58;ING_FINDINGS=59;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1130;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=797;ING_AFFECTED_HOM=207;ING_UNAFFECTED=82;PUBMED=15655560,24689082,12115348,20937110,19741564,24793746,20931542,15937982,19419416,19685281,16810763,24674628,19930554,9087566,25430799,22386861,11179758,12655564,12655562,7881445,11870161,20305446,11879922,18406877,9036882,18772310,19250818,11376800,22283331,11920650,10495924,16251890,19526325,24562863,11112663,12658575,14961575,12362047,11606497,10874307,15365996,9322509,22766992,18561205,15849733,12792735,10978353,16237223,15520370;TRANSCRIPT_ID=NM_000251.2;HGVS_TRANSCRIPT=c.1661+12G>A;GENE_REGION=Intronic;GENE_SYMBOL=MSH2;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000030241.2; RCV000144614.1; RCV000132147.1"	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	47693959	.	G	A	.	PASS	DBSNP=3732183;1000G_AF=48.34;ESP_AF=37.87;ESP_AF_AA=59.93;ESP_AF_EA=26.58;ING_FINDINGS=59;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1130;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=797;ING_AFFECTED_HOM=207;ING_UNAFFECTED=82;PUBMED=15655560,24689082,12115348,20937110,19741564,24793746,20931542,15937982,19419416,19685281,16810763,24674628,19930554,9087566,25430799,22386861,11179758,12655564,12655562,7881445,11870161,20305446,11879922,18406877,9036882,18772310,19250818,11376800,22283331,11920650,10495924,16251890,19526325,24562863,11112663,12658575,14961575,12362047,11606497,10874307,15365996,9322509,22766992,18561205,15849733,12792735,10978353,16237223,15520370;TRANSCRIPT_ID=NM_001258281.1;HGVS_TRANSCRIPT=c.1463+12G>A;GENE_REGION=Intronic;GENE_SYMBOL=MSH2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	47702460	.	T	G	.	PASS	DBSNP=17218452;1000G_AF=4.27;ESP_AF=3.54;ESP_AF_AA=10.28;ESP_AF_EA=0.14;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=25;TRANSCRIPT_ID=NM_000251.2;HGVS_TRANSCRIPT=c.2005+51T>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	47702460	.	T	G	.	PASS	DBSNP=17218452;1000G_AF=4.27;ESP_AF=3.54;ESP_AF_AA=10.28;ESP_AF_EA=0.14;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=25;TRANSCRIPT_ID=NM_001258281.1;HGVS_TRANSCRIPT=c.1807+51T>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	48032740	.	AT	A	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary neoplastic syndrome";TRANSCRIPT_ID=NM_001281493.1;HGVS_TRANSCRIPT=c.2651-16delT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	48032740	.	AT	A	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary neoplastic syndrome";TRANSCRIPT_ID=NM_001281492.1;HGVS_TRANSCRIPT=c.3167-16delT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	48032740	.	AT	A	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary neoplastic syndrome";TRANSCRIPT_ID=NM_001281494.1;HGVS_TRANSCRIPT=c.2651-16delT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	48032740	.	AT	A	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary neoplastic syndrome";TRANSCRIPT_ID=NM_000179.2;HGVS_TRANSCRIPT=c.3557-16delT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	48032874	.	ACTAT	A	.	PASS	DBSNP=2234731;1000G_AF=76.22;ESP_AF=70.81;ESP_AF_AA=79.17;ESP_AF_EA=66.48;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3178;ING_AFFECTED=40;ING_AFFECTED_HOM=35;PUBMED=19250818,15805151,20937110;TRANSCRIPT_ID=NM_001281493.1;HGVS_TRANSCRIPT=c.2740+29_2740+32delCTAT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48032874	.	ACTAT	A	.	PASS	DBSNP=2234731;1000G_AF=76.22;ESP_AF=70.81;ESP_AF_AA=79.17;ESP_AF_EA=66.48;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3178;ING_AFFECTED=40;ING_AFFECTED_HOM=35;PUBMED=19250818,15805151,20937110;TRANSCRIPT_ID=NM_001281492.1;HGVS_TRANSCRIPT=c.3256+29_3256+32delCTAT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48032874	.	ACTAT	A	.	PASS	DBSNP=2234731;1000G_AF=76.22;ESP_AF=70.81;ESP_AF_AA=79.17;ESP_AF_EA=66.48;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3178;ING_AFFECTED=40;ING_AFFECTED_HOM=35;PUBMED=19250818,15805151,20937110;TRANSCRIPT_ID=NM_001281494.1;HGVS_TRANSCRIPT=c.2740+29_2740+32delCTAT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48032874	.	ACTAT	A	.	PASS	DBSNP=2234731;1000G_AF=76.22;ESP_AF=70.81;ESP_AF_AA=79.17;ESP_AF_EA=66.48;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3178;ING_AFFECTED=40;ING_AFFECTED_HOM=35;PUBMED=19250818,15805151,20937110;TRANSCRIPT_ID=NM_000179.2;HGVS_TRANSCRIPT=c.3646+29_3646+32delCTAT;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48033551	.	C	G	.	PASS	DBSNP=3136367;1000G_AF=80.91;ESP_AF=78.72;ESP_AF_AA=91.24;ESP_AF_EA=72.31;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4095;ING_AFFECTED=352;PUBMED=22495361,20937110,10537275,10699937;TRANSCRIPT_ID=NM_001281493.1;HGVS_TRANSCRIPT=c.2896-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48033551	.	C	G	.	PASS	DBSNP=3136367;1000G_AF=80.91;ESP_AF=78.72;ESP_AF_AA=91.24;ESP_AF_EA=72.31;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4095;ING_AFFECTED=352;PUBMED=22495361,20937110,10537275,10699937;TRANSCRIPT_ID=NM_001281492.1;HGVS_TRANSCRIPT=c.3412-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48033551	.	C	G	.	PASS	DBSNP=3136367;1000G_AF=80.91;ESP_AF=78.72;ESP_AF_AA=91.24;ESP_AF_EA=72.31;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4095;ING_AFFECTED=352;PUBMED=22495361,20937110,10537275,10699937;TRANSCRIPT_ID=NM_001281494.1;HGVS_TRANSCRIPT=c.2896-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH6	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	48033551	.	C	G	.	PASS	DBSNP=3136367;1000G_AF=80.91;ESP_AF=78.72;ESP_AF_AA=91.24;ESP_AF_EA=72.31;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4095;ING_AFFECTED=352;PUBMED=22495361,20937110,10537275,10699937;TRANSCRIPT_ID=NM_000179.2;HGVS_TRANSCRIPT=c.3802-40C>G;GENE_REGION=Intronic;GENE_SYMBOL=MSH6;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000030272.2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.580T>C;HGVS_PROTEIN=p.C194R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=327	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1876T>C;HGVS_PROTEIN=p.C626R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=759	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.523T>C;HGVS_PROTEIN=p.C175R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=308	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NR_104216.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.394T>C;HGVS_PROTEIN=p.C132R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=265	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215595203	.	A	G	.	PASS	DBSNP=2228456;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=2.54;ESP_AF=2.29;ESP_AF_AA=6.70;ESP_AF_EA=0.03;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=1;PUBMED=23680151,17550235,16061562,20077502,23056176;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1933T>C;HGVS_PROTEIN=p.C645R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000130983.1;ING_MIN_PROTEIN_LENGTH=778	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr2	215632155	.	T	C	.	PASS	DBSNP=5031009;1000G_AF=36.62;ESP_AF=35.93;ESP_AF_AA=36.43;ESP_AF_EA=35.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=838;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.216-14876A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632155	.	T	C	.	PASS	DBSNP=5031009;1000G_AF=36.62;ESP_AF=35.93;ESP_AF_AA=36.43;ESP_AF_EA=35.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=838;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1511+51A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632155	.	T	C	.	PASS	DBSNP=5031009;1000G_AF=36.62;ESP_AF=35.93;ESP_AF_AA=36.43;ESP_AF_EA=35.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=838;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-14876A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632155	.	T	C	.	PASS	DBSNP=5031009;1000G_AF=36.62;ESP_AF=35.93;ESP_AF_AA=36.43;ESP_AF_EA=35.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=838;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+24866A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632155	.	T	C	.	PASS	DBSNP=5031009;1000G_AF=36.62;ESP_AF=35.93;ESP_AF_AA=36.43;ESP_AF_EA=35.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=838;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1568+51A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632192	.	G	A	.	PASS	DBSNP=5031011;1000G_AF=35.22;ESP_AF=33.53;ESP_AF_AA=33.93;ESP_AF_EA=33.33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=723;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.216-14913C>T;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632192	.	G	A	.	PASS	DBSNP=5031011;1000G_AF=35.22;ESP_AF=33.53;ESP_AF_AA=33.93;ESP_AF_EA=33.33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=723;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1511+14C>T;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632192	.	G	A	.	PASS	DBSNP=5031011;1000G_AF=35.22;ESP_AF=33.53;ESP_AF_AA=33.93;ESP_AF_EA=33.33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=723;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-14913C>T;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632192	.	G	A	.	PASS	DBSNP=5031011;1000G_AF=35.22;ESP_AF=33.53;ESP_AF_AA=33.93;ESP_AF_EA=33.33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=723;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+24829C>T;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632192	.	G	A	.	PASS	DBSNP=5031011;1000G_AF=35.22;ESP_AF=33.53;ESP_AF_AA=33.93;ESP_AF_EA=33.33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=723;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1568+14C>T;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.216-14976G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1462G>A;HGVS_PROTEIN=p.V488M;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=759	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-14976G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NR_104216.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+24766G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632255	.	C	T	.	PASS	DBSNP=2070094;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;1000G_AF=36.62;ESP_AF=28.06;ESP_AF_AA=29.01;ESP_AF_EA=27.58;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=831;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2356;ING_AFFECTED_HOM=461;PUBMED=19412175,24853695,25069792,16333312,21344236,23222812,19482343,17108146,23966609,17028982,15342711,14550946,9425226,16061562,20077502,23056176,19714462,12776201,16152612;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1519G>A;HGVS_PROTEIN=p.V507M;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000128872.1;ING_MIN_PROTEIN_LENGTH=778	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.216-14977T>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1461T>C;HGVS_PROTEIN=p.H487H;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=759	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-14977T>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NR_104216.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+24765T>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215632256	.	A	G	.	PASS	DBSNP=2070093;1000G_AF=77.06;ESP_AF=71.38;ESP_AF_AA=58.35;ESP_AF_EA=78.06;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3545;ING_AFFECTED=261;ING_AFFECTED_HOM=12;PUBMED=17108146,19536092,17028982,23966609,24853695,19623759,20077502,21344236;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1518T>C;HGVS_PROTEIN=p.H506H;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=778	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215634055	.	C	T	.	PASS	DBSNP=6704780;1000G_AF=36.52;ESP_AF=35.95;ESP_AF_AA=36.45;ESP_AF_EA=35.70;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=835;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.216-16776G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215634055	.	C	T	.	PASS	DBSNP=6704780;1000G_AF=36.52;ESP_AF=35.95;ESP_AF_AA=36.45;ESP_AF_EA=35.70;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=835;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1258-19G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215634055	.	C	T	.	PASS	DBSNP=6704780;1000G_AF=36.52;ESP_AF=35.95;ESP_AF_AA=36.45;ESP_AF_EA=35.70;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=835;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-16776G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215634055	.	C	T	.	PASS	DBSNP=6704780;1000G_AF=36.52;ESP_AF=35.95;ESP_AF_AA=36.45;ESP_AF_EA=35.70;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=835;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+22966G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215634055	.	C	T	.	PASS	DBSNP=6704780;1000G_AF=36.52;ESP_AF=35.95;ESP_AF_AA=36.45;ESP_AF_EA=35.70;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=835;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1315-19G>A;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.215+16321G>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.1077G>C;HGVS_PROTEIN=p.R359S;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=759	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.159-28185G>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+11557G>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645464	.	C	G	.	PASS	DBSNP=2229571;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=45.93;ESP_AF=53.18;ESP_AF_AA=39.72;ESP_AF_EA=60.08;ING_FINDINGS=19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=1890;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1364;ING_AFFECTED_HOM=164;PUBMED=19412175,24853695,25069792,22183965,16333312,21344236,23222812,19482343,17028982,23966609,15342711,14550946,20077502,19714462,12776201,19124506,16574953,19584272,18006695;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.1134G>C;HGVS_PROTEIN=p.R378S;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000132162.1;ING_MIN_PROTEIN_LENGTH=778	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.215+15807A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.563A>G;HGVS_PROTEIN=p.K188R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=3;ING_MIN_PROTEIN_LENGTH=759	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.158+28158A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.364+11043A>G;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215645978	.	T	C	.	PASS	DBSNP="34969857, 386436984";SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.36;ESP_AF=0.22;ESP_AF_AA=0.66;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.620A>G;HGVS_PROTEIN=p.K207R;GENE_REGION=Exonic;GENE_SYMBOL=BARD1;TRANSLATION_IMPACT=missense;BLOSUM50=3;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000115637.2;ING_MIN_PROTEIN_LENGTH=778	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr2	215674090	.	T	G	.	PASS	DBSNP=35933323;1000G_AF=74.48;ESP_AF=74.70;ESP_AF_AA=77.85;ESP_AF_EA=73.15;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3224;ING_AFFECTED=87;PUBMED=20077502;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.158+46A>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674090	.	T	G	.	PASS	DBSNP=35933323;1000G_AF=74.48;ESP_AF=74.70;ESP_AF_AA=77.85;ESP_AF_EA=73.15;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3224;ING_AFFECTED=87;PUBMED=20077502;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.158+46A>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674090	.	T	G	.	PASS	DBSNP=35933323;1000G_AF=74.48;ESP_AF=74.70;ESP_AF_AA=77.85;ESP_AF_EA=73.15;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3224;ING_AFFECTED=87;PUBMED=20077502;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.158+46A>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674090	.	T	G	.	PASS	DBSNP=35933323;1000G_AF=74.48;ESP_AF=74.70;ESP_AF_AA=77.85;ESP_AF_EA=73.15;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3224;ING_AFFECTED=87;PUBMED=20077502;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.158+46A>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674090	.	T	G	.	PASS	DBSNP=35933323;1000G_AF=74.48;ESP_AF=74.70;ESP_AF_AA=77.85;ESP_AF_EA=73.15;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3224;ING_AFFECTED=87;PUBMED=20077502;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.158+46A>C;GENE_REGION=Intronic;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.-30G>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.-30G>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.-30G>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NR_104216.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.-30G>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674323	.	C	G	.	PASS	DBSNP=1129804;1000G_AF=74.46;ESP_AF=77.09;ESP_AF_AA=79.98;ESP_AF_EA=75.67;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3408;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.-30G>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NR_104215.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NM_001282545.1;HGVS_TRANSCRIPT=c.-48T>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NM_001282543.1;HGVS_TRANSCRIPT=c.-48T>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NM_001282548.1;HGVS_TRANSCRIPT=c.-48T>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NR_104216.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NR_104212.1;GENE_REGION=ncRNA;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NM_001282549.1;HGVS_TRANSCRIPT=c.-48T>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr2	215674341	.	A	G	.	PASS	DBSNP=17489363;1000G_AF=74.5;ESP_AF=78.52;ESP_AF_AA=80.96;ESP_AF_EA=77.34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3324;PUBMED=23056176;TRANSCRIPT_ID=NM_000465.3;HGVS_TRANSCRIPT=c.-48T>C;GENE_REGION=5'UTR;GENE_SYMBOL=BARD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr3	30686414	.	A	G	.	PASS	DBSNP=1155705;1000G_AF=41.29;ESP_AF=32.15;ESP_AF_AA=33.23;ESP_AF_EA=31.60;ING_FINDINGS=12;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome";ESP_PUBLIC_HOMOZYGOTES=679;ING_AFFECTED=2716;ING_AFFECTED_HOM=249;ING_UNAFFECTED=900;PUBMED=23578328,16283890,9771922,21542060,19229971,22896741,24465802,24687999,21949523,16478646;TRANSCRIPT_ID=NM_003242.5;HGVS_TRANSCRIPT=c.263+7A>G;GENE_REGION=Intronic;GENE_SYMBOL=TGFBR2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	30686414	.	A	G	.	PASS	DBSNP=1155705;1000G_AF=41.29;ESP_AF=32.15;ESP_AF_AA=33.23;ESP_AF_EA=31.60;ING_FINDINGS=12;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome";ESP_PUBLIC_HOMOZYGOTES=679;ING_AFFECTED=2716;ING_AFFECTED_HOM=249;ING_UNAFFECTED=900;PUBMED=23578328,16283890,9771922,21542060,19229971,22896741,24465802,24687999,21949523,16478646;TRANSCRIPT_ID=NM_001024847.2;HGVS_TRANSCRIPT=c.338+7A>G;GENE_REGION=Intronic;GENE_SYMBOL=TGFBR2;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000030549.1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	30713126	.	T	A	.	PASS	DBSNP=11466512;1000G_AF=27.2;ESP_AF=25.55;ESP_AF_AA=15.25;ESP_AF_EA=30.83;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome";ESP_PUBLIC_HOMOZYGOTES=458;ING_AFFECTED=948;ING_AFFECTED_HOM=131;PUBMED=23578328,23228659,16283890,21542060,9538129,24465802,19091845,16478646,18721526;TRANSCRIPT_ID=NM_003242.5;HGVS_TRANSCRIPT=c.455-4T>A;GENE_REGION=Intronic;GENE_SYMBOL=TGFBR2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	30713126	.	T	A	.	PASS	DBSNP=11466512;1000G_AF=27.2;ESP_AF=25.55;ESP_AF_AA=15.25;ESP_AF_EA=30.83;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome";ESP_PUBLIC_HOMOZYGOTES=458;ING_AFFECTED=948;ING_AFFECTED_HOM=131;PUBMED=23578328,23228659,16283890,21542060,9538129,24465802,19091845,16478646,18721526;TRANSCRIPT_ID=NM_001024847.2;HGVS_TRANSCRIPT=c.530-4T>A;GENE_REGION=Intronic;GENE_SYMBOL=TGFBR2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001167618.1;HGVS_TRANSCRIPT=c.-250C>T;GENE_REGION=5'UTR;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001167619.1;HGVS_TRANSCRIPT=c.-179+1771C>T;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001167617.1;HGVS_TRANSCRIPT=c.180C>T;HGVS_PROTEIN=p.N60N;GENE_REGION=Exonic;GENE_SYMBOL=MLH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=659	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_000249.3;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=MLH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000130926.1; RCV000075732.1";ING_MIN_PROTEIN_LENGTH=757	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001258273.1;HGVS_TRANSCRIPT=c.-250C>T;GENE_REGION=5'UTR;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001258274.1;HGVS_TRANSCRIPT=c.-250C>T;GENE_REGION=5'UTR;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37050325	.	C	T	.	PASS	DBSNP=4647256;1000G_AF=1.08;ESP_AF=1.37;ESP_AF_AA=4.02;ESP_AF_EA=0.01;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=3;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=3;ING_DISCORDANT_FAMILIES=1;PUBMED=16237223,19224586,18792805,20473912,20967208;TRANSCRIPT_ID=NM_001258271.1;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=MLH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=688	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001167618.1;HGVS_TRANSCRIPT=c.945-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001167619.1;HGVS_TRANSCRIPT=c.945-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001167617.1;HGVS_TRANSCRIPT=c.1374-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_000249.3;HGVS_TRANSCRIPT=c.1668-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000030215.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001258273.1;HGVS_TRANSCRIPT=c.945-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001258274.1;HGVS_TRANSCRIPT=c.945-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	37083740	.	A	G	.	PASS	DBSNP=9876116;1000G_AF=31.23;ESP_AF=43.83;ESP_AF_AA=40.83;ESP_AF_EA=45.37;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hereditary Nonpolyposis Colorectal Cancer";ESP_PUBLIC_HOMOZYGOTES=1298;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2580;ING_AFFECTED_HOM=462;ING_UNAFFECTED=16;PUBMED=12011148,15655560,19446403,9718327,8776590,12115348,25232430,15142887,20937110,19741564,17374836,23100212,19237606,8592341,19419416,19930554,16810763,16237216,9087566,24289550,15099349,12655562,14688830,20305446,11879922,11524701,10464596,19250818,19224586,22933969,11376800,11920650,10495924,21212431,21681824,18641418,19526325,9218993,12362047,11606497,15365996,9322509,14985405,15849733,16237223,9298827,24802709,16963262,18547406,23573243,22631669,24307375,11754112,20967208;TRANSCRIPT_ID=NM_001258271.1;HGVS_TRANSCRIPT=c.1668-19A>G;GENE_REGION=Intronic;GENE_SYMBOL=MLH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	52436259	.	G	C	.	PASS	DBSNP=56898787;PHYLOP=6.353E-3;1000G_AF=3.02;ESP_AF=3.26;ESP_AF_AA=8.75;ESP_AF_EA=0.45;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="uveal melanoma";ESP_PUBLIC_HOMOZYGOTES=15;TRANSCRIPT_ID=NM_004656.3;HGVS_TRANSCRIPT=c.*45C>G;GENE_REGION=3'UTR;GENE_SYMBOL=BAP1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_001184967.1;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_000248.3;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_006722.2;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_198177.2;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_198158.2;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_198159.2;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	70014447	.	T	C	.	PASS	DBSNP=9863910;1000G_AF=10.14;ESP_AF=13.23;ESP_AF_AA=18.59;ESP_AF_EA=10.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Waardenburg syndrome type 2";ESP_PUBLIC_HOMOZYGOTES=127;TRANSCRIPT_ID=NM_198178.2;HGVS_TRANSCRIPT=c.*48T>C;GENE_REGION=3'UTR;GENE_SYMBOL=MITF	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	128205860	.	G	C	.	PASS	DBSNP=1573858;1000G_AF=70.99;ESP_AF=69.34;ESP_AF_AA=77.61;ESP_AF_EA=65.08;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="familial myelodysplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3126;ING_AFFECTED=5;TRANSCRIPT_ID=NM_032638.4;HGVS_TRANSCRIPT=c.15C>G;HGVS_PROTEIN=p.P5P;GENE_REGION=Exonic;GENE_SYMBOL=GATA2;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=481	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	128205860	.	G	C	.	PASS	DBSNP=1573858;1000G_AF=70.99;ESP_AF=69.34;ESP_AF_AA=77.61;ESP_AF_EA=65.08;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="familial myelodysplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3126;ING_AFFECTED=5;TRANSCRIPT_ID=NM_001145661.1;HGVS_TRANSCRIPT=c.15C>G;HGVS_PROTEIN=p.P5P;GENE_REGION=Exonic;GENE_SYMBOL=GATA2;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=481	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr3	128205860	.	G	C	.	PASS	DBSNP=1573858;1000G_AF=70.99;ESP_AF=69.34;ESP_AF_AA=77.61;ESP_AF_EA=65.08;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="familial myelodysplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3126;ING_AFFECTED=5;TRANSCRIPT_ID=NM_001145662.1;HGVS_TRANSCRIPT=c.15C>G;HGVS_PROTEIN=p.P5P;GENE_REGION=Exonic;GENE_SYMBOL=GATA2;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=467	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55133715	.	A	G	.	PASS	DBSNP=78405886;1000G_AF=3.57;ESP_AF=3.38;ESP_AF_AA=9.92;ESP_AF_EA=0.03;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=20;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.932-4A>G;GENE_REGION=Intronic;GENE_SYMBOL=PDGFRA	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55133806	.	G	A	.	PASS	DBSNP=77524207;POLYPHEN_FUNCTION=Benign;1000G_AF=1.68;ESP_AF=1.68;ESP_AF_AA=4.93;ESP_AF_EA=0.01;ING_FINDINGS=2;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=3;ING_DRUGGED_GENE=Y;ING_AFFECTED=2;PUBMED=17568391,22703879,24728327;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.1019G>A;HGVS_PROTEIN=p.R340Q;GENE_REGION=Exonic;GENE_SYMBOL=PDGFRA;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=1090	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55141055	.	A	G	.	PASS	DBSNP=1873778;1000G_AF=95.77;ESP_AF=95.89;ESP_AF_AA=88.15;ESP_AF_EA=99.85;ING_FINDINGS=14;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=5991;ING_DRUGGED_GENE=Y;ING_AFFECTED=129;ING_AFFECTED_HOM=61;PUBMED=16434186,17568391,21224473,23211371,23283817,17014709,22009637,22937135,23146028;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.1701A>G;HGVS_PROTEIN=p.P567P;GENE_REGION=Exonic;GENE_SYMBOL=PDGFRA;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1090	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr4	55143577	.	G	A	.	PASS	DBSNP=10028020;1000G_AF=22.8;ESP_AF=16.62;ESP_AF_AA=29.64;ESP_AF_EA=9.94;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=233;ING_DRUGGED_GENE=Y;ING_AFFECTED=3;PUBMED=17568391,21224473,17088437,23146028,22733151;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.1809G>A;HGVS_PROTEIN=p.A603A;GENE_REGION=Exonic;GENE_SYMBOL=PDGFRA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1090	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55151958	.	T	TA	.	PASS	DBSNP=3830355;1000G_AF=71.39;ESP_AF=74.97;ESP_AF_AA=53.75;ESP_AF_EA=85.93;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=3656;ING_DRUGGED_GENE=Y;ING_AFFECTED=8;ING_AFFECTED_HOM=4;PUBMED=16168125;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.2440-50_2440-49insA;GENE_REGION=Intronic;GENE_SYMBOL=PDGFRA	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55152040	.	C	T	.	PASS	DBSNP=2228230;1000G_AF=24.04;ESP_AF=19.83;ESP_AF_AA=31.34;ESP_AF_EA=13.93;ING_FINDINGS=25;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=306;ING_DRUGGED_GENE=Y;ING_AFFECTED=76;ING_AFFECTED_HOM=3;ING_UNAFFECTED=3;PUBMED=18488160,17014709,23741027,16373964,22733151,18084259,17568391,21224473,23831921,23211371,23106360,23283817,18265649,22009637,20023271,16168125,17088437,22350270,20861712;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.2472C>T;HGVS_PROTEIN=p.V824V;GENE_REGION=Exonic;GENE_SYMBOL=PDGFRA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1090	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55161254	.	C	T	.	PASS	DBSNP=3733540;1000G_AF=69.91;ESP_AF=73.58;ESP_AF_AA=48.66;ESP_AF_EA=86.35;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=3709;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.3123-38C>T;GENE_REGION=Intronic;GENE_SYMBOL=PDGFRA	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	55161391	.	T	C	.	PASS	DBSNP=7685117;1000G_AF=99.72;ESP_AF=99.68;ESP_AF_AA=99.05;ESP_AF_EA=100.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastrointestinal stromal tumor";ESP_PUBLIC_HOMOZYGOTES=6461;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006206.4;HGVS_TRANSCRIPT=c.3222T>C;HGVS_PROTEIN=p.D1074D;GENE_REGION=Exonic;GENE_SYMBOL=PDGFRA;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1090	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr4	84383935	.	A	G	.	PASS	DBSNP=138986552;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;PHYLOP=9.572E-3;1000G_AF=0.1;ESP_AF=0.11;ESP_AF_AA=0.30;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";TRANSCRIPT_ID=NM_139076.2;HGVS_TRANSCRIPT=c.917T>C;HGVS_PROTEIN=p.V306A;GENE_REGION=Exonic;GENE_SYMBOL=FAM175A;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=410	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr4	84393475	.	C	T	.	PASS	DBSNP=6535478;1000G_AF=68.47;ESP_AF=62.09;ESP_AF_AA=84.90;ESP_AF_EA=52.07;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2316;ING_AFFECTED=73;ING_AFFECTED_HOM=17;PUBMED=18695986;TRANSCRIPT_ID=NM_139076.2;HGVS_TRANSCRIPT=c.216-34G>A;GENE_REGION=Intronic;GENE_SYMBOL=FAM175A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	226160	.	A	C	.	PASS	DBSNP=6555055;1000G_AF=24.74;ESP_AF=27.10;ESP_AF_AA=53.45;ESP_AF_EA=13.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=710;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.619A>C;HGVS_PROTEIN=p.R207R;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=665	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	226160	.	A	C	.	PASS	DBSNP=6555055;1000G_AF=24.74;ESP_AF=27.10;ESP_AF_AA=53.45;ESP_AF_EA=13.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=710;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.475A>C;HGVS_PROTEIN=p.R159R;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	228362	.	T	C	.	PASS	DBSNP=2115272;1000G_AF=24.74;ESP_AF=27.16;ESP_AF_AA=53.63;ESP_AF_EA=13.60;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=712;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=11;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551,19522824;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.684T>C;HGVS_PROTEIN=p.N228N;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=665	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	228362	.	T	C	.	PASS	DBSNP=2115272;1000G_AF=24.74;ESP_AF=27.16;ESP_AF_AA=53.63;ESP_AF_EA=13.60;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=712;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=11;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551,19522824;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.540T>C;HGVS_PROTEIN=p.N180N;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	230980	.	A	G	.	PASS	DBSNP=2288461;1000G_AF=85.84;ESP_AF=91.26;ESP_AF_AA=97.28;ESP_AF_EA=88.17;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=5426;ING_AFFECTED=1;PUBMED=17041923;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.771-11A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	230980	.	A	G	.	PASS	DBSNP=2288461;1000G_AF=85.84;ESP_AF=91.26;ESP_AF_AA=97.28;ESP_AF_EA=88.17;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=5426;ING_AFFECTED=1;PUBMED=17041923;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.627-11A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	231111	.	T	C	.	PASS	DBSNP=1126417;1000G_AF=65.34;ESP_AF=76.87;ESP_AF_AA=78.92;ESP_AF_EA=75.82;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=3868;ING_AFFECTED=1;PUBMED=19522824;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.891T>C;HGVS_PROTEIN=p.P297P;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=665	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	231111	.	T	C	.	PASS	DBSNP=1126417;1000G_AF=65.34;ESP_AF=76.87;ESP_AF_AA=78.92;ESP_AF_EA=75.82;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=3868;ING_AFFECTED=1;PUBMED=19522824;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.747T>C;HGVS_PROTEIN=p.P249P;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	231143	.	T	C	.	PASS	DBSNP=2288459;1000G_AF=24.74;ESP_AF=27.10;ESP_AF_AA=53.52;ESP_AF_EA=13.56;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=711;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.895+28T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	231143	.	T	C	.	PASS	DBSNP=2288459;1000G_AF=24.74;ESP_AF=27.10;ESP_AF_AA=53.52;ESP_AF_EA=13.56;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=711;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.751+28T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	233572	.	A	G	.	PASS	DBSNP=7710005;1000G_AF=24.72;ESP_AF=27.09;ESP_AF_AA=53.34;ESP_AF_EA=13.64;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=704;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.896-20A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	233572	.	A	G	.	PASS	DBSNP=7710005;1000G_AF=24.72;ESP_AF=27.09;ESP_AF_AA=53.34;ESP_AF_EA=13.64;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=704;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.752-20A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251541	.	A	G	.	PASS	DBSNP=77210621;1000G_AF=24.84;ESP_AF=26.96;ESP_AF_AA=53.09;ESP_AF_EA=13.57;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=710;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.1752A>G;HGVS_PROTEIN=p.A584A;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=665	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251541	.	A	G	.	PASS	DBSNP=77210621;1000G_AF=24.84;ESP_AF=26.96;ESP_AF_AA=53.09;ESP_AF_EA=13.57;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=710;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.1608A>G;HGVS_PROTEIN=p.A536A;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251703	.	TG	T	.	PASS	DBSNP=111797600;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="nonobstructive male infertility";TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.1794+121delG;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251703	.	TG	T	.	PASS	DBSNP=111797600;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="nonobstructive male infertility";TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.1650+121delG;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251707	.	T	C	.	PASS	ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="nonobstructive male infertility";TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.1794+124T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	251707	.	T	C	.	PASS	ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="nonobstructive male infertility";TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.1650+124T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHA	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	256472	.	G	A	.	PASS	DBSNP=6961;1000G_AF=33.53;ESP_AF=27.83;ESP_AF_AA=54.11;ESP_AF_EA=14.36;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=716;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551,19522824;TRANSCRIPT_ID=NM_004168.3;HGVS_TRANSCRIPT=c.1932G>A;HGVS_PROTEIN=p.V644V;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=665	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	256472	.	G	A	.	PASS	DBSNP=6961;1000G_AF=33.53;ESP_AF=27.83;ESP_AF_AA=54.11;ESP_AF_EA=14.36;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="nonobstructive male infertility";ESP_PUBLIC_HOMOZYGOTES=716;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=10;ING_AFFECTED_HOM=1;ING_UNAFFECTED=10;PUBMED=17298551,19522824;TRANSCRIPT_ID=NM_001294332.1;HGVS_TRANSCRIPT=c.1788G>A;HGVS_PROTEIN=p.V596V;GENE_REGION=Exonic;GENE_SYMBOL=SDHA;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	1254451	.	T	C	.	PASS	DBSNP=34742644;1000G_AF=6.61;ESP_AF=6.28;ESP_AF_AA=19.02;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="bladder neoplasia";ESP_PUBLIC_HOMOZYGOTES=71;TRANSCRIPT_ID=NM_001193376.1;HGVS_TRANSCRIPT=c.3106+32A>G;GENE_REGION=Intronic;GENE_SYMBOL=TERT	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	1254451	.	T	C	.	PASS	DBSNP=34742644;1000G_AF=6.61;ESP_AF=6.28;ESP_AF_AA=19.02;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="bladder neoplasia";ESP_PUBLIC_HOMOZYGOTES=71;TRANSCRIPT_ID=NM_198253.2;HGVS_TRANSCRIPT=c.3295+32A>G;GENE_REGION=Intronic;GENE_SYMBOL=TERT	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112111309	.	TA	T	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="adenomatous polyposis coli";TRANSCRIPT_ID=NM_000038.5;HGVS_TRANSCRIPT=c.423-16delA;GENE_REGION=Intronic;GENE_SYMBOL=APC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112111309	.	TA	T	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="adenomatous polyposis coli";TRANSCRIPT_ID=NM_001127510.2;HGVS_TRANSCRIPT=c.423-16delA;GENE_REGION=Intronic;GENE_SYMBOL=APC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112111309	.	TA	T	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="adenomatous polyposis coli";TRANSCRIPT_ID=NM_001127511.2;HGVS_TRANSCRIPT=c.453-16delA;GENE_REGION=Intronic;GENE_SYMBOL=APC	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112174750	.	TGAA	T	.	PASS	PHYLOP=6.699E-4;1000G_AF=0.48;ESP_AF=0.50;ESP_AF_AA=1.38;ESP_AF_EA=0.04;ING_FINDINGS=4;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4;ING_AFFECTED=1;PUBMED=21488257,24599579,11370631,22703879;TRANSCRIPT_ID=NM_000038.5;HGVS_TRANSCRIPT=c.3466_3468delGAA;HGVS_PROTEIN=p.E1157del;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=in-frame;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000131007.1; RCV000115084.2";ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr5	112174750	.	TGAA	T	.	PASS	PHYLOP=6.699E-4;1000G_AF=0.48;ESP_AF=0.50;ESP_AF_AA=1.38;ESP_AF_EA=0.04;ING_FINDINGS=4;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4;ING_AFFECTED=1;PUBMED=21488257,24599579,11370631,22703879;TRANSCRIPT_ID=NM_001127510.2;HGVS_TRANSCRIPT=c.3466_3468delGAA;HGVS_PROTEIN=p.E1157del;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=in-frame;ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr5	112174750	.	TGAA	T	.	PASS	PHYLOP=6.699E-4;1000G_AF=0.48;ESP_AF=0.50;ESP_AF_AA=1.38;ESP_AF_EA=0.04;ING_FINDINGS=4;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4;ING_AFFECTED=1;PUBMED=21488257,24599579,11370631,22703879;TRANSCRIPT_ID=NM_001127511.2;HGVS_TRANSCRIPT=c.3412_3414delGAA;HGVS_PROTEIN=p.E1139del;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=in-frame;ING_MIN_PROTEIN_LENGTH=2826	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr5	112176756	.	T	A	.	PASS	SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=86.54;ESP_AF=82.63;ESP_AF_AA=94.59;ESP_AF_EA=76.50;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4502;ING_AFFECTED=2285;ING_AFFECTED_HOM=3;PUBMED=24735542,25069792,23159591,20844743,23516639,17088437,22703879,16574953;TRANSCRIPT_ID=NM_000038.5;HGVS_TRANSCRIPT=c.5465T>A;HGVS_PROTEIN=p.V1822D;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=missense;BLOSUM50=-4;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000132160.1;ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	112176756	.	T	A	.	PASS	SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=86.54;ESP_AF=82.63;ESP_AF_AA=94.59;ESP_AF_EA=76.50;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4502;ING_AFFECTED=2285;ING_AFFECTED_HOM=3;PUBMED=24735542,25069792,23159591,20844743,23516639,17088437,22703879,16574953;TRANSCRIPT_ID=NM_001127510.2;HGVS_TRANSCRIPT=c.5465T>A;HGVS_PROTEIN=p.V1822D;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	112176756	.	T	A	.	PASS	SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=86.54;ESP_AF=82.63;ESP_AF_AA=94.59;ESP_AF_EA=76.50;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=4502;ING_AFFECTED=2285;ING_AFFECTED_HOM=3;PUBMED=24735542,25069792,23159591,20844743,23516639,17088437,22703879,16574953;TRANSCRIPT_ID=NM_001127511.2;HGVS_TRANSCRIPT=c.5411T>A;HGVS_PROTEIN=p.V1804D;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=2826	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr5	112178995	.	A	G	.	PASS	DBSNP=35043160;1000G_AF=3.51;ESP_AF=3.31;ESP_AF_AA=9.72;ESP_AF_EA=0.02;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=21;PUBMED=8019564;TRANSCRIPT_ID=NM_000038.5;HGVS_TRANSCRIPT=c.7704A>G;HGVS_PROTEIN=p.G2568G;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000128887.1;ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112178995	.	A	G	.	PASS	DBSNP=35043160;1000G_AF=3.51;ESP_AF=3.31;ESP_AF_AA=9.72;ESP_AF_EA=0.02;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=21;PUBMED=8019564;TRANSCRIPT_ID=NM_001127510.2;HGVS_TRANSCRIPT=c.7704A>G;HGVS_PROTEIN=p.G2568G;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=2844	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	112178995	.	A	G	.	PASS	DBSNP=35043160;1000G_AF=3.51;ESP_AF=3.31;ESP_AF_AA=9.72;ESP_AF_EA=0.02;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="adenomatous polyposis coli";ESP_PUBLIC_HOMOZYGOTES=21;PUBMED=8019564;TRANSCRIPT_ID=NM_001127511.2;HGVS_TRANSCRIPT=c.7650A>G;HGVS_PROTEIN=p.G2550G;GENE_REGION=Exonic;GENE_SYMBOL=APC;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=2826	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	131892979	.	G	A	.	PASS	DBSNP=4526098;1000G_AF=92.49;ESP_AF=91.87;ESP_AF_AA=76.46;ESP_AF_EA=99.77;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=5564;PUBMED=19917125;TRANSCRIPT_ID=NM_005732.3;HGVS_TRANSCRIPT=c.-38G>A;GENE_REGION=5'UTR;GENE_SYMBOL=RAD50	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	131927748	.	T	C	.	PASS	DBSNP=10520116;1000G_AF=1.3;ESP_AF=1.23;ESP_AF_AA=3.59;ESP_AF_EA=0.02;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=6;TRANSCRIPT_ID=NM_005732.3;HGVS_TRANSCRIPT=c.1793+22T>C;GENE_REGION=Intronic;GENE_SYMBOL=RAD50	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr5	131944964	.	C	CT	.	PASS	DBSNP="2066742, 369718330";1000G_AF=7.35;ESP_AF=7.95;ESP_AF_AA=22.84;ESP_AF_EA=0.27;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=116;TRANSCRIPT_ID=NM_005732.3;HGVS_TRANSCRIPT=c.2923-11_2923-10insT;GENE_REGION=Intronic;GENE_SYMBOL=RAD50;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000128884.1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	6026988	.	G	A	.	PASS	DBSNP=1805321;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=35.82;ESP_AF=37.38;ESP_AF_AA=28.19;ESP_AF_EA=42.09;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=920;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1378;ING_AFFECTED_HOM=254;PUBMED=24735542,24838835,16774946,19543528,22183965,16619239,21212431,24728327,23017166,10479499,21681824,17993636,19526325,22949387,18241037,20698049,21984973,23709753,22703879,15256438,16472587,23629955;TRANSCRIPT_ID=NR_003085.2;GENE_REGION=ncRNA;GENE_SYMBOL=PMS2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	6026988	.	G	A	.	PASS	DBSNP=1805321;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=35.82;ESP_AF=37.38;ESP_AF_AA=28.19;ESP_AF_EA=42.09;ING_FINDINGS=75;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=920;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1378;ING_AFFECTED_HOM=254;PUBMED=24735542,24838835,16774946,19543528,22183965,16619239,21212431,24728327,23017166,10479499,21681824,17993636,19526325,22949387,18241037,20698049,21984973,23709753,22703879,15256438,16472587,23629955;TRANSCRIPT_ID=NM_000535.5;HGVS_TRANSCRIPT=c.1408C>T;HGVS_PROTEIN=p.P470S;GENE_REGION=Exonic;GENE_SYMBOL=PMS2;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=3;CLINVAR="RCV000030364.2; RCV000144645.1; RCV000130721.1";ING_MIN_PROTEIN_LENGTH=863	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	6036980	.	G	C	.	PASS	DBSNP=1805319;1000G_AF=83.13;ESP_AF=82.38;ESP_AF_AA=84.14;ESP_AF_EA=81.48;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4395;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=403;ING_AFFECTED_HOM=49;PUBMED=24735542,17417778,16619239,21212431,23017166,23709753,16472587,23629955;TRANSCRIPT_ID=NR_003085.2;GENE_REGION=ncRNA;GENE_SYMBOL=PMS2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	6036980	.	G	C	.	PASS	DBSNP=1805319;1000G_AF=83.13;ESP_AF=82.38;ESP_AF_AA=84.14;ESP_AF_EA=81.48;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4395;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=403;ING_AFFECTED_HOM=49;PUBMED=24735542,17417778,16619239,21212431,23017166,23709753,16472587,23629955;TRANSCRIPT_ID=NM_000535.5;HGVS_TRANSCRIPT=c.780C>G;HGVS_PROTEIN=p.S260S;GENE_REGION=Exonic;GENE_SYMBOL=PMS2;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000131484.1; RCV000030372.2";ING_MIN_PROTEIN_LENGTH=863	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	6038722	.	T	C	.	PASS	DBSNP=62456182;1000G_AF=32.57;ESP_AF=34.39;ESP_AF_AA=20.27;ESP_AF_EA=41.63;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=815;ING_AFFECTED=9;ING_AFFECTED_HOM=3;PUBMED=15521988,23709753,16472587;TRANSCRIPT_ID=NM_000535.5;HGVS_TRANSCRIPT=c.705+17A>G;GENE_REGION=Intronic;GENE_SYMBOL=PMS2;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000030371.2; RCV000130741.1"	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214348	.	C	T	.	PASS	DBSNP=2072454;1000G_AF=47.54;ESP_AF=51.51;ESP_AF_AA=49.55;ESP_AF_EA=52.52;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1745;ING_DRUGGED_GENE=Y;ING_AFFECTED=4;PUBMED=17088437;TRANSCRIPT_ID=NM_201282.1;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=629	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214348	.	C	T	.	PASS	DBSNP=2072454;1000G_AF=47.54;ESP_AF=51.51;ESP_AF_AA=49.55;ESP_AF_EA=52.52;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1745;ING_DRUGGED_GENE=Y;ING_AFFECTED=4;PUBMED=17088437;TRANSCRIPT_ID=NM_201284.1;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=706	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214348	.	C	T	.	PASS	DBSNP=2072454;1000G_AF=47.54;ESP_AF=51.51;ESP_AF_AA=49.55;ESP_AF_EA=52.52;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1745;ING_DRUGGED_GENE=Y;ING_AFFECTED=4;PUBMED=17088437;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1211	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214348	.	C	T	.	PASS	DBSNP=2072454;1000G_AF=47.54;ESP_AF=51.51;ESP_AF_AA=49.55;ESP_AF_EA=52.52;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1745;ING_DRUGGED_GENE=Y;ING_AFFECTED=4;PUBMED=17088437;TRANSCRIPT_ID=NM_201283.1;HGVS_TRANSCRIPT=c.474C>T;HGVS_PROTEIN=p.N158N;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=406	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214443	.	G	A	.	PASS	DBSNP=7801956;1000G_AF=5.53;ESP_AF=6.79;ESP_AF_AA=2.18;ESP_AF_EA=9.15;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=33;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201282.1;HGVS_TRANSCRIPT=c.559+10G>A;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214443	.	G	A	.	PASS	DBSNP=7801956;1000G_AF=5.53;ESP_AF=6.79;ESP_AF_AA=2.18;ESP_AF_EA=9.15;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=33;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201284.1;HGVS_TRANSCRIPT=c.559+10G>A;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214443	.	G	A	.	PASS	DBSNP=7801956;1000G_AF=5.53;ESP_AF=6.79;ESP_AF_AA=2.18;ESP_AF_EA=9.15;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=33;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.559+10G>A;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55214443	.	G	A	.	PASS	DBSNP=7801956;1000G_AF=5.53;ESP_AF=6.79;ESP_AF_AA=2.18;ESP_AF_EA=9.15;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=33;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201283.1;HGVS_TRANSCRIPT=c.559+10G>A;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55223554	.	C	T	.	PASS	DBSNP=17289893;1000G_AF=0.16;ESP_AF=0.31;ESP_AF_AA=0.91;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201282.1;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.C307C;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=13;ING_MIN_PROTEIN_LENGTH=629	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55223554	.	C	T	.	PASS	DBSNP=17289893;1000G_AF=0.16;ESP_AF=0.31;ESP_AF_AA=0.91;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201284.1;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.C307C;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=13;ING_MIN_PROTEIN_LENGTH=706	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55223554	.	C	T	.	PASS	DBSNP=17289893;1000G_AF=0.16;ESP_AF=0.31;ESP_AF_AA=0.91;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.C307C;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=13;ING_MIN_PROTEIN_LENGTH=1211	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55223554	.	C	T	.	PASS	DBSNP=17289893;1000G_AF=0.16;ESP_AF=0.31;ESP_AF_AA=0.91;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=1;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_201283.1;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.C307C;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=13;ING_MIN_PROTEIN_LENGTH=406	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55228053	.	A	T	.	PASS	DBSNP=1558544;1000G_AF=77.34;ESP_AF=66.34;ESP_AF_AA=52.34;ESP_AF_EA=73.51;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=2969;ING_DRUGGED_GENE=Y;PUBMED=23912956;TRANSCRIPT_ID=NM_201282.1;HGVS_TRANSCRIPT=c.1498+22A>T;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	55228053	.	A	T	.	PASS	DBSNP=1558544;1000G_AF=77.34;ESP_AF=66.34;ESP_AF_AA=52.34;ESP_AF_EA=73.51;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=2969;ING_DRUGGED_GENE=Y;PUBMED=23912956;TRANSCRIPT_ID=NM_201284.1;HGVS_TRANSCRIPT=c.1498+22A>T;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	55228053	.	A	T	.	PASS	DBSNP=1558544;1000G_AF=77.34;ESP_AF=66.34;ESP_AF_AA=52.34;ESP_AF_EA=73.51;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=2969;ING_DRUGGED_GENE=Y;PUBMED=23912956;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.1498+22A>T;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	55238087	.	C	T	.	PASS	DBSNP=10258429;1000G_AF=11.24;ESP_AF=11.75;ESP_AF_AA=20.93;ESP_AF_EA=7.05;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=124;ING_DRUGGED_GENE=Y;ING_AFFECTED=2;TRANSCRIPT_ID=NM_201284.1;HGVS_TRANSCRIPT=c.1968C>T;HGVS_PROTEIN=p.H656H;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=706	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55238087	.	C	T	.	PASS	DBSNP=10258429;1000G_AF=11.24;ESP_AF=11.75;ESP_AF_AA=20.93;ESP_AF_EA=7.05;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=124;ING_DRUGGED_GENE=Y;ING_AFFECTED=2;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.1881-781C>T;GENE_REGION=Intronic;GENE_SYMBOL=EGFR	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55238874	.	T	A	.	PASS	DBSNP=2227984;1000G_AF=39.04;ESP_AF=32.25;ESP_AF_AA=27.53;ESP_AF_EA=34.66;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=705;ING_DRUGGED_GENE=Y;ING_AFFECTED=1;PUBMED=22183965,17088437;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.1887T>A;HGVS_PROTEIN=p.T629T;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1211	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	55266417	.	T	C	.	PASS	DBSNP=1140475;1000G_AF=91.67;ESP_AF=88.91;ESP_AF_AA=91.99;ESP_AF_EA=87.33;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non-small cell lung cancer";ESP_PUBLIC_HOMOZYGOTES=5159;ING_DRUGGED_GENE=Y;ING_AFFECTED=16;ING_AFFECTED_HOM=3;ING_UNAFFECTED=5;PUBMED=18182111;TRANSCRIPT_ID=NM_005228.3;HGVS_TRANSCRIPT=c.2709T>C *;HGVS_PROTEIN=p.T903T;GENE_REGION=Exonic;GENE_SYMBOL=EGFR;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1211	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr7	116399698	.	C	G	.	PASS	1000G_AF=0.16;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=atherosclerosis;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_001127500.1;HGVS_TRANSCRIPT=c.2418+154C>G;GENE_REGION=Intronic;GENE_SYMBOL=MET	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	116399698	.	C	G	.	PASS	1000G_AF=0.16;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=atherosclerosis;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_000245.2;HGVS_TRANSCRIPT=c.2364+154C>G;GENE_REGION=Intronic;GENE_SYMBOL=MET	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	116409675	.	CT	C	.	PASS	DBSNP=72220100;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=atherosclerosis;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_001127500.1;HGVS_TRANSCRIPT=c.2638-23delT;GENE_REGION=Intronic;GENE_SYMBOL=MET	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr7	116409675	.	CT	C	.	PASS	DBSNP=72220100;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=atherosclerosis;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_000245.2;HGVS_TRANSCRIPT=c.2584-23delT;GENE_REGION=Intronic;GENE_SYMBOL=MET	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	90967711	.	A	G	.	PASS	DBSNP=709816;1000G_AF=60.86;ESP_AF=49.03;ESP_AF_AA=75.27;ESP_AF_EA=35.59;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=1782;ING_AFFECTED=4902;ING_AFFECTED_HOM=959;PUBMED=18593981,19383352,24853695,14684699,16810201,24093751,19917125,22982660,15924337,16714331,24674628,18270339,12023982,22864661,19151620,17894553,20571895,18691878,12066197,12353271,20478923,24349281,21898661,24166361,12036913,19276285,22752646,19452044,21472885,19523210;TRANSCRIPT_ID=NM_002485.4;HGVS_TRANSCRIPT=c.1197T>C;HGVS_PROTEIN=p.D399D;GENE_REGION=Exonic;GENE_SYMBOL=NBN;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=755	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145737374	.	C	T	.	PASS	DBSNP=34915097;SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=0.2;ESP_AF=0.37;ESP_AF_AA=1.07;ESP_AF_EA=0.02;ING_FINDINGS=2;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=1;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1;PUBMED=18504617,24728327;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.3313G>A;HGVS_PROTEIN=p.G1105S;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:gain
chr8	145737514	.	G	A	.	PASS	DBSNP=4244610;1000G_AF=43.33;ESP_AF=39.32;ESP_AF_AA=24.58;ESP_AF_EA=46.35;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=1047;PUBMED=23418865;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.3236+13C>T;GENE_REGION=Intronic;GENE_SYMBOL=RECQL4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145737636	.	A	G	.	PASS	DBSNP=4925828;1000G_AF=94.61;ESP_AF=99.84;ESP_AF_AA=99.71;ESP_AF_EA=99.90;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=6253;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.3127T>C *;HGVS_PROTEIN=p.L1043L;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr8	145738213	.	T	TA	.	PASS	1000G_AF=0.32;ESP_AF=0.49;ESP_AF_AA=1.46;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=5;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.2755+16_2755+17insT;GENE_REGION=Intronic;GENE_SYMBOL=RECQL4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145738384	.	G	C	.	PASS	DBSNP=34358597;1000G_AF=0.34;ESP_AF=0.29;ESP_AF_AA=0.90;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=1;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.2601C>G;HGVS_PROTEIN=p.A867A;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145738767	.	CG	C	.	PASS	DBSNP=11342077;1000G_AF=100.0;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="rothmund-thomson syndrome";TRANSCRIPT_ID=NM_004260.3;GENE_REGION=MismatchInsertionToRefseq;GENE_SYMBOL=RECQL4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr8	145739679	.	G	A	.	PASS	DBSNP=2721191;SIFT_FUNCTION=Damaging;POLYPHEN_FUNCTION=Benign;PHYLOP=6.699E-4;1000G_AF=2.92;ESP_AF=2.81;ESP_AF_AA=8.37;ESP_AF_EA=0.05;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=16;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1;PUBMED=18504617,24728327;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.1772C>T;HGVS_PROTEIN=p.P591L;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145741702	.	C	G	.	PASS	DBSNP=4244612;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=44.77;ESP_AF=39.19;ESP_AF_AA=41.01;ESP_AF_EA=38.32;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rothmund-thomson syndrome";ESP_PUBLIC_HOMOZYGOTES=976;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=6;ING_AFFECTED_HOM=1;PUBMED=23418865,25069792,22183965,24728327;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.801G>C;HGVS_PROTEIN=p.E267D;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=missense;BLOSUM50=2;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145742514	.	A	G	.	PASS	DBSNP=2721190;1000G_AF=94.33;ESP_AF=99.52;ESP_AF_AA=98.65;ESP_AF_EA=99.93;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=6045;ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=25069792,22183965,24728327;TRANSCRIPT_ID=NM_014665.3;HGVS_TRANSCRIPT=c.-1023A>G;GENE_REGION=Promoter;GENE_SYMBOL=LRRC14	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr8	145742514	.	A	G	.	PASS	DBSNP=2721190;1000G_AF=94.33;ESP_AF=99.52;ESP_AF_AA=98.65;ESP_AF_EA=99.93;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=6045;ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=25069792,22183965,24728327;TRANSCRIPT_ID=NM_001272036.1;HGVS_TRANSCRIPT=c.-1090A>G;GENE_REGION=Promoter;GENE_SYMBOL=LRRC14	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr8	145742514	.	A	G	.	PASS	DBSNP=2721190;1000G_AF=94.33;ESP_AF=99.52;ESP_AF_AA=98.65;ESP_AF_EA=99.93;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=6045;ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=25069792,22183965,24728327;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.274T>C *;HGVS_PROTEIN=p.P92P;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr8	145742879	.	T	C	.	PASS	DBSNP=2306386;1000G_AF=57.51;ESP_AF=55.07;ESP_AF_AA=63.50;ESP_AF_EA=51.48;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1769;ING_AFFECTED=106;ING_AFFECTED_HOM=33;ING_UNAFFECTED=111;PUBMED=23418865,17494052,18270339;TRANSCRIPT_ID=NM_014665.3;HGVS_TRANSCRIPT=c.-658T>C;GENE_REGION=Promoter;GENE_SYMBOL=LRRC14	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145742879	.	T	C	.	PASS	DBSNP=2306386;1000G_AF=57.51;ESP_AF=55.07;ESP_AF_AA=63.50;ESP_AF_EA=51.48;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1769;ING_AFFECTED=106;ING_AFFECTED_HOM=33;ING_UNAFFECTED=111;PUBMED=23418865,17494052,18270339;TRANSCRIPT_ID=NM_001272036.1;HGVS_TRANSCRIPT=c.-725T>C;GENE_REGION=Promoter;GENE_SYMBOL=LRRC14	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr8	145742879	.	T	C	.	PASS	DBSNP=2306386;1000G_AF=57.51;ESP_AF=55.07;ESP_AF_AA=63.50;ESP_AF_EA=51.48;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="gastric adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1769;ING_AFFECTED=106;ING_AFFECTED_HOM=33;ING_UNAFFECTED=111;PUBMED=23418865,17494052,18270339;TRANSCRIPT_ID=NM_004260.3;HGVS_TRANSCRIPT=c.132A>G;HGVS_PROTEIN=p.E44E;GENE_REGION=Exonic;GENE_SYMBOL=RECQL4;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=1209	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	5050706	.	C	T	.	PASS	DBSNP=2230722;1000G_AF=35.82;ESP_AF=35.65;ESP_AF_AA=46.46;ESP_AF_EA=30.10;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="polycythemia vera";ESP_PUBLIC_HOMOZYGOTES=854;ING_DRUGGED_GENE=Y;ING_AFFECTED=243;ING_AFFECTED_HOM=55;PUBMED=23670291,17639043;TRANSCRIPT_ID=NM_004972.3;HGVS_TRANSCRIPT=c.489C>T;HGVS_PROTEIN=p.H163H;GENE_REGION=Exonic;GENE_SYMBOL=JAK2;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1133	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	5081780	.	G	A	.	PASS	DBSNP=2230724;1000G_AF=61.68;ESP_AF=62.43;ESP_AF_AA=86.81;ESP_AF_EA=49.93;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="polycythemia vera";ESP_PUBLIC_HOMOZYGOTES=2744;ING_DRUGGED_GENE=Y;ING_AFFECTED=18;PUBMED=23670291,17639043,19077438;TRANSCRIPT_ID=NM_004972.3;HGVS_TRANSCRIPT=c.2490G>A;HGVS_PROTEIN=p.L830L;GENE_REGION=Exonic;GENE_SYMBOL=JAK2;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1133	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	5090934	.	A	T	.	PASS	DBSNP=2274649;1000G_AF=24.12;ESP_AF=22.64;ESP_AF_AA=13.51;ESP_AF_EA=27.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="polycythemia vera";ESP_PUBLIC_HOMOZYGOTES=346;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_004972.3;HGVS_TRANSCRIPT=c.3059+23A>T;GENE_REGION=Intronic;GENE_SYMBOL=JAK2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	21968199	.	C	G	.	PASS	DBSNP=11515;1000G_AF=90.22;ESP_AF=84.91;ESP_AF_AA=83.82;ESP_AF_EA=85.48;ING_FINDINGS=18;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4714;ING_AFFECTED=831;ING_AFFECTED_HOM=86;ING_UNAFFECTED=20;PUBMED=21159888,18507837,17505264,23546221,19680556,22939228,19543528,17108146,19237606,19626602,18174243,19124506,20922573;TRANSCRIPT_ID=NM_058197.4;HGVS_TRANSCRIPT=c.*423G>C;GENE_REGION=3'UTR;GENE_SYMBOL=CDKN2A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	21968199	.	C	G	.	PASS	DBSNP=11515;1000G_AF=90.22;ESP_AF=84.91;ESP_AF_AA=83.82;ESP_AF_EA=85.48;ING_FINDINGS=18;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4714;ING_AFFECTED=831;ING_AFFECTED_HOM=86;ING_UNAFFECTED=20;PUBMED=21159888,18507837,17505264,23546221,19680556,22939228,19543528,17108146,19237606,19626602,18174243,19124506,20922573;TRANSCRIPT_ID=NM_000077.4;HGVS_TRANSCRIPT=c.*29G>C;GENE_REGION=3'UTR;GENE_SYMBOL=CDKN2A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	21968199	.	C	G	.	PASS	DBSNP=11515;1000G_AF=90.22;ESP_AF=84.91;ESP_AF_AA=83.82;ESP_AF_EA=85.48;ING_FINDINGS=18;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4714;ING_AFFECTED=831;ING_AFFECTED_HOM=86;ING_UNAFFECTED=20;PUBMED=21159888,18507837,17505264,23546221,19680556,22939228,19543528,17108146,19237606,19626602,18174243,19124506,20922573;TRANSCRIPT_ID=NM_001195132.1;HGVS_TRANSCRIPT=c.*193G>C;GENE_REGION=3'UTR;GENE_SYMBOL=CDKN2A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	21968199	.	C	G	.	PASS	DBSNP=11515;1000G_AF=90.22;ESP_AF=84.91;ESP_AF_AA=83.82;ESP_AF_EA=85.48;ING_FINDINGS=18;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=4714;ING_AFFECTED=831;ING_AFFECTED_HOM=86;ING_UNAFFECTED=20;PUBMED=21159888,18507837,17505264,23546221,19680556,22939228,19543528,17108146,19237606,19626602,18174243,19124506,20922573;TRANSCRIPT_ID=NM_058195.3;HGVS_TRANSCRIPT=c.*144G>C;GENE_REGION=3'UTR;GENE_SYMBOL=CDKN2A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280550.1;HGVS_TRANSCRIPT=c.791C>T;HGVS_PROTEIN=p.T264I;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=296	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280554.1;HGVS_TRANSCRIPT=c.981C>T;HGVS_PROTEIN=p.Y327Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=349	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280547.1;HGVS_TRANSCRIPT=c.1008C>T;HGVS_PROTEIN=p.Y336Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=358	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280552.1;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.Y307Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=329	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280553.1;HGVS_TRANSCRIPT=c.894C>T;HGVS_PROTEIN=p.Y298Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=320	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280551.1;HGVS_TRANSCRIPT=c.597C>T;HGVS_PROTEIN=p.Y199Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=221	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280556.1;HGVS_TRANSCRIPT=c.786C>T;HGVS_PROTEIN=p.Y262Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=284	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_016734.2;HGVS_TRANSCRIPT=c.1110C>T;HGVS_PROTEIN=p.Y370Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=392	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NR_104000.1;GENE_REGION=ncRNA;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280549.1;HGVS_TRANSCRIPT=c.878C>T;HGVS_PROTEIN=p.T293I;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=325	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280548.1;HGVS_TRANSCRIPT=c.1023C>T;HGVS_PROTEIN=p.Y341Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=363	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NM_001280555.1;HGVS_TRANSCRIPT=c.810C>T;HGVS_PROTEIN=p.Y270Y;GENE_REGION=Exonic;GENE_SYMBOL=PAX5;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=292	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	36840623	.	G	A	.	PASS	DBSNP=3780135;SIFT_FUNCTION=Tolerated;1000G_AF=74.2;ESP_AF=76.31;ESP_AF_AA=42.08;ESP_AF_EA=93.81;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=4166;ING_AFFECTED=1;PUBMED=24728327;TRANSCRIPT_ID=NR_103999.1;GENE_REGION=ncRNA;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280550.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280554.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280547.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280552.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280553.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280551.1;HGVS_TRANSCRIPT=c.-112-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280556.1;HGVS_TRANSCRIPT=c.-112-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_016734.2;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280549.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280548.1;HGVS_TRANSCRIPT=c.213-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37015234	.	A	G	.	PASS	DBSNP=73646310;1000G_AF=3.49;ESP_AF=3.33;ESP_AF_AA=9.69;ESP_AF_EA=0.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=12;TRANSCRIPT_ID=NM_001280555.1;HGVS_TRANSCRIPT=c.212+5399T>C;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280550.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280554.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280547.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280552.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280553.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280551.1;HGVS_TRANSCRIPT=c.-112-5431T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280556.1;HGVS_TRANSCRIPT=c.-112-5431T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_016734.2;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280549.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280548.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	37020622	.	A	C	.	PASS	DBSNP=2297105;1000G_AF=55.17;ESP_AF=46.94;ESP_AF_AA=61.67;ESP_AF_EA=39.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="primary central nervous system lymphoma";ESP_PUBLIC_HOMOZYGOTES=1494;TRANSCRIPT_ID=NM_001280555.1;HGVS_TRANSCRIPT=c.212+11T>G;GENE_REGION=Intronic;GENE_SYMBOL=PAX5	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083603.1;HGVS_TRANSCRIPT=c.2884+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083606.1;HGVS_TRANSCRIPT=c.2434+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083605.1;HGVS_TRANSCRIPT=c.2434+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_000264.3;HGVS_TRANSCRIPT=c.2887+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083607.1;HGVS_TRANSCRIPT=c.2434+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083604.1;HGVS_TRANSCRIPT=c.2434+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98221861	.	T	C	.	PASS	DBSNP=2236406;1000G_AF=39.26;ESP_AF=45.59;ESP_AF_AA=64.62;ESP_AF_EA=35.85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=1483;TRANSCRIPT_ID=NM_001083602.1;HGVS_TRANSCRIPT=c.2689+21A>G;GENE_REGION=Intronic;GENE_SYMBOL=PTCH1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083603.1;HGVS_TRANSCRIPT=c.2180C>T;HGVS_PROTEIN=p.T727M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1447	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083606.1;HGVS_TRANSCRIPT=c.1730C>T;HGVS_PROTEIN=p.T577M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083605.1;HGVS_TRANSCRIPT=c.1730C>T;HGVS_PROTEIN=p.T577M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_000264.3;HGVS_TRANSCRIPT=c.2183C>T;HGVS_PROTEIN=p.T728M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000008705.1; OMIM_gene:601309.0012";ING_MIN_PROTEIN_LENGTH=1448	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083607.1;HGVS_TRANSCRIPT=c.1730C>T;HGVS_PROTEIN=p.T577M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083604.1;HGVS_TRANSCRIPT=c.1730C>T;HGVS_PROTEIN=p.T577M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98231100	.	G	A	.	PASS	DBSNP=115556836;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=2.128E-4;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_FINDINGS=5;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=11941477,17237122,20981092,17096318,22703879,24728327;TRANSCRIPT_ID=NM_001083602.1;HGVS_TRANSCRIPT=c.1985C>T;HGVS_PROTEIN=p.T662M;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1382	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083603.1;HGVS_TRANSCRIPT=c.1662T>C;HGVS_PROTEIN=p.N554N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1447	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083606.1;HGVS_TRANSCRIPT=c.1212T>C;HGVS_PROTEIN=p.N404N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083605.1;HGVS_TRANSCRIPT=c.1212T>C;HGVS_PROTEIN=p.N404N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_000264.3;HGVS_TRANSCRIPT=c.1665T>C;HGVS_PROTEIN=p.N555N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1448	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083607.1;HGVS_TRANSCRIPT=c.1212T>C;HGVS_PROTEIN=p.N404N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083604.1;HGVS_TRANSCRIPT=c.1212T>C;HGVS_PROTEIN=p.N404N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98238379	.	A	G	.	PASS	DBSNP=1805155;1000G_AF=11.16;ESP_AF=13.09;ESP_AF_AA=18.45;ESP_AF_EA=10.35;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=126;ING_AFFECTED=58;ING_AFFECTED_HOM=8;ING_UNAFFECTED=44;PUBMED=18538319,21188540,18302678;TRANSCRIPT_ID=NM_001083602.1;HGVS_TRANSCRIPT=c.1467T>C;HGVS_PROTEIN=p.N489N;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=1382	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083603.1;HGVS_TRANSCRIPT=c.1116C>T;HGVS_PROTEIN=p.Y372Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1447	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083606.1;HGVS_TRANSCRIPT=c.666C>T;HGVS_PROTEIN=p.Y222Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083605.1;HGVS_TRANSCRIPT=c.666C>T;HGVS_PROTEIN=p.Y222Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_000264.3;HGVS_TRANSCRIPT=c.1119C>T;HGVS_PROTEIN=p.Y373Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1448	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083607.1;HGVS_TRANSCRIPT=c.666C>T;HGVS_PROTEIN=p.Y222Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083604.1;HGVS_TRANSCRIPT=c.666C>T;HGVS_PROTEIN=p.Y222Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241378	.	G	A	.	PASS	DBSNP=2066831;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083602.1;HGVS_TRANSCRIPT=c.921C>T;HGVS_PROTEIN=p.Y307Y;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1382	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083603.1;HGVS_TRANSCRIPT=c.1071T>C;HGVS_PROTEIN=p.H357H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1447	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083606.1;HGVS_TRANSCRIPT=c.621T>C;HGVS_PROTEIN=p.H207H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083605.1;HGVS_TRANSCRIPT=c.621T>C;HGVS_PROTEIN=p.H207H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_000264.3;HGVS_TRANSCRIPT=c.1074T>C;HGVS_PROTEIN=p.H358H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1448	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083607.1;HGVS_TRANSCRIPT=c.621T>C;HGVS_PROTEIN=p.H207H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083604.1;HGVS_TRANSCRIPT=c.621T>C;HGVS_PROTEIN=p.H207H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1297	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	98241423	.	A	G	.	PASS	DBSNP=2066832;1000G_AF=0.54;ESP_AF=0.74;ESP_AF_AA=2.18;ESP_AF_EA=0.00;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="basal cell nevus syndrome";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001083602.1;HGVS_TRANSCRIPT=c.876T>C;HGVS_PROTEIN=p.H292H;GENE_REGION=Exonic;GENE_SYMBOL=PTCH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=1382	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135777121	.	A	G	.	PASS	DBSNP=11243931;1000G_AF=17.49;ESP_AF=21.51;ESP_AF_AA=34.59;ESP_AF_EA=14.80;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=379;ING_AFFECTED=38;ING_UNAFFECTED=1;PUBMED=10363127,16981987,10533066,10533067,17304050;TRANSCRIPT_ID=NM_001162427.1;HGVS_TRANSCRIPT=c.2239-35T>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135777121	.	A	G	.	PASS	DBSNP=11243931;1000G_AF=17.49;ESP_AF=21.51;ESP_AF_AA=34.59;ESP_AF_EA=14.80;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=379;ING_AFFECTED=38;ING_UNAFFECTED=1;PUBMED=10363127,16981987,10533066,10533067,17304050;TRANSCRIPT_ID=NM_000368.4;HGVS_TRANSCRIPT=c.2392-35T>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC1;CLINVAR_OBSERVATIONS=7;CLINVAR=RCV000042199.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135777121	.	A	G	.	PASS	DBSNP=11243931;1000G_AF=17.49;ESP_AF=21.51;ESP_AF_AA=34.59;ESP_AF_EA=14.80;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=379;ING_AFFECTED=38;ING_UNAFFECTED=1;PUBMED=10363127,16981987,10533066,10533067,17304050;TRANSCRIPT_ID=NM_001162426.1;HGVS_TRANSCRIPT=c.2389-35T>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135781563	.	G	A	.	PASS	DBSNP=10901220;1000G_AF=13.88;ESP_AF=15.61;ESP_AF_AA=20.36;ESP_AF_EA=13.20;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=170;ING_AFFECTED=6;PUBMED=11179759,10533067;TRANSCRIPT_ID=NM_001162427.1;HGVS_TRANSCRIPT=c.1286-37C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135781563	.	G	A	.	PASS	DBSNP=10901220;1000G_AF=13.88;ESP_AF=15.61;ESP_AF_AA=20.36;ESP_AF_EA=13.20;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=170;ING_AFFECTED=6;PUBMED=11179759,10533067;TRANSCRIPT_ID=NM_000368.4;HGVS_TRANSCRIPT=c.1439-37C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC1;CLINVAR_OBSERVATIONS=4;CLINVAR=RCV000042031.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135781563	.	G	A	.	PASS	DBSNP=10901220;1000G_AF=13.88;ESP_AF=15.61;ESP_AF_AA=20.36;ESP_AF_EA=13.20;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=170;ING_AFFECTED=6;PUBMED=11179759,10533067;TRANSCRIPT_ID=NM_001162426.1;HGVS_TRANSCRIPT=c.1436-37C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135782221	.	T	C	.	PASS	DBSNP=7862221;1000G_AF=13.86;ESP_AF=17.09;ESP_AF_AA=21.90;ESP_AF_EA=14.63;ING_FINDINGS=17;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=221;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=60;ING_UNAFFECTED=62;PUBMED=21102627,9328481,16042315,18772611,11179759,12111193,10363127,11058899,15477556,21555252,10533067,11437991;TRANSCRIPT_ID=NM_001162427.1;HGVS_TRANSCRIPT=c.1182A>G;HGVS_PROTEIN=p.E394E;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=1114	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135782221	.	T	C	.	PASS	DBSNP=7862221;1000G_AF=13.86;ESP_AF=17.09;ESP_AF_AA=21.90;ESP_AF_EA=14.63;ING_FINDINGS=17;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=221;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=60;ING_UNAFFECTED=62;PUBMED=21102627,9328481,16042315,18772611,11179759,12111193,10363127,11058899,15477556,21555252,10533067,11437991;TRANSCRIPT_ID=NM_000368.4;HGVS_TRANSCRIPT=c.1335A>G;HGVS_PROTEIN=p.E445E;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;CLINVAR_OBSERVATIONS=14;CLINVAR=RCV000042015.2;ING_MIN_PROTEIN_LENGTH=1165	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135782221	.	T	C	.	PASS	DBSNP=7862221;1000G_AF=13.86;ESP_AF=17.09;ESP_AF_AA=21.90;ESP_AF_EA=14.63;ING_FINDINGS=17;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=221;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=60;ING_UNAFFECTED=62;PUBMED=21102627,9328481,16042315,18772611,11179759,12111193,10363127,11058899,15477556,21555252,10533067,11437991;TRANSCRIPT_ID=NM_001162426.1;HGVS_TRANSCRIPT=c.1332A>G;HGVS_PROTEIN=p.E444E;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=1164	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786112	.	T	C	.	PASS	DBSNP=6597586;1000G_AF=13.46;ESP_AF=16.49;ESP_AF_AA=21.83;ESP_AF_EA=13.76;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_AFFECTED=14;ING_UNAFFECTED=1;PUBMED=16981987;TRANSCRIPT_ID=NM_001162427.1;HGVS_TRANSCRIPT=c.989-33A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786112	.	T	C	.	PASS	DBSNP=6597586;1000G_AF=13.46;ESP_AF=16.49;ESP_AF_AA=21.83;ESP_AF_EA=13.76;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_AFFECTED=14;ING_UNAFFECTED=1;PUBMED=16981987;TRANSCRIPT_ID=NM_000368.4;HGVS_TRANSCRIPT=c.1142-33A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC1;CLINVAR_OBSERVATIONS=5;CLINVAR="RCV000041994.2; RCV000055040.1"	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786112	.	T	C	.	PASS	DBSNP=6597586;1000G_AF=13.46;ESP_AF=16.49;ESP_AF_AA=21.83;ESP_AF_EA=13.76;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_AFFECTED=14;ING_UNAFFECTED=1;PUBMED=16981987;TRANSCRIPT_ID=NM_001162426.1;HGVS_TRANSCRIPT=c.1142-36A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786904	.	A	G	.	PASS	DBSNP=1073123;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=13.52;ESP_AF=16.55;ESP_AF_AA=21.95;ESP_AF_EA=13.78;ING_FINDINGS=28;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=246;ING_UNAFFECTED=21;PUBMED=23180272,9328481,23254740,18772611,21510812,16981987,11058899,11208653,9863590,24728327,10607950,21102627,24073910,10363127,15595939,15477556,9924605,21984973,10533067,22703879,10570911;TRANSCRIPT_ID=NM_001162427.1;HGVS_TRANSCRIPT=c.812T>C;HGVS_PROTEIN=p.M271T;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1114	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786904	.	A	G	.	PASS	DBSNP=1073123;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=13.52;ESP_AF=16.55;ESP_AF_AA=21.95;ESP_AF_EA=13.78;ING_FINDINGS=28;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=246;ING_UNAFFECTED=21;PUBMED=23180272,9328481,23254740,18772611,21510812,16981987,11058899,11208653,9863590,24728327,10607950,21102627,24073910,10363127,15595939,15477556,9924605,21984973,10533067,22703879,10570911;TRANSCRIPT_ID=NM_000368.4;HGVS_TRANSCRIPT=c.965T>C;HGVS_PROTEIN=p.M322T;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=26;CLINVAR="RCV000054992.1; RCV000054853.1";ING_MIN_PROTEIN_LENGTH=1165	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr9	135786904	.	A	G	.	PASS	DBSNP=1073123;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=13.52;ESP_AF=16.55;ESP_AF_AA=21.95;ESP_AF_EA=13.78;ING_FINDINGS=28;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=210;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=246;ING_UNAFFECTED=21;PUBMED=23180272,9328481,23254740,18772611,21510812,16981987,11058899,11208653,9863590,24728327,10607950,21102627,24073910,10363127,15595939,15477556,9924605,21984973,10533067,22703879,10570911;TRANSCRIPT_ID=NM_001162426.1;HGVS_TRANSCRIPT=c.965T>C;HGVS_PROTEIN=p.M322T;GENE_REGION=Exonic;GENE_SYMBOL=TSC1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;ING_MIN_PROTEIN_LENGTH=1164	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr10	43595968	.	A	G	.	PASS	DBSNP=1800858;1000G_AF=75.36;ESP_AF=80.92;ESP_AF_AA=94.53;ESP_AF_EA=73.94;ING_FINDINGS=110;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=4316;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2630;ING_AFFECTED_HOM=515;ING_UNAFFECTED=1053;PUBMED=14627689,10022819,23114404,23527089,21311890,23059849,10859088,24152999,19853744,22169991,22648184,11953745,20977903,17009072,16443855,14557473,11950855,22345297,18284634,19185836,19138318,9745455,10528857,23441071,22312249,16040858,16877807,15829955,16091499,15834508,14600022,20123584,15548547,11955539,11857550,19443294,21222160,12960220,15933516,14633923,22068382,16646689,24845513,16424056,12181638,21349203,11935126,17108762,18365214,10922382,21490379,12566528,23084198,17267408,17270543,14566559,10323403,16441254,15326638,10521317,12628594;TRANSCRIPT_ID=NM_020630.4;HGVS_TRANSCRIPT=c.135A>G *;HGVS_PROTEIN=p.A45A;GENE_REGION=Exonic;GENE_SYMBOL=RET;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR="OMIM_gene:164761.0038; RCV000014967.1";ING_MIN_PROTEIN_LENGTH=1073	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43595968	.	A	G	.	PASS	DBSNP=1800858;1000G_AF=75.36;ESP_AF=80.92;ESP_AF_AA=94.53;ESP_AF_EA=73.94;ING_FINDINGS=110;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=4316;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2630;ING_AFFECTED_HOM=515;ING_UNAFFECTED=1053;PUBMED=14627689,10022819,23114404,23527089,21311890,23059849,10859088,24152999,19853744,22169991,22648184,11953745,20977903,17009072,16443855,14557473,11950855,22345297,18284634,19185836,19138318,9745455,10528857,23441071,22312249,16040858,16877807,15829955,16091499,15834508,14600022,20123584,15548547,11955539,11857550,19443294,21222160,12960220,15933516,14633923,22068382,16646689,24845513,16424056,12181638,21349203,11935126,17108762,18365214,10922382,21490379,12566528,23084198,17267408,17270543,14566559,10323403,16441254,15326638,10521317,12628594;TRANSCRIPT_ID=NM_020975.4;HGVS_TRANSCRIPT=c.135A>G *;HGVS_PROTEIN=p.A45A;GENE_REGION=Exonic;GENE_SYMBOL=RET;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR=OMIM_gene:164761.0038;ING_MIN_PROTEIN_LENGTH=1115	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43600689	.	A	G	.	PASS	DBSNP=2435352;1000G_AF=39.1;ESP_AF=37.30;ESP_AF_AA=30.22;ESP_AF_EA=40.92;ING_FINDINGS=10;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=910;ING_DRUGGED_GENE=Y;ING_AFFECTED=81;ING_AFFECTED_HOM=22;ING_UNAFFECTED=188;PUBMED=12872262,22169991,21222160,24845513,17108762;TRANSCRIPT_ID=NM_020630.4;HGVS_TRANSCRIPT=c.867+48A>G;GENE_REGION=Intronic;GENE_SYMBOL=RET	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43600689	.	A	G	.	PASS	DBSNP=2435352;1000G_AF=39.1;ESP_AF=37.30;ESP_AF_AA=30.22;ESP_AF_EA=40.92;ING_FINDINGS=10;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=910;ING_DRUGGED_GENE=Y;ING_AFFECTED=81;ING_AFFECTED_HOM=22;ING_UNAFFECTED=188;PUBMED=12872262,22169991,21222160,24845513,17108762;TRANSCRIPT_ID=NM_020975.4;HGVS_TRANSCRIPT=c.867+48A>G;GENE_REGION=Intronic;GENE_SYMBOL=RET	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43604730	.	TG	T	.	PASS	1000G_AF=0.34;ESP_AF=0.70;ESP_AF_AA=1.90;ESP_AF_EA=0.07;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Hirschsprung disease";ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_020630.4;HGVS_TRANSCRIPT=c.1263+53delG;GENE_REGION=Intronic;GENE_SYMBOL=RET	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43604730	.	TG	T	.	PASS	1000G_AF=0.34;ESP_AF=0.70;ESP_AF_AA=1.90;ESP_AF_EA=0.07;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Hirschsprung disease";ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_020975.4;HGVS_TRANSCRIPT=c.1263+53delG;GENE_REGION=Intronic;GENE_SYMBOL=RET	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43606650	.	C	T	.	PASS	DBSNP=9282835;1000G_AF=3.0;ESP_AF=3.41;ESP_AF_AA=9.92;ESP_AF_EA=0.07;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=24;ING_DRUGGED_GENE=Y;ING_AFFECTED=3;PUBMED=21490379,22035350,7581377,9174404;TRANSCRIPT_ID=NM_020630.4;HGVS_TRANSCRIPT=c.1264-5C>T;GENE_REGION=Intronic;GENE_SYMBOL=RET;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000129654.1; RCV000119158.1"	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43606650	.	C	T	.	PASS	DBSNP=9282835;1000G_AF=3.0;ESP_AF=3.41;ESP_AF_AA=9.92;ESP_AF_EA=0.07;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=24;ING_DRUGGED_GENE=Y;ING_AFFECTED=3;PUBMED=21490379,22035350,7581377,9174404;TRANSCRIPT_ID=NM_020975.4;HGVS_TRANSCRIPT=c.1264-5C>T;GENE_REGION=Intronic;GENE_SYMBOL=RET	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43606687	.	A	G	.	PASS	DBSNP=1800860;1000G_AF=77.52;ESP_AF=74.86;ESP_AF_AA=86.25;ESP_AF_EA=69.02;ING_FINDINGS=69;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=3697;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=848;ING_AFFECTED_HOM=141;ING_UNAFFECTED=540;PUBMED=22584711,14627689,10022819,11849247,23114404,21475823,19201392,21222160,19443294,23059849,10859088,24152999,15933516,22169991,11953745,9497256,22068382,24845513,17009072,16424056,16818057,21349203,23617071,17108762,10922382,21490379,18820179,19185836,23084198,12355085,10528857,14566559,21821672,22035350,16091499,10521317,20123584;TRANSCRIPT_ID=NM_020630.4;HGVS_TRANSCRIPT=c.1296A>G;HGVS_PROTEIN=p.A432A;GENE_REGION=Exonic;GENE_SYMBOL=RET;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000131068.1;ING_MIN_PROTEIN_LENGTH=1073	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	43606687	.	A	G	.	PASS	DBSNP=1800860;1000G_AF=77.52;ESP_AF=74.86;ESP_AF_AA=86.25;ESP_AF_EA=69.02;ING_FINDINGS=69;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Hirschsprung disease";ESP_PUBLIC_HOMOZYGOTES=3697;ING_DRUGGED_GENE=Y;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=848;ING_AFFECTED_HOM=141;ING_UNAFFECTED=540;PUBMED=22584711,14627689,10022819,11849247,23114404,21475823,19201392,21222160,19443294,23059849,10859088,24152999,15933516,22169991,11953745,9497256,22068382,24845513,17009072,16424056,16818057,21349203,23617071,17108762,10922382,21490379,18820179,19185836,23084198,12355085,10528857,14566559,21821672,22035350,16091499,10521317,20123584;TRANSCRIPT_ID=NM_020975.4;HGVS_TRANSCRIPT=c.1296A>G;HGVS_PROTEIN=p.A432A;GENE_REGION=Exonic;GENE_SYMBOL=RET;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1115	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	88635779	.	C	A	.	PASS	DBSNP="11528010, 3182217";POLYPHEN_FUNCTION=Benign;1000G_AF=49.98;ESP_AF=38.95;ESP_AF_AA=64.98;ESP_AF_EA=25.62;ING_FINDINGS=12;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1221;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=297;PUBMED=25069792,17344846,21984973,22703879,24728327,16436638;TRANSCRIPT_ID=NM_004329.2;HGVS_TRANSCRIPT=c.4C>A;HGVS_PROTEIN=p.P2T;GENE_REGION=Exonic;GENE_SYMBOL=BMPR1A;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000131909.1;ING_MIN_PROTEIN_LENGTH=533	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	88683122	.	T	C	.	PASS	DBSNP=7074064;1000G_AF=49.66;ESP_AF=38.98;ESP_AF_AA=65.30;ESP_AF_EA=25.50;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1231;TRANSCRIPT_ID=NM_004329.2;HGVS_TRANSCRIPT=c.1343-11T>C;GENE_REGION=Intronic;GENE_SYMBOL=BMPR1A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	89720907	.	T	G	.	PASS	DBSNP=555895;1000G_AF=43.25;ESP_AF=37.86;ESP_AF_AA=47.90;ESP_AF_EA=32.74;ING_FINDINGS=16;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1051;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=648;ING_AFFECTED_HOM=97;PUBMED=10096247,16574322,9371495,11021816,24154570,18805939,9354427,23068025,17636424,17033968,12920084,9443042,10777362,10817502,17563403,11270682,9467011,23695273,11494117,10959096;TRANSCRIPT_ID=NM_000314.4;HGVS_TRANSCRIPT=c.1026+32T>G;GENE_REGION=Intronic;GENE_SYMBOL=PTEN	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	104268877	.	G	C	.	PASS	DBSNP=2281879;1000G_AF=31.73;ESP_AF=35.57;ESP_AF_AA=40.13;ESP_AF_EA=33.23;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=805;ING_AFFECTED=55;ING_AFFECTED_HOM=9;PUBMED=22958902;TRANSCRIPT_ID=NM_016169.3;HGVS_TRANSCRIPT=c.183-49G>C;GENE_REGION=Intronic;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	104268877	.	G	C	.	PASS	DBSNP=2281879;1000G_AF=31.73;ESP_AF=35.57;ESP_AF_AA=40.13;ESP_AF_EA=33.23;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=805;ING_AFFECTED=55;ING_AFFECTED_HOM=9;PUBMED=22958902;TRANSCRIPT_ID=NM_001178133.1;HGVS_TRANSCRIPT=c.183-49G>C;GENE_REGION=Intronic;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr10	104359350	.	T	C	.	PASS	DBSNP=3824756;1000G_AF=24.8;ESP_AF=12.87;ESP_AF_AA=21.84;ESP_AF_EA=8.27;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=124;ING_AFFECTED=12;PUBMED=22958902;TRANSCRIPT_ID=NM_016169.3;HGVS_TRANSCRIPT=c.1022+49T>C;GENE_REGION=Intronic;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr10	104359350	.	T	C	.	PASS	DBSNP=3824756;1000G_AF=24.8;ESP_AF=12.87;ESP_AF_AA=21.84;ESP_AF_EA=8.27;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=124;ING_AFFECTED=12;PUBMED=22958902;TRANSCRIPT_ID=NM_001178133.1;HGVS_TRANSCRIPT=c.1022+49T>C;GENE_REGION=Intronic;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr10	104387019	.	T	C	.	PASS	DBSNP=12414407;1000G_AF=71.96;ESP_AF=68.11;ESP_AF_AA=73.79;ESP_AF_EA=65.21;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=3026;ING_AFFECTED=22;ING_AFFECTED_HOM=11;PUBMED=22958902;TRANSCRIPT_ID=NM_016169.3;HGVS_TRANSCRIPT=c.1365+19T>C;GENE_REGION=Intronic;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr10	104389932	.	T	G	.	PASS	DBSNP=4917980;1000G_AF=99.74;ESP_AF=99.78;ESP_AF_AA=99.36;ESP_AF_EA=100.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=meningioma;ESP_PUBLIC_HOMOZYGOTES=6475;TRANSCRIPT_ID=NM_016169.3;HGVS_TRANSCRIPT=c.*20T>G;GENE_REGION=3'UTR;GENE_SYMBOL=SUFU	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	534242	.	A	G	.	PASS	DBSNP=12628;1000G_AF=29.71;ESP_AF=35.45;ESP_AF_AA=37.49;ESP_AF_EA=34.41;ING_FINDINGS=34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Costello syndrome";ESP_PUBLIC_HOMOZYGOTES=819;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=504;ING_AFFECTED_HOM=68;ING_UNAFFECTED=142;PUBMED=20824047,8175026,23240926,22433386,17314276,18097554,16488657,15503312,23150177,18470943,19280649,18553519,22985334,12540507,14688016,21514184,24578935,17088437,17164262,19787272;TRANSCRIPT_ID=NM_001130442.1;HGVS_TRANSCRIPT=c.81T>C;HGVS_PROTEIN=p.H27H;GENE_REGION=Exonic;GENE_SYMBOL=HRAS;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=190	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	534242	.	A	G	.	PASS	DBSNP=12628;1000G_AF=29.71;ESP_AF=35.45;ESP_AF_AA=37.49;ESP_AF_EA=34.41;ING_FINDINGS=34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Costello syndrome";ESP_PUBLIC_HOMOZYGOTES=819;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=504;ING_AFFECTED_HOM=68;ING_UNAFFECTED=142;PUBMED=20824047,8175026,23240926,22433386,17314276,18097554,16488657,15503312,23150177,18470943,19280649,18553519,22985334,12540507,14688016,21514184,24578935,17088437,17164262,19787272;TRANSCRIPT_ID=NM_005343.2;HGVS_TRANSCRIPT=c.81T>C;HGVS_PROTEIN=p.H27H;GENE_REGION=Exonic;GENE_SYMBOL=HRAS;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=190	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	534242	.	A	G	.	PASS	DBSNP=12628;1000G_AF=29.71;ESP_AF=35.45;ESP_AF_AA=37.49;ESP_AF_EA=34.41;ING_FINDINGS=34;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Costello syndrome";ESP_PUBLIC_HOMOZYGOTES=819;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=504;ING_AFFECTED_HOM=68;ING_UNAFFECTED=142;PUBMED=20824047,8175026,23240926,22433386,17314276,18097554,16488657,15503312,23150177,18470943,19280649,18553519,22985334,12540507,14688016,21514184,24578935,17088437,17164262,19787272;TRANSCRIPT_ID=NM_176795.3;HGVS_TRANSCRIPT=c.81T>C;HGVS_PROTEIN=p.H27H;GENE_REGION=Exonic;GENE_SYMBOL=HRAS;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=171	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130800.2;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130799.2;HGVS_TRANSCRIPT=c.1621A>G *;HGVS_PROTEIN=p.A541A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=611	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130803.2;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130801.2;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130802.2;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_130804.2;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572018	.	T	C	.	PASS	DBSNP=2959656;1000G_AF=83.45;ESP_AF=90.84;ESP_AF_AA=73.76;ESP_AF_EA=99.59;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=5484;ING_AFFECTED=1;PUBMED=21819486,25031887,22183965,22026581,18775714,24997771,22703879,24728327;TRANSCRIPT_ID=NM_000244.3;HGVS_TRANSCRIPT=c.1636A>G *;HGVS_PROTEIN=p.A546A;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130800.2;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130799.2;HGVS_TRANSCRIPT=c.1299T>C *;HGVS_PROTEIN=p.H433H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=611	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130803.2;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130801.2;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130802.2;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_130804.2;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	64572557	.	A	G	.	PASS	DBSNP=540012;1000G_AF=97.6;ESP_AF=97.61;ESP_AF_AA=93.03;ESP_AF_EA=99.97;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="multiple endocrine neoplasia type 1";ESP_PUBLIC_HOMOZYGOTES=6196;ING_AFFECTED=3;PUBMED=16595707,22490989;TRANSCRIPT_ID=NM_000244.3;HGVS_TRANSCRIPT=c.1314T>C *;HGVS_PROTEIN=p.H438H;GENE_REGION=Exonic;GENE_SYMBOL=MEN1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=616	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	94197260	.	A	G	.	PASS	DBSNP=641936;1000G_AF=38.88;ESP_AF=35.21;ESP_AF_AA=37.60;ESP_AF_EA=33.99;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=850;ING_AFFECTED=389;ING_AFFECTED_HOM=76;PUBMED=19383352,18638378,19124506;TRANSCRIPT_ID=NM_005590.3;HGVS_TRANSCRIPT=c.1225+19T>C;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	94197260	.	A	G	.	PASS	DBSNP=641936;1000G_AF=38.88;ESP_AF=35.21;ESP_AF_AA=37.60;ESP_AF_EA=33.99;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=850;ING_AFFECTED=389;ING_AFFECTED_HOM=76;PUBMED=19383352,18638378,19124506;TRANSCRIPT_ID=NM_005591.3;HGVS_TRANSCRIPT=c.1225+19T>C;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	94200962	.	A	G	.	PASS	DBSNP=1805365;1000G_AF=5.39;ESP_AF=5.59;ESP_AF_AA=14.15;ESP_AF_EA=1.21;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=51;ING_AFFECTED=9;PUBMED=18638378,19917125;TRANSCRIPT_ID=NM_005590.3;HGVS_TRANSCRIPT=c.1098+17T>C;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94200962	.	A	G	.	PASS	DBSNP=1805365;1000G_AF=5.39;ESP_AF=5.59;ESP_AF_AA=14.15;ESP_AF_EA=1.21;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=51;ING_AFFECTED=9;PUBMED=18638378,19917125;TRANSCRIPT_ID=NM_005591.3;HGVS_TRANSCRIPT=c.1098+17T>C;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000128913.1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94212048	.	C	T	.	PASS	DBSNP="111177591, 535801";1000G_AF=31.31;ESP_AF=26.96;ESP_AF_AA=20.81;ESP_AF_EA=30.11;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=517;ING_AFFECTED=595;ING_AFFECTED_HOM=59;PUBMED=19383352,18638378,23457540;TRANSCRIPT_ID=NM_005590.3;HGVS_TRANSCRIPT=c.403-6G>A;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94212048	.	C	T	.	PASS	DBSNP="111177591, 535801";1000G_AF=31.31;ESP_AF=26.96;ESP_AF_AA=20.81;ESP_AF_EA=30.11;ING_FINDINGS=5;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=517;ING_AFFECTED=595;ING_AFFECTED_HOM=59;PUBMED=19383352,18638378,23457540;TRANSCRIPT_ID=NM_005591.3;HGVS_TRANSCRIPT=c.403-6G>A;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94212930	.	T	TA	.	PASS	DBSNP=35062043;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="breast cancer";TRANSCRIPT_ID=NM_005590.3;HGVS_TRANSCRIPT=c.315-4_315-3insT;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94212930	.	T	TA	.	PASS	DBSNP=35062043;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="breast cancer";TRANSCRIPT_ID=NM_005591.3;HGVS_TRANSCRIPT=c.315-4_315-3insT;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94225920	.	C	T	.	PASS	DBSNP=497763;1000G_AF=45.73;ESP_AF=41.01;ESP_AF_AA=37.32;ESP_AF_EA=42.90;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=1120;ING_AFFECTED=499;ING_AFFECTED_HOM=119;PUBMED=19383352,18638378,19917125,19584272;TRANSCRIPT_ID=NM_005590.3;HGVS_TRANSCRIPT=c.20+28G>A;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	94225920	.	C	T	.	PASS	DBSNP=497763;1000G_AF=45.73;ESP_AF=41.01;ESP_AF_AA=37.32;ESP_AF_EA=42.90;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="breast cancer";ESP_PUBLIC_HOMOZYGOTES=1120;ING_AFFECTED=499;ING_AFFECTED_HOM=119;PUBMED=19383352,18638378,19917125,19584272;TRANSCRIPT_ID=NM_005591.3;HGVS_TRANSCRIPT=c.20+28G>A;GENE_REGION=Intronic;GENE_SYMBOL=MRE11A	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	108123551	.	C	T	.	PASS	DBSNP=2227922;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=7.063E-4;1000G_AF=0.26;ESP_AF=0.40;ESP_AF_AA=0.61;ESP_AF_EA=0.29;ING_FINDINGS=31;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_COMPLEX_VARIANT=Y;ING_AFFECTED=45;ING_UNAFFECTED=4;PUBMED=17517479,11606401,12149228,22529920,20305132,22190243,16461462,23555315,23322442,12473594,17490827,12810666,24728327,24628946,14735203,22213089,15629612,25587027,17393301,21792198,22995991,12697903,12673797;TRANSCRIPT_ID=NM_000051.3;HGVS_TRANSCRIPT=c.1810C>T;HGVS_PROTEIN=p.P604S;GENE_REGION=Exonic;GENE_SYMBOL=ATM;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000122824.1; RCV000115147.2";ING_MIN_PROTEIN_LENGTH=3057	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr11	108151707	.	T	TA	.	PASS	DBSNP=3218681;1000G_AF=54.21;ESP_AF=55.62;ESP_AF_AA=53.46;ESP_AF_EA=56.72;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1988;TRANSCRIPT_ID=NM_000051.3;HGVS_TRANSCRIPT=c.3403-15_3403-14insA;GENE_REGION=Intronic;GENE_SYMBOL=ATM	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	108183167	.	A	G	.	PASS	DBSNP=659243;1000G_AF=100.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";PUBMED=24728327;TRANSCRIPT_ID=NM_000051.3;HGVS_TRANSCRIPT=c.5948A>G *;HGVS_PROTEIN=p.S1983S;GENE_REGION=Exonic;GENE_SYMBOL=ATM;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=3057	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	108188266	.	AT	A	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";TRANSCRIPT_ID=NM_000051.3;HGVS_TRANSCRIPT=c.6347+19delT;GENE_REGION=Intronic;GENE_SYMBOL=ATM	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	108205658	.	A	G	.	PASS	DBSNP=200440370;1000G_AF=0.14;ESP_AF=0.25;ESP_AF_AA=0.75;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";TRANSCRIPT_ID=NM_000051.3;HGVS_TRANSCRIPT=c.8011-38A>G;GENE_REGION=Intronic;GENE_SYMBOL=ATM	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr11	111959562	.	A	G	.	PASS	DBSNP=9919624;1000G_AF=11.36;ESP_AF=12.00;ESP_AF_AA=32.92;ESP_AF_EA=1.28;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=236;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=3;ING_UNAFFECTED=1;PUBMED=17298551,17102081;TRANSCRIPT_ID=NM_001276504.1;HGVS_TRANSCRIPT=c.53-29A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959562	.	A	G	.	PASS	DBSNP=9919624;1000G_AF=11.36;ESP_AF=12.00;ESP_AF_AA=32.92;ESP_AF_EA=1.28;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=236;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=3;ING_UNAFFECTED=1;PUBMED=17298551,17102081;TRANSCRIPT_ID=NM_001276506.1;HGVS_TRANSCRIPT=c.170-29A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959562	.	A	G	.	PASS	DBSNP=9919624;1000G_AF=11.36;ESP_AF=12.00;ESP_AF_AA=32.92;ESP_AF_EA=1.28;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=236;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=3;ING_UNAFFECTED=1;PUBMED=17298551,17102081;TRANSCRIPT_ID=NM_001276503.1;HGVS_TRANSCRIPT=c.169+865A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959562	.	A	G	.	PASS	DBSNP=9919624;1000G_AF=11.36;ESP_AF=12.00;ESP_AF_AA=32.92;ESP_AF_EA=1.28;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=236;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=3;ING_UNAFFECTED=1;PUBMED=17298551,17102081;TRANSCRIPT_ID=NM_003002.3;HGVS_TRANSCRIPT=c.170-29A>G;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959625	.	C	T	.	PASS	DBSNP=9919552;1000G_AF=11.34;ESP_AF=12.01;ESP_AF_AA=32.96;ESP_AF_EA=1.28;ING_FINDINGS=33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=235;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=48;ING_UNAFFECTED=20;PUBMED=21945342,14500403,12807974,11397905,17848412,14985401,15331017,12111639,19768395,11391798,11526495,17639058,15774781,12007193,17298551,17102082,17102081,14974914;TRANSCRIPT_ID=NM_001276504.1;HGVS_TRANSCRIPT=c.87C>T;HGVS_PROTEIN=p.S29S;GENE_REGION=Exonic;GENE_SYMBOL=SDHD;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=121	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959625	.	C	T	.	PASS	DBSNP=9919552;1000G_AF=11.34;ESP_AF=12.01;ESP_AF_AA=32.96;ESP_AF_EA=1.28;ING_FINDINGS=33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=235;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=48;ING_UNAFFECTED=20;PUBMED=21945342,14500403,12807974,11397905,17848412,14985401,15331017,12111639,19768395,11391798,11526495,17639058,15774781,12007193,17298551,17102082,17102081,14974914;TRANSCRIPT_ID=NM_001276506.1;HGVS_TRANSCRIPT=c.204C>T;HGVS_PROTEIN=p.S68S;GENE_REGION=Exonic;GENE_SYMBOL=SDHD;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=144	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959625	.	C	T	.	PASS	DBSNP=9919552;1000G_AF=11.34;ESP_AF=12.01;ESP_AF_AA=32.96;ESP_AF_EA=1.28;ING_FINDINGS=33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=235;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=48;ING_UNAFFECTED=20;PUBMED=21945342,14500403,12807974,11397905,17848412,14985401,15331017,12111639,19768395,11391798,11526495,17639058,15774781,12007193,17298551,17102082,17102081,14974914;TRANSCRIPT_ID=NM_001276503.1;HGVS_TRANSCRIPT=c.169+928C>T;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111959625	.	C	T	.	PASS	DBSNP=9919552;1000G_AF=11.34;ESP_AF=12.01;ESP_AF_AA=32.96;ESP_AF_EA=1.28;ING_FINDINGS=33;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=235;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=48;ING_UNAFFECTED=20;PUBMED=21945342,14500403,12807974,11397905,17848412,14985401,15331017,12111639,19768395,11391798,11526495,17639058,15774781,12007193,17298551,17102082,17102081,14974914;TRANSCRIPT_ID=NM_003002.3;HGVS_TRANSCRIPT=c.204C>T;HGVS_PROTEIN=p.S68S;GENE_REGION=Exonic;GENE_SYMBOL=SDHD;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=160	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111965497	.	T	C	.	PASS	DBSNP=4151637;1000G_AF=11.34;ESP_AF=11.46;ESP_AF_AA=31.46;ESP_AF_EA=1.25;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=226;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=7;PUBMED=15331017,11391798,17298551,17102081;TRANSCRIPT_ID=NM_001276504.1;HGVS_TRANSCRIPT=c.198-32T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111965497	.	T	C	.	PASS	DBSNP=4151637;1000G_AF=11.34;ESP_AF=11.46;ESP_AF_AA=31.46;ESP_AF_EA=1.25;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=226;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=7;PUBMED=15331017,11391798,17298551,17102081;TRANSCRIPT_ID=NM_001276506.1;HGVS_TRANSCRIPT=c.*13-32T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111965497	.	T	C	.	PASS	DBSNP=4151637;1000G_AF=11.34;ESP_AF=11.46;ESP_AF_AA=31.46;ESP_AF_EA=1.25;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=226;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=7;PUBMED=15331017,11391798,17298551,17102081;TRANSCRIPT_ID=NM_001276503.1;HGVS_TRANSCRIPT=c.170-32T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr11	111965497	.	T	C	.	PASS	DBSNP=4151637;1000G_AF=11.34;ESP_AF=11.46;ESP_AF_AA=31.46;ESP_AF_EA=1.25;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=226;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=7;ING_UNAFFECTED=7;PUBMED=15331017,11391798,17298551,17102081;TRANSCRIPT_ID=NM_003002.3;HGVS_TRANSCRIPT=c.315-32T>C;GENE_REGION=Intronic;GENE_SYMBOL=SDHD	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	25368462	.	C	T	.	PASS	DBSNP=4362222;PHYLOP=4.560E-3;1000G_AF=99.76;ESP_AF=99.85;ESP_AF_AA=99.57;ESP_AF_EA=100.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=6484;PUBMED=21102627,24853695;TRANSCRIPT_ID=NM_033360.3;HGVS_TRANSCRIPT=c.483G>A;HGVS_PROTEIN=p.R161R;GENE_REGION=Exonic;GENE_SYMBOL=KRAS;TRANSLATION_IMPACT=synonymous;BLOSUM50=7;ING_MIN_PROTEIN_LENGTH=190	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	25368462	.	C	T	.	PASS	DBSNP=4362222;PHYLOP=4.560E-3;1000G_AF=99.76;ESP_AF=99.85;ESP_AF_AA=99.57;ESP_AF_EA=100.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=6484;PUBMED=21102627,24853695;TRANSCRIPT_ID=NM_004985.4;HGVS_TRANSCRIPT=c.451-5617G>A;GENE_REGION=Intronic;GENE_SYMBOL=KRAS	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133202215	.	G	A	.	PASS	DBSNP=5745075;1000G_AF=42.33;ESP_AF=32.03;ESP_AF_AA=36.22;ESP_AF_EA=29.88;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=678;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.6657+16C>T;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133208886	.	C	T	.	PASS	DBSNP=5745023;1000G_AF=56.51;ESP_AF=48.03;ESP_AF_AA=57.88;ESP_AF_EA=42.99;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1548;ING_DRUGGED_GENE=Y;ING_AFFECTED=121;ING_AFFECTED_HOM=29;PUBMED=19237606;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.6330+15G>A;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133208979	.	T	C	.	PASS	DBSNP=5745022;1000G_AF=69.91;ESP_AF=64.27;ESP_AF_AA=75.67;ESP_AF_EA=58.43;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=2715;ING_DRUGGED_GENE=Y;ING_AFFECTED=150;ING_AFFECTED_HOM=59;PUBMED=19237606,18270339;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.6252A>G;HGVS_PROTEIN=p.S2084S;GENE_REGION=Exonic;GENE_SYMBOL=POLE;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=2287	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133210985	.	C	T	.	PASS	DBSNP=5745005;1000G_AF=71.35;ESP_AF=65.65;ESP_AF_AA=79.66;ESP_AF_EA=58.48;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=2856;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.5812-21G>A;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133214768	.	A	G	.	PASS	DBSNP=5744970;1000G_AF=72.9;ESP_AF=67.48;ESP_AF_AA=85.02;ESP_AF_EA=58.49;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=3038;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.5553-43T>C;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133218724	.	C	T	.	PASS	DBSNP=5744951;1000G_AF=58.87;ESP_AF=50.29;ESP_AF_AA=64.53;ESP_AF_EA=43.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1715;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.5173+39G>A;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133219831	.	T	C	.	PASS	DBSNP="386599709, 5744944";1000G_AF=60.52;ESP_AF=52.24;ESP_AF_AA=70.15;ESP_AF_EA=43.06;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1873;ING_DRUGGED_GENE=Y;ING_AFFECTED=116;ING_AFFECTED_HOM=49;PUBMED=19237606,18270339;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.4530A>G;HGVS_PROTEIN=p.A1510A;GENE_REGION=Exonic;GENE_SYMBOL=POLE;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=2287	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133233705	.	T	C	.	PASS	DBSNP=5744889;1000G_AF=98.38;ESP_AF=97.29;ESP_AF_AA=99.05;ESP_AF_EA=96.40;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=6156;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.3582+17A>G;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133236000	.	C	T	.	PASS	DBSNP=5744857;1000G_AF=60.54;ESP_AF=52.25;ESP_AF_AA=70.15;ESP_AF_EA=43.07;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1874;ING_DRUGGED_GENE=Y;PUBMED=18270339;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.3156G>A;HGVS_PROTEIN=p.T1052T;GENE_REGION=Exonic;GENE_SYMBOL=POLE;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=2287	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133238076	.	T	C	.	PASS	DBSNP="386599703, 5744844";1000G_AF=57.73;ESP_AF=49.27;ESP_AF_AA=61.48;ESP_AF_EA=43.01;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1643;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.2864+37A>G;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133240782	.	A	G	.	PASS	DBSNP=4883592;1000G_AF=60.58;ESP_AF=52.26;ESP_AF_AA=70.18;ESP_AF_EA=43.08;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1876;ING_DRUGGED_GENE=Y;ING_AFFECTED=536;ING_AFFECTED_HOM=30;PUBMED=19237606,24615621;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.2562-48T>C;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr12	133241063	.	C	T	.	PASS	DBSNP=5744833;1000G_AF=6.95;ESP_AF=7.70;ESP_AF_AA=22.51;ESP_AF_EA=0.12;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=108;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.2469-15G>A;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr12	133250118	.	C	T	.	PASS	DBSNP=4883555;1000G_AF=57.65;ESP_AF=49.26;ESP_AF_AA=61.44;ESP_AF_EA=43.02;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=1639;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_006231.3;HGVS_TRANSCRIPT=c.1359+43G>A;GENE_REGION=Intronic;GENE_SYMBOL=POLE	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr13	32906729	.	A	C	.	PASS	DBSNP=144848;SIFT_FUNCTION=Tolerated;1000G_AF=24.94;ESP_AF=23.32;ESP_AF_AA=12.89;ESP_AF_EA=28.59;ING_FINDINGS=330;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=387;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=25626;ING_AFFECTED_HOM=2971;ING_UNAFFECTED=472;PUBMED=12011148,22921312,21285147,17764108,22513257,20807450,22652532,22713736,22253860,22034289,15113441,14987381,11062481,11556836,19949853,11948123,22426013,12070551,16438707,20383589,18288416,19185836,17850627,21671020,19367188,18824251,15609317,20813000,23886119,17108146,16774934,22430443,21702907,24052750,19656164,15138483,14555511,15784178,18844490,16572816,24289560,21147080,22366370,15168169,18694767,16825431,25374063,24504028,11257104,16638864,16956909,19941162,16939956,15894703,18270339,17606447,18451181,23315985,12618335,12471628,16978908,21212067,21129811,18768505,16308313,22486713,15918047,17289875,11920621,15876480,15689453,14734460,23767878,20932271,19902366,19476645,19276285,12474142,16170354,23961350,15933498,9971877,18431743,19030985,18271933,25136594,21514219,16857995,11207042,20127978,22874498,16280055,24884828,18579371,19237606,19471317,20167696,21952622,20003265,21346221,17341484,18024013,18547414,20927582,15353005,16214912,20872766,16713266,19661094,25069792,21523855,15254695,17700570,24728327,16847550,16257105,25178586,22684231,20731661,20858050,19626602,22752604,15937087,22977638,19012493,24853695,16485136,22875147,19619314,16738949,21156845,15668505,19543528,18830263,12684407,19253839,16650867,16760289,24323938,20135345,18283561,21161372,17018785,12442265,17428325,21042765,15890268,16835750,22044372,12496039,22126563,16574953,16465622,17767707,19623759,21520273,21990134,12955716,22065914,22913592,24062231,23555315,23451180,21476145,20104584,17182175,12917199,15365993,15695382,11927503,12036913,17602170,16758124,23964347,19046423,24312913,15317758,18974877,20960228,22425665,12670525,23619945,16683254,20352487,14647438,16026807,23313170,19124506,17088437,22703879,23249957;TRANSCRIPT_ID=NM_000059.3;HGVS_TRANSCRIPT=c.1114A>C;HGVS_PROTEIN=p.N372H;GENE_REGION=Exonic;GENE_SYMBOL=BRCA2;TRANSLATION_IMPACT=missense;BLOSUM50=1;CLINVAR_OBSERVATIONS=1;CLINVAR="OMIM_gene:600185.0013; RCV000130720.1; RCV000009916.3";ING_MIN_PROTEIN_LENGTH=3419	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	32913055	.	A	G	.	PASS	DBSNP=206075;1000G_AF=97.4;ESP_AF=97.58;ESP_AF_AA=92.96;ESP_AF_EA=99.94;ING_FINDINGS=31;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=6196;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=91;ING_AFFECTED_HOM=29;ING_UNAFFECTED=8;PUBMED=21918854,22652532,24853695,24884828,23113073,22684231,21702907,23961350,20104584,20127978,23315985,23767878;TRANSCRIPT_ID=NM_000059.3;HGVS_TRANSCRIPT=c.4563A>G;HGVS_PROTEIN=p.L1521L;GENE_REGION=Exonic;GENE_SYMBOL=BRCA2;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000119245.1; RCV000132170.1";ING_MIN_PROTEIN_LENGTH=3419	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	32915005	.	G	C	.	PASS	DBSNP=206076;1000G_AF=97.36;ESP_AF=97.55;ESP_AF_AA=92.87;ESP_AF_EA=99.94;ING_FINDINGS=32;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=6195;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=135;ING_AFFECTED_HOM=34;ING_UNAFFECTED=26;PUBMED=24853695,22426013,23113073,22913592,20127978,21918854,24884828,22652532,15317758,22684231,23961350,20858050,23315985,22977638;TRANSCRIPT_ID=NM_000059.3;HGVS_TRANSCRIPT=c.6513G>C;HGVS_PROTEIN=p.V2171V;GENE_REGION=Exonic;GENE_SYMBOL=BRCA2;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000119246.1;ING_MIN_PROTEIN_LENGTH=3419	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	32929387	.	T	C	.	PASS	DBSNP=169547;PHYLOP=6.081E-3;1000G_AF=97.58;ESP_AF=97.77;ESP_AF_AA=93.53;ESP_AF_EA=99.94;ING_FINDINGS=85;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=6222;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=929;ING_AFFECTED_HOM=19;PUBMED=8673091,18284688,15172753,20981092,20127978,22874498,18724707,22652532,22713736,15937982,12552570,22034289,16685647,20167696,21952622,17341484,20215541,16234499,8665505,21523855,15983021,24728327,16847550,22684231,20858050,10464609,24853695,23884293,21769658,24916970,24323938,16760289,24504028,12942367,23320992,19941162,19491284,23315985,12491487,16574953,23231788,22486713,10644434,21520273,12955716,22913592,23555315,20104584,21673748,16758124,15317758,18500671,20960228,22425665,23961350,21218378,22505045,16683254,9971877,23108138;TRANSCRIPT_ID=NM_000059.3;HGVS_TRANSCRIPT=c.7397C>T *;HGVS_PROTEIN=p.A2466V;GENE_REGION=Exonic;GENE_SYMBOL=BRCA2;TRANSLATION_IMPACT=missense;BLOSUM50=0;CLINVAR_OBSERVATIONS=7;CLINVAR="RCV000045197.2; BIC";ING_MIN_PROTEIN_LENGTH=3419	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	32936646	.	T	C	.	PASS	DBSNP=9534262;1000G_AF=53.16;ESP_AF=52.02;ESP_AF_AA=55.22;ESP_AF_EA=50.37;ING_FINDINGS=84;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1762;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=8744;ING_AFFECTED_HOM=199;ING_UNAFFECTED=53;ING_DISCORDANT_FAMILIES=1;PUBMED=25136594,18284688,22921312,10728701,21305653,11185744,15172753,16261400,21190077,17453335,22874498,22713736,15937982,12552570,22034289,20167696,12461697,20927582,20383589,16847550,10449599,16764716,9012404,22684231,24152768,21702907,20858050,14684619,19656164,18844490,17333343,21147080,22933969,19619314,21203900,22366370,25483746,15168169,18694767,12442274,16760289,24884479,21161372,21042765,19536649,18270339,11013445,21156238,16835750,12100744,11512557,22486713,10644434,15918047,21520273,12955716,22913592,20104584,15365993,16758124,24312913,18006916,21232165,22425665,23961350,20352487,16683254,14647438,9971877,24123850,23249957;TRANSCRIPT_ID=NM_000059.3;HGVS_TRANSCRIPT=c.7806-14T>C;GENE_REGION=Intronic;GENE_SYMBOL=BRCA2;CLINVAR_OBSERVATIONS=668;CLINVAR="BIC; RCV000132168.1; RCV000113823.2"	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	48919358	.	T	G	.	PASS	DBSNP=198617;1000G_AF=91.37;ESP_AF=92.83;ESP_AF_AA=82.77;ESP_AF_EA=98.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="retinoblastoma cancer";ESP_PUBLIC_HOMOZYGOTES=5639;TRANSCRIPT_ID=NM_000321.2;HGVS_TRANSCRIPT=c.500+23T>G;GENE_REGION=Intronic;GENE_SYMBOL=RB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr13	49051012	.	C	T	.	PASS	DBSNP=3020646;1000G_AF=88.5;ESP_AF=89.58;ESP_AF_AA=73.33;ESP_AF_EA=97.91;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="retinoblastoma cancer";ESP_PUBLIC_HOMOZYGOTES=5304;ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=18849522;TRANSCRIPT_ID=NM_000321.2;HGVS_TRANSCRIPT=c.2663+33C>T;GENE_REGION=Intronic;GENE_SYMBOL=RB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65472874	.	C	CT	.	PASS	DBSNP=367570902;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=pheochromocytoma;TRANSCRIPT_ID=NM_197957.3;HGVS_TRANSCRIPT=c.*47_*48insA;GENE_REGION=3'UTR;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65472874	.	C	CT	.	PASS	DBSNP=367570902;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=pheochromocytoma;TRANSCRIPT_ID=NM_002028.3;HGVS_TRANSCRIPT=c.209+1843_209+1844insT;GENE_REGION=Intronic;GENE_SYMBOL=FNTB	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65472874	.	C	CT	.	PASS	DBSNP=367570902;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=pheochromocytoma;TRANSCRIPT_ID=NM_001202558.1;HGVS_TRANSCRIPT=c.71+1843_71+1844insT;GENE_REGION=Intronic;GENE_SYMBOL=CHURC1-FNTB	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65472874	.	C	CT	.	PASS	DBSNP=367570902;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=pheochromocytoma;TRANSCRIPT_ID=NM_001202559.1;HGVS_TRANSCRIPT=c.392+1843_392+1844insT;GENE_REGION=Intronic;GENE_SYMBOL=CHURC1-FNTB	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65472874	.	C	CT	.	PASS	DBSNP=367570902;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE=pheochromocytoma;TRANSCRIPT_ID=NM_001271069.1;HGVS_TRANSCRIPT=c.*47_*48insA;GENE_REGION=3'UTR;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_145114.2;HGVS_TRANSCRIPT=c.63+49C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_001271068.1;HGVS_TRANSCRIPT=c.36+807C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_145113.2;HGVS_TRANSCRIPT=c.63+49C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_197957.3;HGVS_TRANSCRIPT=c.63+49C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_002382.4;HGVS_TRANSCRIPT=c.63+49C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_001271069.1;HGVS_TRANSCRIPT=c.36+807C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	65568215	.	G	A	.	PASS	DBSNP=2781373;1000G_AF=51.22;ESP_AF=50.72;ESP_AF_AA=76.04;ESP_AF_EA=37.74;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=pheochromocytoma;ESP_PUBLIC_HOMOZYGOTES=1887;TRANSCRIPT_ID=NM_145112.2;HGVS_TRANSCRIPT=c.36+807C>T;GENE_REGION=Intronic;GENE_SYMBOL=MAX	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95562577	.	C	T	.	PASS	DBSNP=61729797;1000G_AF=3.37;ESP_AF=3.92;ESP_AF_AA=11.46;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001195573.1;HGVS_TRANSCRIPT=c.4680G>A;HGVS_PROTEIN=p.A1560A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1830	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95562577	.	C	T	.	PASS	DBSNP=61729797;1000G_AF=3.37;ESP_AF=3.92;ESP_AF_AA=11.46;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_177438.2;HGVS_TRANSCRIPT=c.4680G>A;HGVS_PROTEIN=p.A1560A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95562577	.	C	T	.	PASS	DBSNP=61729797;1000G_AF=3.37;ESP_AF=3.92;ESP_AF_AA=11.46;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001271282.2;HGVS_TRANSCRIPT=c.4680G>A;HGVS_PROTEIN=p.A1560A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95562577	.	C	T	.	PASS	DBSNP=61729797;1000G_AF=3.37;ESP_AF=3.92;ESP_AF_AA=11.46;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001291628.1;HGVS_TRANSCRIPT=c.4680G>A;HGVS_PROTEIN=p.A1560A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95562577	.	C	T	.	PASS	DBSNP=61729797;1000G_AF=3.37;ESP_AF=3.92;ESP_AF_AA=11.46;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_030621.4;HGVS_TRANSCRIPT=c.4680G>A;HGVS_PROTEIN=p.A1560A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95566108	.	C	A	.	PASS	DBSNP=1778057;1000G_AF=87.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001195573.1;HGVS_TRANSCRIPT=c.4206+9G>T;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95566108	.	C	A	.	PASS	DBSNP=1778057;1000G_AF=87.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_177438.2;HGVS_TRANSCRIPT=c.4206+9G>T;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95566108	.	C	A	.	PASS	DBSNP=1778057;1000G_AF=87.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001271282.2;HGVS_TRANSCRIPT=c.4206+9G>T;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95566108	.	C	A	.	PASS	DBSNP=1778057;1000G_AF=87.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001291628.1;HGVS_TRANSCRIPT=c.4206+9G>T;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95566108	.	C	A	.	PASS	DBSNP=1778057;1000G_AF=87.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_030621.4;HGVS_TRANSCRIPT=c.4206+9G>T;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95571635	.	GA	G	.	PASS	DBSNP=371156380;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001195573.1;HGVS_TRANSCRIPT=c.3094-53delT;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95571635	.	GA	G	.	PASS	DBSNP=371156380;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_177438.2;HGVS_TRANSCRIPT=c.3094-53delT;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95571635	.	GA	G	.	PASS	DBSNP=371156380;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001271282.2;HGVS_TRANSCRIPT=c.3094-53delT;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95571635	.	GA	G	.	PASS	DBSNP=371156380;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_001291628.1;HGVS_TRANSCRIPT=c.3094-53delT;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95571635	.	GA	G	.	PASS	DBSNP=371156380;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="cystic nephroma";TRANSCRIPT_ID=NM_030621.4;HGVS_TRANSCRIPT=c.3094-53delT;GENE_REGION=Intronic;GENE_SYMBOL=DICER1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95572075	.	C	T	.	PASS	DBSNP=8019857;1000G_AF=3.49;ESP_AF=3.91;ESP_AF_AA=11.42;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001195573.1;HGVS_TRANSCRIPT=c.3033G>A;HGVS_PROTEIN=p.A1011A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1830	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95572075	.	C	T	.	PASS	DBSNP=8019857;1000G_AF=3.49;ESP_AF=3.91;ESP_AF_AA=11.42;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_177438.2;HGVS_TRANSCRIPT=c.3033G>A;HGVS_PROTEIN=p.A1011A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95572075	.	C	T	.	PASS	DBSNP=8019857;1000G_AF=3.49;ESP_AF=3.91;ESP_AF_AA=11.42;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001271282.2;HGVS_TRANSCRIPT=c.3033G>A;HGVS_PROTEIN=p.A1011A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95572075	.	C	T	.	PASS	DBSNP=8019857;1000G_AF=3.49;ESP_AF=3.91;ESP_AF_AA=11.42;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_001291628.1;HGVS_TRANSCRIPT=c.3033G>A;HGVS_PROTEIN=p.A1011A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr14	95572075	.	C	T	.	PASS	DBSNP=8019857;1000G_AF=3.49;ESP_AF=3.91;ESP_AF_AA=11.42;ESP_AF_EA=0.06;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="cystic nephroma";ESP_PUBLIC_HOMOZYGOTES=27;ING_AFFECTED=1;PUBMED=23620094;TRANSCRIPT_ID=NM_030621.4;HGVS_TRANSCRIPT=c.3033G>A;HGVS_PROTEIN=p.A1011A;GENE_REGION=Exonic;GENE_SYMBOL=DICER1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=1923	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33009697	.	G	T	.	PASS	DBSNP=59171836;1000G_AF=2.2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_001191322.1;HGVS_TRANSCRIPT=c.-667G>T;GENE_REGION=Promoter;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33009697	.	G	T	.	PASS	DBSNP=59171836;1000G_AF=2.2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_001191323.1;HGVS_TRANSCRIPT=c.-667G>T;GENE_REGION=Promoter;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33009697	.	G	T	.	PASS	DBSNP=59171836;1000G_AF=2.2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_013372.6;HGVS_TRANSCRIPT=c.-667G>T;GENE_REGION=Promoter;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33026667	.	A	T	.	PASS	DBSNP="1129456, 386425984";1000G_AF=21.39;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_001191322.1;HGVS_TRANSCRIPT=c.*3221A>T;GENE_REGION=3'UTR;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33026667	.	A	T	.	PASS	DBSNP="1129456, 386425984";1000G_AF=21.39;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_001191323.1;HGVS_TRANSCRIPT=c.*3221A>T;GENE_REGION=3'UTR;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	33026667	.	A	T	.	PASS	DBSNP="1129456, 386425984";1000G_AF=21.39;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="limb reduction defect";TRANSCRIPT_ID=NM_013372.6;HGVS_TRANSCRIPT=c.*3221A>T;GENE_REGION=3'UTR;GENE_SYMBOL=GREM1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	40998342	.	T	G	.	PASS	DBSNP=45457497;1000G_AF=35.42;ESP_AF=18.88;ESP_AF_AA=23.98;ESP_AF_EA=16.27;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=245;ING_AFFECTED=5;PUBMED=16762046;TRANSCRIPT_ID=NM_133487.3;HGVS_TRANSCRIPT=c.347-2881T>G;GENE_REGION=Intronic;GENE_SYMBOL=RAD51	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	40998342	.	T	G	.	PASS	DBSNP=45457497;1000G_AF=35.42;ESP_AF=18.88;ESP_AF_AA=23.98;ESP_AF_EA=16.27;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=245;ING_AFFECTED=5;PUBMED=16762046;TRANSCRIPT_ID=NM_001164269.1;HGVS_TRANSCRIPT=c.347-2881T>G;GENE_REGION=Intronic;GENE_SYMBOL=RAD51	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	40998342	.	T	G	.	PASS	DBSNP=45457497;1000G_AF=35.42;ESP_AF=18.88;ESP_AF_AA=23.98;ESP_AF_EA=16.27;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=245;ING_AFFECTED=5;PUBMED=16762046;TRANSCRIPT_ID=NM_002875.4;HGVS_TRANSCRIPT=c.226-33T>G;GENE_REGION=Intronic;GENE_SYMBOL=RAD51	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	40998342	.	T	G	.	PASS	DBSNP=45457497;1000G_AF=35.42;ESP_AF=18.88;ESP_AF_AA=23.98;ESP_AF_EA=16.27;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=245;ING_AFFECTED=5;PUBMED=16762046;TRANSCRIPT_ID=NM_001164270.1;HGVS_TRANSCRIPT=c.226-33T>G;GENE_REGION=Intronic;GENE_SYMBOL=RAD51	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67457335	.	A	G	.	PASS	DBSNP=1065080;1000G_AF=83.41;ESP_AF=88.00;ESP_AF_AA=87.28;ESP_AF_EA=88.37;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=5033;ING_AFFECTED=872;PUBMED=18095113,22923420,21984931,16478646;TRANSCRIPT_ID=NM_001145103.1;HGVS_TRANSCRIPT=c.177A>G;HGVS_PROTEIN=p.L59L;GENE_REGION=Exonic;GENE_SYMBOL=SMAD3;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=382	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	67457335	.	A	G	.	PASS	DBSNP=1065080;1000G_AF=83.41;ESP_AF=88.00;ESP_AF_AA=87.28;ESP_AF_EA=88.37;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=5033;ING_AFFECTED=872;PUBMED=18095113,22923420,21984931,16478646;TRANSCRIPT_ID=NM_001145102.1;HGVS_TRANSCRIPT=c.-7A>G;GENE_REGION=5'UTR;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	67457335	.	A	G	.	PASS	DBSNP=1065080;1000G_AF=83.41;ESP_AF=88.00;ESP_AF_AA=87.28;ESP_AF_EA=88.37;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=5033;ING_AFFECTED=872;PUBMED=18095113,22923420,21984931,16478646;TRANSCRIPT_ID=NM_005902.3;HGVS_TRANSCRIPT=c.309A>G;HGVS_PROTEIN=p.L103L;GENE_REGION=Exonic;GENE_SYMBOL=SMAD3;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=426	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	67457698	.	A	G	.	PASS	DBSNP=35874463;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=7.345E-3;1000G_AF=1.9;ESP_AF=4.05;ESP_AF_AA=1.27;ESP_AF_EA=5.47;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=27;PUBMED=19499547,22923420;TRANSCRIPT_ID=NM_001145103.1;HGVS_TRANSCRIPT=c.376A>G;HGVS_PROTEIN=p.I126V;GENE_REGION=Exonic;GENE_SYMBOL=SMAD3;TRANSLATION_IMPACT=missense;BLOSUM50=4;ING_MIN_PROTEIN_LENGTH=382	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67457698	.	A	G	.	PASS	DBSNP=35874463;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=7.345E-3;1000G_AF=1.9;ESP_AF=4.05;ESP_AF_AA=1.27;ESP_AF_EA=5.47;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=27;PUBMED=19499547,22923420;TRANSCRIPT_ID=NM_001145102.1;HGVS_TRANSCRIPT=c.193A>G;HGVS_PROTEIN=p.I65V;GENE_REGION=Exonic;GENE_SYMBOL=SMAD3;TRANSLATION_IMPACT=missense;BLOSUM50=4;ING_MIN_PROTEIN_LENGTH=321	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67457698	.	A	G	.	PASS	DBSNP=35874463;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=7.345E-3;1000G_AF=1.9;ESP_AF=4.05;ESP_AF_AA=1.27;ESP_AF_EA=5.47;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=27;PUBMED=19499547,22923420;TRANSCRIPT_ID=NM_001145104.1;HGVS_TRANSCRIPT=c.-887A>G;GENE_REGION=Promoter;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67457698	.	A	G	.	PASS	DBSNP=35874463;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;PHYLOP=7.345E-3;1000G_AF=1.9;ESP_AF=4.05;ESP_AF_AA=1.27;ESP_AF_EA=5.47;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Loeys-Dietz syndrome type 3";ESP_PUBLIC_HOMOZYGOTES=15;ING_AFFECTED=27;PUBMED=19499547,22923420;TRANSCRIPT_ID=NM_005902.3;HGVS_TRANSCRIPT=c.508A>G;HGVS_PROTEIN=p.I170V;GENE_REGION=Exonic;GENE_SYMBOL=SMAD3;TRANSLATION_IMPACT=missense;BLOSUM50=4;ING_MIN_PROTEIN_LENGTH=426	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67473814	.	G	C	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Loeys-Dietz syndrome type 3";TRANSCRIPT_ID=NM_001145103.1;HGVS_TRANSCRIPT=c.739+23G>C;GENE_REGION=Intronic;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67473814	.	G	C	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Loeys-Dietz syndrome type 3";TRANSCRIPT_ID=NM_001145102.1;HGVS_TRANSCRIPT=c.556+23G>C;GENE_REGION=Intronic;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67473814	.	G	C	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Loeys-Dietz syndrome type 3";TRANSCRIPT_ID=NM_001145104.1;HGVS_TRANSCRIPT=c.286+23G>C;GENE_REGION=Intronic;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	67473814	.	G	C	.	PASS	ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="Loeys-Dietz syndrome type 3";TRANSCRIPT_ID=NM_005902.3;HGVS_TRANSCRIPT=c.871+23G>C;GENE_REGION=Intronic;GENE_SYMBOL=SMAD3	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr15	91312823	.	T	C	.	PASS	DBSNP=3815003;1000G_AF=36.66;ESP_AF=38.19;ESP_AF_AA=58.58;ESP_AF_EA=27.77;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1070;ING_AFFECTED=179;ING_AFFECTED_HOM=91;PUBMED=19237606,23028338,18270339,19917125;TRANSCRIPT_ID=NM_001287247.1;HGVS_TRANSCRIPT=c.2555+7T>C;GENE_REGION=Intronic;GENE_SYMBOL=BLM	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	91312823	.	T	C	.	PASS	DBSNP=3815003;1000G_AF=36.66;ESP_AF=38.19;ESP_AF_AA=58.58;ESP_AF_EA=27.77;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1070;ING_AFFECTED=179;ING_AFFECTED_HOM=91;PUBMED=19237606,23028338,18270339,19917125;TRANSCRIPT_ID=NM_001287248.1;HGVS_TRANSCRIPT=c.1430+7T>C;GENE_REGION=Intronic;GENE_SYMBOL=BLM	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	91312823	.	T	C	.	PASS	DBSNP=3815003;1000G_AF=36.66;ESP_AF=38.19;ESP_AF_AA=58.58;ESP_AF_EA=27.77;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1070;ING_AFFECTED=179;ING_AFFECTED_HOM=91;PUBMED=19237606,23028338,18270339,19917125;TRANSCRIPT_ID=NM_001287246.1;HGVS_TRANSCRIPT=c.2555+7T>C;GENE_REGION=Intronic;GENE_SYMBOL=BLM	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr15	91312823	.	T	C	.	PASS	DBSNP=3815003;1000G_AF=36.66;ESP_AF=38.19;ESP_AF_AA=58.58;ESP_AF_EA=27.77;ING_FINDINGS=3;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=1070;ING_AFFECTED=179;ING_AFFECTED_HOM=91;PUBMED=19237606,23028338,18270339,19917125;TRANSCRIPT_ID=NM_000057.3;HGVS_TRANSCRIPT=c.2555+7T>C;GENE_REGION=Intronic;GENE_SYMBOL=BLM	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	2105400	.	C	T	.	PASS	DBSNP=1800720;1000G_AF=9.21;ESP_AF=12.84;ESP_AF_AA=19.06;ESP_AF_EA=9.66;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=127;ING_AFFECTED=31;PUBMED=10735580,10533067;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.482-3C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2105400	.	C	T	.	PASS	DBSNP=1800720;1000G_AF=9.21;ESP_AF=12.84;ESP_AF_AA=19.06;ESP_AF_EA=9.66;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=127;ING_AFFECTED=31;PUBMED=10735580,10533067;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.482-3C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2105400	.	C	T	.	PASS	DBSNP=1800720;1000G_AF=9.21;ESP_AF=12.84;ESP_AF_AA=19.06;ESP_AF_EA=9.66;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=127;ING_AFFECTED=31;PUBMED=10735580,10533067;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.482-3C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=10;CLINVAR="RCV000043224.2; RCV000055133.1"	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2122822	.	A	G	.	PASS	DBSNP=7196184;1000G_AF=10.94;ESP_AF=11.24;ESP_AF_AA=33.01;ESP_AF_EA=0.12;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=238;ING_AFFECTED=3;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.2221-28A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2122822	.	A	G	.	PASS	DBSNP=7196184;1000G_AF=10.94;ESP_AF=11.24;ESP_AF_AA=33.01;ESP_AF_EA=0.12;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=238;ING_AFFECTED=3;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.2221-28A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2122822	.	A	G	.	PASS	DBSNP=7196184;1000G_AF=10.94;ESP_AF=11.24;ESP_AF_AA=33.01;ESP_AF_EA=0.12;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=238;ING_AFFECTED=3;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.2221-28A>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=3;CLINVAR=RCV000042865.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2125788	.	C	T	.	PASS	DBSNP=13331451;1000G_AF=20.55;ESP_AF=22.50;ESP_AF_AA=52.09;ESP_AF_EA=7.36;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=617;ING_AFFECTED=4;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.2546-12C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2125788	.	C	T	.	PASS	DBSNP=13331451;1000G_AF=20.55;ESP_AF=22.50;ESP_AF_AA=52.09;ESP_AF_EA=7.36;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=617;ING_AFFECTED=4;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.2546-12C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2125788	.	C	T	.	PASS	DBSNP=13331451;1000G_AF=20.55;ESP_AF=22.50;ESP_AF_AA=52.09;ESP_AF_EA=7.36;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=617;ING_AFFECTED=4;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.2546-12C>T;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=4;CLINVAR=RCV000042472.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2125937	.	C	G	.	PASS	DBSNP=1800715;1000G_AF=21.47;ESP_AF=23.55;ESP_AF_AA=52.62;ESP_AF_EA=8.70;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=645;ING_AFFECTED=6;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.2639+44C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	2125937	.	C	G	.	PASS	DBSNP=1800715;1000G_AF=21.47;ESP_AF=23.55;ESP_AF_AA=52.62;ESP_AF_EA=8.70;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=645;ING_AFFECTED=6;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.2639+44C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	2125937	.	C	G	.	PASS	DBSNP=1800715;1000G_AF=21.47;ESP_AF=23.55;ESP_AF_AA=52.62;ESP_AF_EA=8.70;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=645;ING_AFFECTED=6;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.2639+44C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=6;CLINVAR=RCV000043350.2	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	2130419	.	T	TC	.	PASS	DBSNP=147340842;1000G_AF=4.93;ESP_AF=4.41;ESP_AF_AA=12.87;ESP_AF_EA=0.05;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=65;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.3610+41_3610+42insC;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2130419	.	T	TC	.	PASS	DBSNP=147340842;1000G_AF=4.93;ESP_AF=4.41;ESP_AF_AA=12.87;ESP_AF_EA=0.05;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=65;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.3478+41_3478+42insC;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2130419	.	T	TC	.	PASS	DBSNP=147340842;1000G_AF=4.93;ESP_AF=4.41;ESP_AF_AA=12.87;ESP_AF_EA=0.05;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=65;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.3610+41_3610+42insC;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2133798	.	G	A	.	PASS	DBSNP=45517323;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=2.02;ESP_AF=1.65;ESP_AF_AA=4.76;ESP_AF_EA=0.07;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=6;ING_AFFECTED=9;PUBMED=16114042,24618965,20981092,22995991,10732801,17304050,22703879,24728327;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.3917G>A;HGVS_PROTEIN=p.R1306H;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=1785	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2133798	.	G	A	.	PASS	DBSNP=45517323;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=2.02;ESP_AF=1.65;ESP_AF_AA=4.76;ESP_AF_EA=0.07;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=6;ING_AFFECTED=9;PUBMED=16114042,24618965,20981092,22995991,10732801,17304050,22703879,24728327;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.3785G>A;HGVS_PROTEIN=p.R1262H;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=1741	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2133798	.	G	A	.	PASS	DBSNP=45517323;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=2.02;ESP_AF=1.65;ESP_AF_AA=4.76;ESP_AF_EA=0.07;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=6;ING_AFFECTED=9;PUBMED=16114042,24618965,20981092,22995991,10732801,17304050,22703879,24728327;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.3986G>A;HGVS_PROTEIN=p.R1329H;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=missense;BLOSUM50=0;CLINVAR_OBSERVATIONS=6;CLINVAR=RCV000054856.1;ING_MIN_PROTEIN_LENGTH=1808	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138218	.	A	C	.	PASS	DBSNP=1800718;1000G_AF=25.7;ESP_AF=32.85;ESP_AF_AA=54.28;ESP_AF_EA=21.90;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=845;ING_AFFECTED=8;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.5092-10A>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138218	.	A	C	.	PASS	DBSNP=1800718;1000G_AF=25.7;ESP_AF=32.85;ESP_AF_AA=54.28;ESP_AF_EA=21.90;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=845;ING_AFFECTED=8;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.4960-10A>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138218	.	A	C	.	PASS	DBSNP=1800718;1000G_AF=25.7;ESP_AF=32.85;ESP_AF_AA=54.28;ESP_AF_EA=21.90;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=845;ING_AFFECTED=8;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.5161-10A>C;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=8;CLINVAR=RCV000042691.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138269	.	T	C	.	PASS	1000G_AF=27.64;ESP_AF=33.25;ESP_AF_AA=63.44;ESP_AF_EA=17.81;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1025;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=49;ING_UNAFFECTED=30;PUBMED=14641237,21102627,16042315,11068191,12111193,11208653,11437991,10430776;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.5133T>C;HGVS_PROTEIN=p.D1711D;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1785	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138269	.	T	C	.	PASS	1000G_AF=27.64;ESP_AF=33.25;ESP_AF_AA=63.44;ESP_AF_EA=17.81;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1025;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=49;ING_UNAFFECTED=30;PUBMED=14641237,21102627,16042315,11068191,12111193,11208653,11437991,10430776;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.5001T>C;HGVS_PROTEIN=p.D1667D;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1741	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138269	.	T	C	.	PASS	1000G_AF=27.64;ESP_AF=33.25;ESP_AF_AA=63.44;ESP_AF_EA=17.81;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=1025;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=49;ING_UNAFFECTED=30;PUBMED=14641237,21102627,16042315,11068191,12111193,11208653,11437991,10430776;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.5202T>C;HGVS_PROTEIN=p.D1734D;GENE_REGION=Exonic;GENE_SYMBOL=TSC2;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;CLINVAR_OBSERVATIONS=9;CLINVAR=RCV000043161.2;ING_MIN_PROTEIN_LENGTH=1808	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138422	.	C	G	.	PASS	DBSNP=13332222;1000G_AF=20.09;ESP_AF=23.13;ESP_AF_AA=47.84;ESP_AF_EA=10.49;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=559;ING_AFFECTED=5;TRANSCRIPT_ID=NM_001114382.1;HGVS_TRANSCRIPT=c.5191-25C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138422	.	C	G	.	PASS	DBSNP=13332222;1000G_AF=20.09;ESP_AF=23.13;ESP_AF_AA=47.84;ESP_AF_EA=10.49;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=559;ING_AFFECTED=5;TRANSCRIPT_ID=NM_001077183.1;HGVS_TRANSCRIPT=c.5059-25C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	2138422	.	C	G	.	PASS	DBSNP=13332222;1000G_AF=20.09;ESP_AF=23.13;ESP_AF_AA=47.84;ESP_AF_EA=10.49;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=559;ING_AFFECTED=5;TRANSCRIPT_ID=NM_000548.3;HGVS_TRANSCRIPT=c.5260-25C>G;GENE_REGION=Intronic;GENE_SYMBOL=TSC2;CLINVAR_OBSERVATIONS=5;CLINVAR=RCV000043243.2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	23625463	.	A	T	.	PASS	DBSNP=249936;1000G_AF=99.68;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_FINDINGS=55;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_COMPLEX_VARIANT=Y;ING_AFFECTED=794;ING_AFFECTED_HOM=540;PUBMED=21279724,20582465,19333784,23824750;TRANSCRIPT_ID=NM_024675.3;HGVS_TRANSCRIPT=c.3114-51T>A;GENE_REGION=Intronic;GENE_SYMBOL=PALB2;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000114594.1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23646154	.	T	C	.	PASS	DBSNP=74320059;1000G_AF=2.5;ESP_AF=2.19;ESP_AF_AA=6.42;ESP_AF_EA=0.02;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=4;ING_AFFECTED=1;PUBMED=22052327;TRANSCRIPT_ID=NM_024675.3;HGVS_TRANSCRIPT=c.1684+29A>G;GENE_REGION=Intronic;GENE_SYMBOL=PALB2;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000114489.1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23646191	.	T	C	.	PASS	SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=15.08;ESP_AF=13.48;ESP_AF_AA=22.08;ESP_AF_EA=9.09;ING_FINDINGS=72;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=139;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=1491;ING_AFFECTED_HOM=29;ING_UNAFFECTED=23;PUBMED=18302019,21618343,24853695,21153565,17420451,23977390,24556926,21165770,23448497,17287723,21356067,20852946,20091115,20927582,18446436,25069792,25225577,21279724,19763884,20180015,23555315,21365267,22052327,19635604,23824750,22310028,21113654,23935836,21932393,20582465,18288683,21409391,24171766,19333784,17200668,20722467;TRANSCRIPT_ID=NM_024675.3;HGVS_TRANSCRIPT=c.1676A>G;HGVS_PROTEIN=p.Q559R;GENE_REGION=Exonic;GENE_SYMBOL=PALB2;TRANSLATION_IMPACT=missense;BLOSUM50=1;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000128962.1; RCV000114486.1";ING_MIN_PROTEIN_LENGTH=1187	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23647238	.	G	A	.	PASS	DBSNP=57605939;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=2.5;ESP_AF=2.22;ESP_AF_AA=6.49;ESP_AF_EA=0.03;ING_FINDINGS=13;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=5;ING_AFFECTED=78;ING_AFFECTED_HOM=1;ING_UNAFFECTED=1;PUBMED=18302019,21113654,25225577,21932393,22241545,23555315,20589654,17200668,24728327;TRANSCRIPT_ID=NM_024675.3;HGVS_TRANSCRIPT=c.629C>T;HGVS_PROTEIN=p.P210L;GENE_REGION=Exonic;GENE_SYMBOL=PALB2;TRANSLATION_IMPACT=missense;BLOSUM50=-4;CLINVAR_OBSERVATIONS=1;CLINVAR="RCV000114650.2; RCV000131969.1";ING_MIN_PROTEIN_LENGTH=1187	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23652525	.	C	T	.	PASS	DBSNP=8053188;1000G_AF=6.63;ESP_AF=4.17;ESP_AF_AA=8.50;ESP_AF_EA=1.96;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=adenocarcinoma;ESP_PUBLIC_HOMOZYGOTES=21;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=143;ING_AFFECTED_HOM=1;PUBMED=21618343,18446436,25225577,24556926,19763884,20180015,22052327,23824750,22310028,19921424,23935836,23448497,20582465,21356067,20852946,24460267,22692731,20722467;TRANSCRIPT_ID=NM_032486.3;HGVS_TRANSCRIPT=c.-339C>T;GENE_REGION=Promoter;GENE_SYMBOL=DCTN5	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23652525	.	C	T	.	PASS	DBSNP=8053188;1000G_AF=6.63;ESP_AF=4.17;ESP_AF_AA=8.50;ESP_AF_EA=1.96;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=adenocarcinoma;ESP_PUBLIC_HOMOZYGOTES=21;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=143;ING_AFFECTED_HOM=1;PUBMED=21618343,18446436,25225577,24556926,19763884,20180015,22052327,23824750,22310028,19921424,23935836,23448497,20582465,21356067,20852946,24460267,22692731,20722467;TRANSCRIPT_ID=NM_001199743.1;HGVS_TRANSCRIPT=c.-339C>T;GENE_REGION=Promoter;GENE_SYMBOL=DCTN5	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23652525	.	C	T	.	PASS	DBSNP=8053188;1000G_AF=6.63;ESP_AF=4.17;ESP_AF_AA=8.50;ESP_AF_EA=1.96;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=adenocarcinoma;ESP_PUBLIC_HOMOZYGOTES=21;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=143;ING_AFFECTED_HOM=1;PUBMED=21618343,18446436,25225577,24556926,19763884,20180015,22052327,23824750,22310028,19921424,23935836,23448497,20582465,21356067,20852946,24460267,22692731,20722467;TRANSCRIPT_ID=NM_001199011.1;HGVS_TRANSCRIPT=c.-339C>T;GENE_REGION=Promoter;GENE_SYMBOL=DCTN5	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	23652525	.	C	T	.	PASS	DBSNP=8053188;1000G_AF=6.63;ESP_AF=4.17;ESP_AF_AA=8.50;ESP_AF_EA=1.96;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE=adenocarcinoma;ESP_PUBLIC_HOMOZYGOTES=21;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=143;ING_AFFECTED_HOM=1;PUBMED=21618343,18446436,25225577,24556926,19763884,20180015,22052327,23824750,22310028,19921424,23935836,23448497,20582465,21356067,20852946,24460267,22692731,20722467;TRANSCRIPT_ID=NM_024675.3;HGVS_TRANSCRIPT=c.-47G>A;GENE_REGION=5'UTR;GENE_SYMBOL=PALB2;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000114446.1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr16	68771372	.	C	T	.	PASS	DBSNP=3743674;1000G_AF=76.34;ESP_AF=86.03;ESP_AF_AA=76.03;ESP_AF_EA=90.74;ING_FINDINGS=23;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3633;ING_AFFECTED=562;ING_AFFECTED_HOM=79;ING_UNAFFECTED=120;PUBMED=11968083,11968084,12647996,16801346,18788075,18768510,21356067,23431106,24204729,14630673,15617552,11948460;TRANSCRIPT_ID=NM_004360.3;HGVS_TRANSCRIPT=c.48+6C>T;GENE_REGION=Intronic;GENE_SYMBOL=CDH1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000132163.1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	68771418	.	C	CGCCCCAGCCCCGT	.	PASS	DBSNP=147838237;1000G_AF=68.87;ESP_AF=80.33;ESP_AF_AA=75.57;ESP_AF_EA=82.52;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=2667;TRANSCRIPT_ID=NM_004360.3;HGVS_TRANSCRIPT=c.48+52_48+53insGCCCCAGCCCCGT;GENE_REGION=Intronic;GENE_SYMBOL=CDH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	68847443	.	G	C	.	PASS	DBSNP=33950903;1000G_AF=2.34;ESP_AF=2.55;ESP_AF_AA=7.48;ESP_AF_EA=0.03;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=9;PUBMED=16372334,18007144;TRANSCRIPT_ID=NM_004360.3;HGVS_TRANSCRIPT=c.1320+45G>C;GENE_REGION=Intronic;GENE_SYMBOL=CDH1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	68857289	.	T	C	.	PASS	DBSNP=2276330;1000G_AF=5.79;ESP_AF=9.64;ESP_AF_AA=2.37;ESP_AF_EA=13.36;ING_FINDINGS=18;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=78;ING_AFFECTED=109;ING_AFFECTED_HOM=8;ING_UNAFFECTED=25;PUBMED=20233471,16372334,18342503,16801346,9744472,11948460,24684952,16189707,11968083,12647996,11158177,18788075,24204729,21356067;TRANSCRIPT_ID=NM_004360.3;HGVS_TRANSCRIPT=c.1937-13T>C;GENE_REGION=Intronic;GENE_SYMBOL=CDH1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000128989.1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr16	68857441	.	T	C	.	PASS	DBSNP=1801552;1000G_AF=71.87;ESP_AF=71.61;ESP_AF_AA=88.03;ESP_AF_EA=63.22;ING_FINDINGS=66;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=3428;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=2994;ING_AFFECTED_HOM=482;ING_UNAFFECTED=354;PUBMED=21459793,24838934,23341533,16801346,15750927,10206317,11305955,19339270,15617552,9744472,10896919,11948460,10682667,24684952,25150394,16189707,19965908,18788075,21356067,24204729,9195232,11171827,11332401,16531765,10051639,10408414,19269290,17434710,17852867,11562785,12216071,20842455,15313375,21106365,22535324,23555086,17627168,20844743,24493355;TRANSCRIPT_ID=NM_004360.3;HGVS_TRANSCRIPT=c.2076T>C;HGVS_PROTEIN=p.A692A;GENE_REGION=Exonic;GENE_SYMBOL=CDH1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000132164.1;ING_MIN_PROTEIN_LENGTH=883	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126114.2;HGVS_TRANSCRIPT=c.672+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276761.1;HGVS_TRANSCRIPT=c.555+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126115.1;HGVS_TRANSCRIPT=c.276+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276695.1;HGVS_TRANSCRIPT=c.555+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276696.1;HGVS_TRANSCRIPT=c.555+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126116.1;HGVS_TRANSCRIPT=c.276+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276760.1;HGVS_TRANSCRIPT=c.555+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276697.1;HGVS_TRANSCRIPT=c.195+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126118.1;HGVS_TRANSCRIPT=c.555+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_000546.5;HGVS_TRANSCRIPT=c.672+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126113.2;HGVS_TRANSCRIPT=c.672+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276699.1;HGVS_TRANSCRIPT=c.195+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001276698.1;HGVS_TRANSCRIPT=c.195+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126117.1;HGVS_TRANSCRIPT=c.276+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	7578115	.	T	C	.	PASS	DBSNP="1625895, 386539980";1000G_AF=83.37;ING_FINDINGS=46;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ING_AFFECTED=3852;ING_AFFECTED_HOM=553;PUBMED=24271138,17096406,21810023,19543528,16039051,17449902,21403619,17634560,17932347,19386249,20445773,19222838,18715757,17428325,19237606,9246190,19423538,18640487,21402718,19276375,19094228,19193430,21268124,14740296,18854777,24336192,21838531,18361427,16172235,21896987,17683073,19626602,17541742,23412385,23716179,19124506,17908995,23029260;TRANSCRIPT_ID=NM_001126112.2;HGVS_TRANSCRIPT=c.672+62A>G;GENE_REGION=Intronic;GENE_SYMBOL=TP53	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	17119761	.	C	T	.	PASS	DBSNP=61750032;1000G_AF=3.29;ESP_AF=3.81;ESP_AF_AA=10.62;ESP_AF_EA=0.33;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Birt-Hogg-Dube syndrome";ESP_PUBLIC_HOMOZYGOTES=25;TRANSCRIPT_ID=NM_144997.5;HGVS_TRANSCRIPT=c.1233G>A;HGVS_PROTEIN=p.E411E;GENE_REGION=Exonic;GENE_SYMBOL=FLCN;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000131066.1;ING_MIN_PROTEIN_LENGTH=580	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	17122286	.	C	T	.	PASS	DBSNP=8065572;1000G_AF=99.58;ESP_AF=99.83;ESP_AF_AA=99.95;ESP_AF_EA=99.77;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Birt-Hogg-Dube syndrome";ESP_PUBLIC_HOMOZYGOTES=6480;TRANSCRIPT_ID=NM_144997.5;HGVS_TRANSCRIPT=c.1062+47G>A;GENE_REGION=Intronic;GENE_SYMBOL=FLCN	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	17122327	.	G	A	.	PASS	DBSNP=8065832;1000G_AF=50.3;ESP_AF=44.91;ESP_AF_AA=36.88;ESP_AF_EA=49.02;ING_FINDINGS=10;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Birt-Hogg-Dube syndrome";ESP_PUBLIC_HOMOZYGOTES=1324;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=43;ING_AFFECTED_HOM=41;PUBMED=14627671,19733897,22146830,17133269;TRANSCRIPT_ID=NM_144997.5;HGVS_TRANSCRIPT=c.1062+6C>T;GENE_REGION=Intronic;GENE_SYMBOL=FLCN	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	17127470	.	C	T	.	PASS	DBSNP=3744123;1000G_AF=6.53;ESP_AF=7.69;ESP_AF_AA=17.64;ESP_AF_EA=2.60;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Birt-Hogg-Dube syndrome";ESP_PUBLIC_HOMOZYGOTES=68;TRANSCRIPT_ID=NM_144606.5;HGVS_TRANSCRIPT=c.397-13G>A;GENE_REGION=Intronic;GENE_SYMBOL=FLCN	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	17127470	.	C	T	.	PASS	DBSNP=3744123;1000G_AF=6.53;ESP_AF=7.69;ESP_AF_AA=17.64;ESP_AF_EA=2.60;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Birt-Hogg-Dube syndrome";ESP_PUBLIC_HOMOZYGOTES=68;TRANSCRIPT_ID=NM_144997.5;HGVS_TRANSCRIPT=c.397-13G>A;GENE_REGION=Intronic;GENE_SYMBOL=FLCN	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29490255	.	C	T	.	PASS	DBSNP=7207410;PHYLOP=4.227E-3;1000G_AF=0.18;ESP_AF=0.40;ESP_AF_AA=1.16;ESP_AF_EA=0.01;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.340C>T;HGVS_PROTEIN=p.L114L;GENE_REGION=Exonic;GENE_SYMBOL=NF1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000129656.1;ING_MIN_PROTEIN_LENGTH=2819	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	29490255	.	C	T	.	PASS	DBSNP=7207410;PHYLOP=4.227E-3;1000G_AF=0.18;ESP_AF=0.40;ESP_AF_AA=1.16;ESP_AF_EA=0.01;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1;TRANSCRIPT_ID=NM_001128147.2;HGVS_TRANSCRIPT=c.340C>T;HGVS_PROTEIN=p.L114L;GENE_REGION=Exonic;GENE_SYMBOL=NF1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=594	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	29490255	.	C	T	.	PASS	DBSNP=7207410;PHYLOP=4.227E-3;1000G_AF=0.18;ESP_AF=0.40;ESP_AF_AA=1.16;ESP_AF_EA=0.01;ING_FINDINGS=1;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.340C>T;HGVS_PROTEIN=p.L114L;GENE_REGION=Exonic;GENE_SYMBOL=NF1;TRANSLATION_IMPACT=synonymous;BLOSUM50=5;ING_MIN_PROTEIN_LENGTH=2840	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	29545987	.	A	AT	.	PASS	DBSNP=67472948;1000G_AF=51.88;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=24413922;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.1528-36_1528-35insT;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29545987	.	A	AT	.	PASS	DBSNP=67472948;1000G_AF=51.88;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=24413922;TRANSCRIPT_ID=NM_001128147.2;HGVS_TRANSCRIPT=c.1528-36_1528-35insT;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29545987	.	A	AT	.	PASS	DBSNP=67472948;1000G_AF=51.88;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ING_AFFECTED=1;ING_AFFECTED_HOM=1;PUBMED=24413922;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.1528-36_1528-35insT;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29553485	.	G	A	.	PASS	DBSNP=2285892;1000G_AF=49.68;ESP_AF=41.63;ESP_AF_AA=66.48;ESP_AF_EA=28.91;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1340;ING_AFFECTED=9;ING_AFFECTED_HOM=3;PUBMED=21102627,23322702,24413922,25480383,16944272,17551851,10712197;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.2034G>A;HGVS_PROTEIN=p.P678P;GENE_REGION=Exonic;GENE_SYMBOL=NF1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=2819	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29553485	.	G	A	.	PASS	DBSNP=2285892;1000G_AF=49.68;ESP_AF=41.63;ESP_AF_AA=66.48;ESP_AF_EA=28.91;ING_FINDINGS=8;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1340;ING_AFFECTED=9;ING_AFFECTED_HOM=3;PUBMED=21102627,23322702,24413922,25480383,16944272,17551851,10712197;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.2034G>A;HGVS_PROTEIN=p.P678P;GENE_REGION=Exonic;GENE_SYMBOL=NF1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=2840	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29559932	.	C	A	.	PASS	DBSNP=2066736;1000G_AF=45.81;ESP_AF=39.04;ESP_AF_AA=59.06;ESP_AF_EA=28.78;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1122;ING_AFFECTED=19;ING_AFFECTED_HOM=3;PUBMED=23322702,24413922,25480383,15146469,12552569;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.3496+33C>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29559932	.	C	A	.	PASS	DBSNP=2066736;1000G_AF=45.81;ESP_AF=39.04;ESP_AF_AA=59.06;ESP_AF_EA=28.78;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=1122;ING_AFFECTED=19;ING_AFFECTED_HOM=3;PUBMED=23322702,24413922,25480383,15146469,12552569;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.3496+33C>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29563085	.	T	G	.	PASS	DBSNP=72813695;1000G_AF=9.88;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.3974+46T>G;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29563085	.	T	G	.	PASS	DBSNP=72813695;1000G_AF=9.88;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.3974+46T>G;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29653293	.	T	C	.	PASS	DBSNP=9894648;1000G_AF=60.58;ESP_AF=67.67;ESP_AF_AA=75.33;ESP_AF_EA=63.74;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=2999;ING_AFFECTED=9;PUBMED=24413922,17052657,25480383,11735023,16944272,10712197,10980545;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.5205+23T>C;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29653293	.	T	C	.	PASS	DBSNP=9894648;1000G_AF=60.58;ESP_AF=67.67;ESP_AF_AA=75.33;ESP_AF_EA=63.74;ING_FINDINGS=7;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=2999;ING_AFFECTED=9;PUBMED=24413922,17052657,25480383,11735023,16944272,10712197,10980545;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.5268+23T>C;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29663625	.	T	A	.	PASS	DBSNP=7406039;1000G_AF=47.34;ESP_AF=0.46;ESP_AF_AA=0.53;ESP_AF_EA=0.42;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=6;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.6085-28T>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29663625	.	T	A	.	PASS	DBSNP=7406039;1000G_AF=47.34;ESP_AF=0.46;ESP_AF_AA=0.53;ESP_AF_EA=0.42;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=6;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.6148-28T>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29664645	.	T	A	.	PASS	DBSNP=17883614;1000G_AF=14.34;ESP_AF=9.60;ESP_AF_AA=27.36;ESP_AF_EA=0.65;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=231;ING_AFFECTED=5;PUBMED=25480383,15146469,16944272,10712197;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.6579+45T>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29664645	.	T	A	.	PASS	DBSNP=17883614;1000G_AF=14.34;ESP_AF=9.60;ESP_AF_AA=27.36;ESP_AF_EA=0.65;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=231;ING_AFFECTED=5;PUBMED=25480383,15146469,16944272,10712197;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.6642+45T>A;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29670190	.	C	G	.	PASS	DBSNP=7405740;1000G_AF=87.38;ESP_AF=88.31;ESP_AF_AA=81.27;ESP_AF_EA=91.91;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=5074;ING_AFFECTED=6;ING_AFFECTED_HOM=3;PUBMED=23322702,24413922,25480383,16199547,16944272;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.7126+37C>G;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29670190	.	C	G	.	PASS	DBSNP=7405740;1000G_AF=87.38;ESP_AF=88.31;ESP_AF_AA=81.27;ESP_AF_EA=91.91;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=5074;ING_AFFECTED=6;ING_AFFECTED_HOM=3;PUBMED=23322702,24413922,25480383,16199547,16944272;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.7189+37C>G;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	29676104	.	CTTGT	C	.	PASS	DBSNP=149197458;1000G_AF=3.75;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.7127-33_7127-30delTTGT;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29676104	.	CTTGT	C	.	PASS	DBSNP=149197458;1000G_AF=3.75;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.7190-33_7190-30delTTGT;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29677184	.	C	T	.	PASS	DBSNP=17884859;1000G_AF=0.7;ESP_AF=0.83;ESP_AF_AA=2.29;ESP_AF_EA=0.08;ING_FINDINGS=3;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=24413922,10712197;TRANSCRIPT_ID=NM_000267.3;HGVS_TRANSCRIPT=c.7259-17C>T;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	29677184	.	C	T	.	PASS	DBSNP=17884859;1000G_AF=0.7;ESP_AF=0.83;ESP_AF_AA=2.29;ESP_AF_EA=0.08;ING_FINDINGS=3;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="neurofibromatosis 1";ESP_PUBLIC_HOMOZYGOTES=2;ING_AFFECTED=2;PUBMED=24413922,10712197;TRANSCRIPT_ID=NM_001042492.2;HGVS_TRANSCRIPT=c.7322-17C>T;GENE_REGION=Intronic;GENE_SYMBOL=NF1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NM_007300.3;HGVS_TRANSCRIPT=c.3418A>G;HGVS_PROTEIN=p.S1140G;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=1885	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NM_007297.3;HGVS_TRANSCRIPT=c.3277A>G;HGVS_PROTEIN=p.S1093G;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=0;ING_MIN_PROTEIN_LENGTH=1817	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NM_007294.3;HGVS_TRANSCRIPT=c.3418A>G;HGVS_PROTEIN=p.S1140G;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=0;CLINVAR_OBSERVATIONS=32;CLINVAR="BIC; RCV000112092.2; RCV000048187.3";ING_MIN_PROTEIN_LENGTH=1864	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NR_027676.1;GENE_REGION=ncRNA;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NM_007299.3;HGVS_TRANSCRIPT=c.788-1081A>G;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244130	.	T	C	.	PASS	DBSNP=386561654;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=1.0;ESP_AF=1.05;ESP_AF_AA=3.09;ESP_AF_EA=0.01;ING_FINDINGS=58;ING_CLASSIFICATION="Likely Benign";ING_PHENOTYPE="hereditary breast cancer";ESP_PUBLIC_HOMOZYGOTES=2;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=271;ING_AFFECTED_HOM=16;ING_UNAFFECTED=7;PUBMED=23867111,18284688,16397213,16014699,10800284,17453335,15937982,22034289,16267036,20167696,10480351,17341484,16234499,8644752,18973698,12531920,11030417,22753008,18559594,24728327,15385441,22711857,19593635,25085752,22684231,20858050,19370767,15726418,11183185,9150171,24916970,18273839,24884479,23704879,18418466,16103107,19491284,9544765,12491487,16574953,23231788,23113073,21120943,21520273,21990134,15235020,20104584,21918854,8872468,16758124,8898983,24312913,22425665,23192404,10612800,22703879,23249957;TRANSCRIPT_ID=NM_007298.3;HGVS_TRANSCRIPT=c.788-1081A>G;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NM_007300.3;HGVS_TRANSCRIPT=c.2612C>T;HGVS_PROTEIN=p.P871L;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=1885	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NM_007297.3;HGVS_TRANSCRIPT=c.2471C>T;HGVS_PROTEIN=p.P824L;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;ING_MIN_PROTEIN_LENGTH=1817	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NM_007294.3;HGVS_TRANSCRIPT=c.2612C>T;HGVS_PROTEIN=p.P871L;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=-4;CLINVAR_OBSERVATIONS=806;CLINVAR="BIC; RCV000111903.3; RCV000132149.1; RCV000114986.1";ING_MIN_PROTEIN_LENGTH=1864	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NR_027676.1;GENE_REGION=ncRNA;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NM_007299.3;HGVS_TRANSCRIPT=c.787+1825C>T;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41244936	.	G	A	.	PASS	DBSNP="386614652, 799917";SIFT_FUNCTION=Activating;POLYPHEN_FUNCTION=Benign;1000G_AF=54.39;ESP_AF=49.32;ESP_AF_AA=80.00;ESP_AF_EA=33.59;ING_FINDINGS=435;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast cancer";ING_PGX_DRUGS="anthracycline/cyclophosphamide chemotherapy regimen,cyclophosphamide/5-fluorouracil/methotrexate";ESP_PUBLIC_HOMOZYGOTES=1889;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=19276;ING_AFFECTED_HOM=2153;ING_UNAFFECTED=61;PUBMED=21765009,22921312,17221156,16014699,15172753,23674270,10070866,17591842,20807450,17591844,22652532,16084575,11933198,22034289,15944772,16515586,11556835,11556836,21708019,19656415,25418591,18973698,17233897,12070551,19185836,10548311,16465413,11462239,19656164,24052750,12505256,15726418,20332227,21147080,21203900,11183185,25483746,24504028,19941162,12602912,19205873,18413725,10980541,22486713,15918047,10196379,15235020,21890493,10502781,12827452,10479726,21603858,11149425,18284688,17317153,20127978,11248423,9523200,17902052,19912264,18512148,15743496,23175448,8634698,10340909,12188064,24372583,15998910,15353005,11149413,12531920,18559551,11102978,11199332,23984822,19012246,18334730,20858050,22752604,19012493,12872265,24853695,19619314,22933969,12872263,19484476,17039264,18830263,12684407,19482343,15924337,21161372,24502646,17428325,9063749,21042765,15146556,11013445,12007222,12402332,23996866,12491487,21520273,12955716,24062231,25114582,14507240,15365993,24729269,8900426,18951449,18500671,22425665,8531968,15735322,17452776,16683254,19638463,22703879,17088437,16949048,23749772,15162129,21050672,16397213,19352458,11044644,8776600,10480358,22713736,16267036,18491400,22426013,8807330,18288416,15001988,19672706,18824251,24986639,10424822,10528853,18431501,17108146,15159312,19370767,21702907,22136207,17719744,15138483,18763032,18844490,14555511,24756092,24289560,16111488,10406662,22366370,15168169,18694767,10200350,21204206,20223018,16956909,16103107,19751749,17250666,16939956,15681486,12457999,21156238,23315985,21129811,17100994,16308313,18431737,14734460,17661172,12815604,7545954,8898983,21232165,23961350,11284041,15933498,24933103,25136594,8566965,10728701,21305653,21287534,18662409,9654203,17453335,22874498,17219973,10686936,15937982,23635950,19471317,25273865,20167696,20003265,17174087,19661094,22753153,25069792,22753008,10932184,12655560,23034506,24728327,15385441,21410590,23415752,22684231,20331623,20731661,11733976,18311584,14684619,12053566,17333343,25194442,12142080,12442274,18273839,24884479,10408690,15890268,25337278,16835750,22277901,12481264,19287957,20864405,10323242,23113073,10644434,19623759,21990134,22065914,22913592,9685507,23555315,20104584,23817386,15256476,17922257,8872468,16758124,23964347,24312913,20352487,16026807,23249957;TRANSCRIPT_ID=NM_007298.3;HGVS_TRANSCRIPT=c.787+1825C>T;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:gain
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NM_007300.3;HGVS_TRANSCRIPT=c.2155A>G;HGVS_PROTEIN=p.K719E;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=1885	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NM_007297.3;HGVS_TRANSCRIPT=c.2014A>G;HGVS_PROTEIN=p.K672E;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=1;ING_MIN_PROTEIN_LENGTH=1817	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NM_007294.3;HGVS_TRANSCRIPT=c.2155A>G;HGVS_PROTEIN=p.K719E;GENE_REGION=Exonic;GENE_SYMBOL=BRCA1;TRANSLATION_IMPACT=missense;BLOSUM50=1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000047732.2;ING_MIN_PROTEIN_LENGTH=1864	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NR_027676.1;GENE_REGION=ncRNA;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NM_007299.3;HGVS_TRANSCRIPT=c.787+1368A>G;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	41245393	.	T	C	.	PASS	DBSNP=80357147;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=0.02;ESP_AF=0.04;ESP_AF_AA=0.11;ESP_AF_EA=0.00;ING_FINDINGS=2;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast cancer";ING_AFFECTED=1;PUBMED=15385441,12531920,16267036,15001988;TRANSCRIPT_ID=NM_007298.3;HGVS_TRANSCRIPT=c.787+1368A>G;GENE_REGION=Intronic;GENE_SYMBOL=BRCA1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	56787258	.	T	C	.	PASS	DBSNP=150142859;ESP_AF=0.02;ESP_AF_AA=0.05;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="hereditary breast and/or ovarian cancer";TRANSCRIPT_ID=NM_058216.2;HGVS_TRANSCRIPT=c.744T>C;HGVS_PROTEIN=p.F248F;GENE_REGION=Exonic;GENE_SYMBOL=RAD51C;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=377	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr17	58677865	.	G	A	.	PASS	DBSNP=16944543;1000G_AF=5.37;ESP_AF=4.98;ESP_AF_AA=14.60;ESP_AF_EA=0.06;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=40;ING_AFFECTED=1;PUBMED=23649806;TRANSCRIPT_ID=NM_003620.3;HGVS_TRANSCRIPT=c.90G>A;HGVS_PROTEIN=p.E30E;GENE_REGION=Exonic;GENE_SYMBOL=PPM1D;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=606	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	59760996	.	A	G	.	PASS	DBSNP=4986763;1000G_AF=62.08;ESP_AF=60.60;ESP_AF_AA=64.35;ESP_AF_EA=58.69;ING_FINDINGS=15;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=2397;ING_AFFECTED=939;ING_AFFECTED_HOM=207;PUBMED=24301948,19935797,24853695,18414782,21279724,23473757,17557904,16280053,19276285,21409391,18270339,23644138,22692731;TRANSCRIPT_ID=NM_032043.2;HGVS_TRANSCRIPT=c.3411T>C;HGVS_PROTEIN=p.Y1137Y;GENE_REGION=Exonic;GENE_SYMBOL=BRIP1;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1250	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	59763114	.	A	T	.	PASS	DBSNP=4988357;1000G_AF=34.31;ING_FINDINGS=4;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ING_AFFECTED=102;ING_AFFECTED_HOM=11;ING_UNAFFECTED=27;PUBMED=18414782,12872252,18270339;TRANSCRIPT_ID=NM_032043.2;HGVS_TRANSCRIPT=c.2905+83T>A;GENE_REGION=Intronic;GENE_SYMBOL=BRIP1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr17	59763347	.	A	G	.	PASS	DBSNP=4986764;SIFT_FUNCTION=Tolerated;POLYPHEN_FUNCTION=Benign;1000G_AF=62.78;ESP_AF=61.34;ESP_AF_AA=66.11;ESP_AF_EA=58.90;ING_FINDINGS=43;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=2453;ING_COMPLEX_VARIANT=Y;ING_AFFECTED=5960;ING_AFFECTED_HOM=1715;PUBMED=16430786,24301948,19012493,16485136,23318652,19127258,19484476,22183965,23473757,17764108,17557904,17342202,15113441,18270339,23644138,20150366,22692731,19935797,25069792,21279724,23555315,24137204,24728327,23225146,24312913,19276285,17504528,21409391,19714462,21984973;TRANSCRIPT_ID=NM_032043.2;HGVS_TRANSCRIPT=c.2755T>C;HGVS_PROTEIN=p.S919P;GENE_REGION=Exonic;GENE_SYMBOL=BRIP1;TRANSLATION_IMPACT=missense;BLOSUM50=-1;CLINVAR_OBSERVATIONS=1;CLINVAR=RCV000132148.1;ING_MIN_PROTEIN_LENGTH=1250	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	59763465	.	T	C	.	PASS	DBSNP="386596996, 4986765";1000G_AF=81.51;ESP_AF=73.43;ESP_AF_AA=88.81;ESP_AF_EA=65.55;ING_FINDINGS=10;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=3593;ING_AFFECTED=892;ING_AFFECTED_HOM=119;PUBMED=17342202,19935797,24853695,18414782,19276285,21279724,21409391,18270339,17557904,22692731;TRANSCRIPT_ID=NM_032043.2;HGVS_TRANSCRIPT=c.2637A>G;HGVS_PROTEIN=p.E879E;GENE_REGION=Exonic;GENE_SYMBOL=BRIP1;TRANSLATION_IMPACT=synonymous;BLOSUM50=6;ING_MIN_PROTEIN_LENGTH=1250	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr17	59857809	.	C	G	.	PASS	DBSNP=4988351;1000G_AF=78.97;ESP_AF=78.59;ESP_AF_AA=85.69;ESP_AF_EA=74.95;ING_FINDINGS=2;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary breast and/or ovarian cancer";ESP_PUBLIC_HOMOZYGOTES=4043;ING_AFFECTED=1240;ING_AFFECTED_HOM=754;PUBMED=23225146,16485136,19536649;TRANSCRIPT_ID=NM_032043.2;HGVS_TRANSCRIPT=c.1795-47G>C;GENE_REGION=Intronic;GENE_SYMBOL=BRIP1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	1218384	.	C	T	.	PASS	DBSNP=57281474;1000G_AF=4.27;ESP_AF=4.30;ESP_AF_AA=12.90;ESP_AF_EA=0.04;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="Peutz Jegher syndrome";ESP_PUBLIC_HOMOZYGOTES=43;PUBMED=16407837;TRANSCRIPT_ID=NM_000455.4;HGVS_TRANSCRIPT=c.291-32C>T;GENE_REGION=Intronic;GENE_SYMBOL=STK11	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128844.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128846.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_003072.3;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128848.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128849.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128845.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11102007	.	C	T	.	PASS	DBSNP=115492175;1000G_AF=1.1;ESP_AF=1.30;ESP_AF_AA=3.83;ESP_AF_EA=0.01;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=2;TRANSCRIPT_ID=NM_001128847.1;HGVS_TRANSCRIPT=c.1419+8C>T;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128844.1;HGVS_TRANSCRIPT=c.4425-35A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128846.1;HGVS_TRANSCRIPT=c.4335-38A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_003072.3;HGVS_TRANSCRIPT=c.4425-35A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128848.1;HGVS_TRANSCRIPT=c.4326-38A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128849.1;HGVS_TRANSCRIPT=c.4521-35A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128845.1;HGVS_TRANSCRIPT=c.4335-35A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11168896	.	A	G	.	PASS	DBSNP=8104480;1000G_AF=38.72;ESP_AF=39.85;ESP_AF_AA=52.63;ESP_AF_EA=33.30;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=1163;TRANSCRIPT_ID=NM_001128847.1;HGVS_TRANSCRIPT=c.4326-35A>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCA4	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128844.1;HGVS_TRANSCRIPT=c.4887T>C;HGVS_PROTEIN=p.D1629D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1648	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128846.1;HGVS_TRANSCRIPT=c.4794T>C;HGVS_PROTEIN=p.D1598D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1617	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_003072.3;HGVS_TRANSCRIPT=c.4887T>C;HGVS_PROTEIN=p.D1629D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1648	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128848.1;HGVS_TRANSCRIPT=c.4785T>C;HGVS_PROTEIN=p.D1595D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1614	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128849.1;HGVS_TRANSCRIPT=c.4983T>C;HGVS_PROTEIN=p.D1661D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1680	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128845.1;HGVS_TRANSCRIPT=c.4797T>C;HGVS_PROTEIN=p.D1599D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1618	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	11170839	.	T	C	.	PASS	DBSNP=7275;1000G_AF=24.98;ESP_AF=25.95;ESP_AF_AA=26.84;ESP_AF_EA=25.50;ING_FINDINGS=6;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="non small cell lung adenocarcinoma";ESP_PUBLIC_HOMOZYGOTES=396;ING_AFFECTED=8;PUBMED=23619168,18660489;TRANSCRIPT_ID=NM_001128847.1;HGVS_TRANSCRIPT=c.4788T>C;HGVS_PROTEIN=p.D1596D;GENE_REGION=Exonic;GENE_SYMBOL=SMARCA4;TRANSLATION_IMPACT=synonymous;BLOSUM50=8;ING_MIN_PROTEIN_LENGTH=1615	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	50909389	.	T	G	.	PASS	DBSNP=1673041;1000G_AF=70.45;ESP_AF=81.09;ESP_AF_AA=89.95;ESP_AF_EA=76.55;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=4295;ING_DRUGGED_GENE=Y;PUBMED=18270339;TRANSCRIPT_ID=NM_001256849.1;HGVS_TRANSCRIPT=c.1243-50T>G;GENE_REGION=Intronic;GENE_SYMBOL=POLD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	50909389	.	T	G	.	PASS	DBSNP=1673041;1000G_AF=70.45;ESP_AF=81.09;ESP_AF_AA=89.95;ESP_AF_EA=76.55;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=4295;ING_DRUGGED_GENE=Y;PUBMED=18270339;TRANSCRIPT_ID=NM_002691.3;HGVS_TRANSCRIPT=c.1243-50T>G;GENE_REGION=Intronic;GENE_SYMBOL=POLD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	50919797	.	C	T	.	PASS	DBSNP=3218776;1000G_AF=40.83;ESP_AF=58.10;ESP_AF_AA=36.49;ESP_AF_EA=69.19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=2449;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_001256849.1;HGVS_TRANSCRIPT=c.2953+12C>T;GENE_REGION=Intronic;GENE_SYMBOL=POLD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr19	50919797	.	C	T	.	PASS	DBSNP=3218776;1000G_AF=40.83;ESP_AF=58.10;ESP_AF_AA=36.49;ESP_AF_EA=69.19;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="colorectal cancer";ESP_PUBLIC_HOMOZYGOTES=2449;ING_DRUGGED_GENE=Y;TRANSCRIPT_ID=NM_002691.3;HGVS_TRANSCRIPT=c.2953+12C>T;GENE_REGION=Intronic;GENE_SYMBOL=POLD1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr21	36164486	.	G	C	.	PASS	DBSNP=61750222;1000G_AF=5.83;ESP_AF=3.06;ESP_AF_AA=7.76;ESP_AF_EA=0.77;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="acute myeloid leukemia";ESP_PUBLIC_HOMOZYGOTES=5;ING_AFFECTED=1;PUBMED=19808697;TRANSCRIPT_ID=NM_001001890.2;HGVS_TRANSCRIPT=c.1308C>G;HGVS_PROTEIN=p.P436P;GENE_REGION=Exonic;GENE_SYMBOL=RUNX1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=454	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr21	36164486	.	G	C	.	PASS	DBSNP=61750222;1000G_AF=5.83;ESP_AF=3.06;ESP_AF_AA=7.76;ESP_AF_EA=0.77;ING_FINDINGS=1;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="acute myeloid leukemia";ESP_PUBLIC_HOMOZYGOTES=5;ING_AFFECTED=1;PUBMED=19808697;TRANSCRIPT_ID=NM_001754.4;HGVS_TRANSCRIPT=c.1389C>G;HGVS_PROTEIN=p.P463P;GENE_REGION=Exonic;GENE_SYMBOL=RUNX1;TRANSLATION_IMPACT=synonymous;BLOSUM50=10;ING_MIN_PROTEIN_LENGTH=481	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr21	36206932	.	G	A	.	PASS	DBSNP=11702841;1000G_AF=100.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="acute myeloid leukemia";TRANSCRIPT_ID=NM_001001890.2;HGVS_TRANSCRIPT=c.533-34C>T;GENE_REGION=Intronic;GENE_SYMBOL=RUNX1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr21	36206932	.	G	A	.	PASS	DBSNP=11702841;1000G_AF=100.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="acute myeloid leukemia";TRANSCRIPT_ID=NM_001122607.1;HGVS_TRANSCRIPT=c.533-34C>T;GENE_REGION=Intronic;GENE_SYMBOL=RUNX1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr21	36206932	.	G	A	.	PASS	DBSNP=11702841;1000G_AF=100.0;ESP_AF=0.00;ESP_AF_AA=0.00;ESP_AF_EA=0.00;ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="acute myeloid leukemia";TRANSCRIPT_ID=NM_001754.4;HGVS_TRANSCRIPT=c.614-34C>T;GENE_REGION=Intronic;GENE_SYMBOL=RUNX1	GT:CQ:DP:AF:ING_CH:ING_IA	1/1:.:.:.:.:normal
chr22	24143502	.	C	G	.	PASS	DBSNP=738797;1000G_AF=71.17;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rhabdoid tumor";PUBMED=24728327;TRANSCRIPT_ID=NM_003073.3;HGVS_TRANSCRIPT=c.500+234C>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	24143502	.	C	G	.	PASS	DBSNP=738797;1000G_AF=71.17;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="rhabdoid tumor";PUBMED=24728327;TRANSCRIPT_ID=NM_001007468.1;HGVS_TRANSCRIPT=c.473+234C>G;GENE_REGION=Intronic;GENE_SYMBOL=SMARCB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	24176677	.	G	GCAACAGGTCATGTTCAATTTCTT	.	PASS	ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="rhabdoid tumor";TRANSCRIPT_ID=NM_003073.3;HGVS_TRANSCRIPT=c.*310_*311insCAACAGGTCATGTTCAATTTCTT;GENE_REGION=3'UTR;GENE_SYMBOL=SMARCB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr22	24176677	.	G	GCAACAGGTCATGTTCAATTTCTT	.	PASS	ING_CLASSIFICATION="Uncertain Significance";ING_PHENOTYPE="rhabdoid tumor";TRANSCRIPT_ID=NM_001007468.1;HGVS_TRANSCRIPT=c.*310_*311insCAACAGGTCATGTTCAATTTCTT;GENE_REGION=3'UTR;GENE_SYMBOL=SMARCB1	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:loss
chr22	29130347	.	G	GT	.	PASS	DBSNP=3841692;1000G_AF=23.04;ESP_AF=14.24;ESP_AF_AA=9.62;ESP_AF_EA=16.62;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=141;ING_AFFECTED=590;ING_AFFECTED_HOM=32;PUBMED=18297428,15239132,14612911,21356067,11479205,12917215,23806170;TRANSCRIPT_ID=NM_145862.2;HGVS_TRANSCRIPT=c.319+43_319+44insA;GENE_REGION=Intronic;GENE_SYMBOL=CHEK2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	29130347	.	G	GT	.	PASS	DBSNP=3841692;1000G_AF=23.04;ESP_AF=14.24;ESP_AF_AA=9.62;ESP_AF_EA=16.62;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=141;ING_AFFECTED=590;ING_AFFECTED_HOM=32;PUBMED=18297428,15239132,14612911,21356067,11479205,12917215,23806170;TRANSCRIPT_ID=NM_001005735.1;HGVS_TRANSCRIPT=c.319+43_319+44insA;GENE_REGION=Intronic;GENE_SYMBOL=CHEK2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	29130347	.	G	GT	.	PASS	DBSNP=3841692;1000G_AF=23.04;ESP_AF=14.24;ESP_AF_AA=9.62;ESP_AF_EA=16.62;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=141;ING_AFFECTED=590;ING_AFFECTED_HOM=32;PUBMED=18297428,15239132,14612911,21356067,11479205,12917215,23806170;TRANSCRIPT_ID=NM_007194.3;HGVS_TRANSCRIPT=c.319+43_319+44insA;GENE_REGION=Intronic;GENE_SYMBOL=CHEK2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	29130347	.	G	GT	.	PASS	DBSNP=3841692;1000G_AF=23.04;ESP_AF=14.24;ESP_AF_AA=9.62;ESP_AF_EA=16.62;ING_FINDINGS=9;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="hereditary neoplastic syndrome";ESP_PUBLIC_HOMOZYGOTES=141;ING_AFFECTED=590;ING_AFFECTED_HOM=32;PUBMED=18297428,15239132,14612911,21356067,11479205,12917215,23806170;TRANSCRIPT_ID=NM_001257387.1;HGVS_TRANSCRIPT=c.-459+43insA;GENE_REGION=Intronic;GENE_SYMBOL=CHEK2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181828.2;HGVS_TRANSCRIPT=c.238-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181833.2;HGVS_TRANSCRIPT=c.364-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181832.2;HGVS_TRANSCRIPT=c.364-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181829.2;HGVS_TRANSCRIPT=c.241-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181830.2;HGVS_TRANSCRIPT=c.115-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_000268.3;HGVS_TRANSCRIPT=c.364-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181831.2;HGVS_TRANSCRIPT=c.115-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_181825.2;HGVS_TRANSCRIPT=c.364-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
chr22	30038152	.	A	C	.	PASS	DBSNP=2530664;1000G_AF=21.47;ESP_AF=13.24;ESP_AF_AA=4.33;ESP_AF_EA=17.80;ING_CLASSIFICATION=Benign;ING_PHENOTYPE="neurofibromatosis 2";ESP_PUBLIC_HOMOZYGOTES=137;TRANSCRIPT_ID=NM_016418.5;HGVS_TRANSCRIPT=c.364-39A>C;GENE_REGION=Intronic;GENE_SYMBOL=NF2	GT:CQ:DP:AF:ING_CH:ING_IA	0/1:.:.:.:.:normal
